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ABSTRACT 
Background Chronic fatigue syndrome (CFS) is characterised by chronic disabling fatigue 
affecting physical and mental function, whereby sufferers can enter a cycle of symptoms, 
avoidance, inactivity, decreased exercise tolerance, fatigue and depression. There are no 
established treatments for CFS and sufferers are often advised to rest, which can lead to 
physical deconditioning and few studies have measured both physiological and psychological 
parameters in the same group of patients. The aims of this study were to compare 
physiological and psychological measures on CFS patients with those of healthy, sedentary 
individuals and then to monitor and examine the efficacy of a graded exercise programme and 
compare this with a control treatment of relaxation and flexibility training on selected 
physiological and symptomatic parameters in patients with CFS. 
Methods Sixty-six subjects with the chronic fatigue syndrome, who had neither a psychiatric 
disorder nor significant sleep disturbance, and 30 healthy sedentary controls and 10 depressed 
patients were recruited, Physiological measurements included a treadmill walking test for 
assessment of maximum aerobic capacity and submaximal exercise tolerance, resting lung 
function, twitch interpolated isometric quadriceps strength, body fat and self-rated 
psychological questionnaires assessed physical and mental fatigue, general health, physical 
and social function, depression and anxiety. Equal numbers of the CFS patients were then 
randomly allocated to 12 weeks of either graded aerobic exercise or flexibility exercises and 
relaxation therapy. The main outcome measure was the self-rated clinical global change 
score, considering "very much better" or "much better" as clinically important 
improvements. Other outcome measures included fatigue, mood and functional capacity as 
well as physiological measures. Those subjects who completed the flexibility programme 
were invited to cross over to the exercise programme afterwards. All subjects were 
reassessed physiologically and symptomatically immediately after completion of either 
treatment and 3 months after completion, with a postal follow-up I year after completion. 
Findings Compared with healthy sedentary controls CFS patients had a significantly lower 
peak oxygen uptake, test duration, post-test blood lactate, peak heart rate and isometric leg 
strength, along with higher levels of physical and mental fatigue and a lower ratings on 
general health and ftinctional capacity. The CFS and depressed patients were equally 
deconditioned, but CFS patients differed in mental and emotional health status and had a 
lower perception to functional capacity. On the treatment trial, 4 subjects receiving exercise 
and 3 having flexibility dropped out before completion. 16/29 (55 %) of subjects rated 
themselves better after exercise, compared to 8/30 (27 %) who completed the flexibility 
treatment (X2 = 3.9,1 df, p=0.03)(28 % difference, 95% ci = 4,52%). Analysing by 
intention to treat gave similar results. No significant differences were observed in any 
physiological measures between the two groups at baseline. After treatment significant 
differences were observed in peak V02, maximum ventilation and in heart rate and perceived 
exertion rating at all submaximal levels stages in the walking test, between the groups after 
treatment. Significant intergroup differences were observed in physical and total fatigue, 
physical ftinction and general health after treatment. 12/22 (55 %) of those subjects who 
crossed over from flexibility to exercise rated themselves better after completing the exercise 
treatment. 32/47 (68 %) of subjects felt better three months after completing exercise 
treatment, with physiological and symptomatic improvements maintained. 36/47 (76 %) 
subjects rated themselves better 18 months after starting the exercise treatment. 
Interpretation These findings support the use of appropriately prescribed aerobic exercise in 
the management of patients with the chronic fatigue syndrome. 
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CHAPTER ONE: INTRODUCTION 
Several chronic medical conditions involve considerable bedrest and inactivity, whether in the 
rehabilitation and recovery from disease or as a consequence of long-term illness. As early 
as 1949, Taylor demonstrated that bedrest leads to severe deconditioning in healthy, athletic 
young men (Taylor, 1949), and later Saltin (1968) recorded a 30% loss of aerobic capacity 
after only 3 weeks of bedrest in trained individuals. In the same manner, chronic disease 
typically leads to a cycle of decreased physical activity (often bedrest), which results in 
deconditioning and a cycle of symptoms associated with decreased functional capacity and 
increased fatigue, which further reduces physical activity. Disease exacerbations tend to 
speed up this debilitative cycle. This can also have adverse psychological consequences, as 
individuals develop a dependency on others for support which can, in turn, lead to 
depression, frustration and anxiety, and ffirther avoidance of activity. To break these cycles, 
exercise therapy is increasingly being advocated in the treatment of several chronic illnesses, 
such as arthritis, osteoporosis, diabetes and chronic hypertension (Basmajian & Wolf, 1990; 
Carlucci, 1991). Exercise therapy can have very positive and beneficial psychological effects 
as well as the well-documented physiological effects (Moses, 1989; Morgan, 1985). Some 
studies have also shown exercise to be equally as effective as traditional psychotherapy and 
drug therapy in the treatment of depression (Martinsen, 1990). 
Although disuse and ageing are not synonymous, they do share common attributes, and much 
recent research has demonstrated the benefit of structured physical activity programmes with 
the elderly (Mengshael, 1995), which suggests the potential beneficial effects of a similar 
approach with certain chronic illnesses. 
Recent research points to a need for a more dynamic approach towards treatment of chronic 
illness with a move away from long term rest towards progressive exercise (Frost et al, 1995; 
Goldstein et al, 1994). Few studies have measured physiological and psychological changes 
associated with a progressive, graded exercise programme in the same group of patients. 
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This thesis discusses a study which examines both the physiological, psychological and 
symptomatic measures before and after a graded exercise programme in a group of patients 
diagnosed as having Chronic Fatigue Syndrome (CFS). The key feature of this illness is 
chronic or recurrent debilitating fatigue exacerbated by physical and mental effort and 
associated with a prolonged recovery time. The fatigue experienced after physical effort is 
greater than would be expected from the intensity of the activity and greater than previously 
experienced by the patient. This state can last up to several years. There are no specific 
diagnostic tests and several potential causes have been proposed for CFS. 
The triggering event is frequently an infection, particularly of viral origin, but other factors 
may potentiate the disease. There are numerous reports on the coexistence of chronic fatigue 
and depression and other psychiatric disorders, and some CFS patients have a history of 
psychiatric disorders prior to the fatigue. Another is that depression is a secondary effect of 
the disability caused by CFS, and this prolonged fatigue can begin a cycle of attributional and 
cognitive factors fuelling avoidant behaviour. Patients can then enter into a vicious circle of 
symptoms, avoidance, inactivity, fatigue and depression. 
Inactivity is known to have a detrimental effect on muscle, as well as on respiratory and 
cardiovascular functions. The evidence to date shows no abnormalities in cardiovascular or 
peripheral muscle response other than what would be expected as a result of deconditioning. 
In addition, CFS patients tend to have an altered perception of effort with any physical 
exertion, which may be associated with a profound fear of exacerbating the symptoms and 
causing a relapse, should they over-exert themselves. 
Initially we compared a group of CFS patients with healthy sedentary individuals and a group 
of patients suffering from major depression, on both physiological and psychological 
measures. This comparison was to determine whether CFS patients were physiologically 
deconditioned (compared to healthy individuals) but dissimilar to depressed patients (on the 
psychological measures), an illness with which they are frequently labelled. The ensuing 
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hypothesis was that a graded and structured exercise programme should have positive 
physiological and symptomatic and outcome effects in CFS patients. 
Since the causes and duration of the chronic fatigue are varied, this approach must be 
individually tailored, graded, realistic and include a very gradual return to physical activity. 
The exercise should be aerobic in nature since cardiovascular and respiratory functions are 
predominately associated with deconditioning. This would support the use of graded exercise 
therapy as a valid treatment for patients suffering from chronic fatigue syndrome. 
The exercise treatment was compared with a more frequently recommended treatment for this 
condition of relaxation and flexibility. Initial baseline measures examined aerobic capacity, 
isometric leg strength, perceived effort rating, blood lactate response to activity and body 
composition, as well as symptomatic measures of physical and mental fatigue, sleep, anxiety, 
depression and general health perceptions. The CFS patients were randomly allocated into 
either a graded aerobic exercise or flexibility and relaxation treatment and reassessed on all 
measures after 12 weeks. Those initially on the flexibility and relaxation programme could 
cross over to the exercise treatment after the first reassessment. The long-term effectiveness 
of the programme was determined by a ftill reassessment at 3 months after treatment 
completion and a postal follow-up 1 year later. Outcome of treatment was determined by 
patient rating of improvement as well as repeated physiological and symptomatic measures. 
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CHAPTER TWO: REVIEW OF LITERAT 
2.1 Definition 
Patients who complain of chronic disabling fatigue of uncertain cause have received much 
attention in recent years. The controversial condition does not lend itself well to normal 
medical concepts, with the complex clinical presentation of patients describing a variety of 
muscular, neurological, psychological and autonomic symptoms in addition to fatigue. 
Numerous outbreaks have been reported over the last 100 years. The most famous of these, 
which was later labelled as rnyalgic encephalornyelitis, was one involving 292 members of 
staff at the Royal Free Hospital, London, in 1955 (Medical staff, 1957), who complained of 
weariness and muscle pain. Before this an epidemic of "neuromyasthemia" affected 198 
employees of Los Angeles County General Hospital, who complained of similar symptoms 
(Gilliam, 1938). Other labels previously given to a similar ranges of symptoms include 
chronic infectious mononucleosis, postviral fatigue syndrome, fibrositis-fibromyalgia, post- 
infectious fatigue syndrome, neuromyasthemia and chronic Epstein-Barr virus infection 
(Wessely, 1993). 
Research into the condition has been approached from several medical and scientific 
disciplines, which are partially responsible for the disparity of terms. In an attempt to address 
this problem of numerous labels for an apparently identical range of symptoms, Holmes and 
colleagues (1988) came up with the label of Chronic Fatigue Syndrome (CFS), which has the 
advantage of referring directly to a major symptom, while making no assumptions about 
aetiology. They also proposed an operational defmition for the syndrome (Appendix A). The 
fatigue must be idiopathic, severe and chronic, but patients must also have at least eight of 
eleven specified symptoms, or at least six of the symptoms together with at least two of three 
specified signs. However, this definition was considered too complicated in application and 
restrictive in scope. Lloyd et al (1988) developed less strict criteria, but these too were 
considered too restrictive, involving tests of cell-mediated immunity. In an attempt to 
remove these obstacles and develop a more workable definition, a meeting of research 
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workers with a known interest in the field was convened. This British consensus meeting in 
Oxford in 1990 developed a simpler and wider definition of two broad syndromes: Chronic 
Fatigue Syndrome and Post-Infectious Fatigue Syndrome (Sharpe et al, 1991). 
From this meeting the Chronic Fatigue Syndrome (CFS) was defined as characterised. by 
severe, disabling fatigue as the principal symptom. The fatigue should be of definite onset 
that is not life long. It should have been present for a minimum of six months and for more 
than 50% of the time. The fatigue must affect physical and mental functioning and other 
symptoms, such as myalgia, mood and sleep disturbance (but a clinical sleep disorder), may 
be present. Patients excluded from the definition are those with established medical 
conditions known to cause fatigue as well as those with a diagnosis of schizophrenia, proven 
organic brain disease, substance abuse, manic depressive illness and eating disorders. Patients 
with other psychiatric disorders such as anxiety or depressive illness need not necessarily be 
excluded. The Post-infectious fatigue syndrome (PIFS) is characterised. by the same 
symptoms as CFS but, in addition there must be definite evidence of an infection at onset or 
presentation and the syndrome must be present for a minimum of 6 months after the onset of 
infection (White et al, 1995; Fukuda et al, 1994). 
2.2 Aetiology 
A definitive cause for the chronic fatigue syndrome has not yet been established and both 
organic and psychological factors have been implicated. Those worthy of discussion in this 
review include viruses, immune. dysfunction, psychological problems, psychiatric disorders, 
sleep disorders, muscle dysfunction and inactivity. 
2.2.1 Viruses 
Some groups believe that CFS is a chronic virus infection and effective treatment must await 
the development anti-viral therapy. The proposal of a viral cause arose from evidence that 
the onset of symptoms, in a large proportion of patients, was preceded by an influenza type 
illness. The viruses incriminated were predominantly enteroviruses in Britain (Youssef et al, 
1988) and Epstein-Barr virus (EBV) in America (Straus et al, 1993). Epstein-Barr virus 
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infects over 95% of humans, most often without producing illness. Infectious mononucleosis 
may develop when the virus infects an adolescent or young adult. Results of several studies in 
the USA (see review, Straus, 1993) reveal that EBV-specific serologies were not helpful in 
the diagnosis of patients with chronic fatigue. There is no good evidence that higher levels of 
antibodies reflect more frequent reactivation of EBV. In a prospective study examining the 
relationship between viral infection and fatigue, White (1995a&b) found that the prevalence 
of fatigue was significantly more common after EBV infections than after upper respiratory 
tract infections, 6 months after onset. However, further evidence from two 
seroepiderniological surveys indicates that EBV is unlikely to be an aetiologic agent in most 
cases of CFS (Horowitz, et al, 1985, Hellinger, 1988). Cytomegalovirus infection has also 
been proposed as a trigger for chronic fatigue, but as with EBV, there is no evidence of 
=Liu CMV in patients with chronic fatigue, although both infections may precede the 
syndrome. Initial findings on herpesviruses indicate a higher prevalence of Human herpes 
virus 6 (HHV6) in the serum of chronic fatigue syndrome patients compared to controls 
(Saxinger et al, 1988). However HHV6 has also been recovered from healthy patients 
(Buchwald et al, 1992) and therefore, its role as a causative factor in CFS is, as yet, 
unconfirmed. 
Enteroviruses are very common in this country and are generally associated with 'summer 
colds'. Although they are highly infectious, most people eliminate the infection within a few 
days. A small minority may retain the infection and may go on to develop CFS symptoms. 
McCartney et al (1986) described a widespread epidemic of an enterovirus. A few of those 
infected appear to be unable to eliminate the virus rapidly, and develop a chronic condition. 
Mowbray (1991) observed that muscle fatigue on exercise was a feature of enteroviral 
Patients more so than EBV patients, suggesting that the latter group tend to show lethargy and 
inanition and do not wish to exercise, in contrast with the very poor exercise tolerance seen 
normally in enteroviral patients. 
The early serological studies of neutralising antibodies to coxsackie viruses suggested a 
possible role for these agents in some cases (Behan et al, 1985), but their use as a diagnostic 
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test was not valid because of the frequency of asymptornatic infections among the population 
(Miller et al 1991). Yousef et al (1988) suggested that the detection of enteroviral antigen 
VP- I was associated with chronic symptomatic infection in up to 45 % of their sample at four 
months. However, Lynch and Seth (1989) found a positive antigen test in 30% of both 
hospital controls and CFS patients, with no differences between the groups. This evidence 
suggested that there was no connection between the severity of symptoms and presence of the 
antigen (Halpin & Wessely, 1989). This group also found similar rates of VPI in depression 
and CFS. Behan et al (1993) detected enteroviral genome sequences in muscle biopsies from 
cases of PIFS, and suggested that it is the presence of persistent virus in muscle, as opposed 
to peripheral blood, that is associated with CFS. This may cause mitochondrial changes that 
lead to cell dysfunction similar to that seen in mitochondrial abnormalities (Behan et al, 
1993). Their results await replication. Evidence exists that there is a specific, self-limiting 
fatigue syndrome following infection with EBV (White et al, 1995) while Hoptof et al (1996) 
found an increased risk of developing CFS after viral meningitis. Psychiatric disorder and 
prolonged convalescence were also found to be predictors of CFS. Both of these recent 
studies suggest that common viral infections do not trigger CFS but several infections do, 
whereby they act as a stressor rather than by any particular molecular process (Cleare & 
Wessely, 1996). 
2.2.2 Ininume Dysfunction 
Both cellular and humoral immune mechanisms participate in the host response to viral and 
other infections. The first line of defence involves natural killer cells. The accompanying 
response involves cytotoxic T cells and cytokines and neutralising antibodies. Immunological 
studies in patients with CFS have examined each of these aspects of the immune response to 
antigen and a wide variety of immunological changes have been reported (For review see 
Buchwald & Komaroff, 1991; Lloyd et al, 1993). As with studies examining persistent virus 
infection as a causative factor in CFS, those examining immune dysftinction report positive 
evidence in some but not all CFS cases. There is evidence of immunologic dysfunction; some 
parameters reflect deficient function while others indicate hyperactivity. It has not been 
9 
shown that these immunologic findings explain the symptomatology of CFS or correlate with 
changes in symptoms over time (Buchwald & Komaroff, 1991). The data on immune 
dysfunction has been somewhat limited to date both by the heterogeneity within the patient 
groups studied and by the lack of standardisation of the available assays. Lloyd et al (1993) 
has suggested that, since the evidence establishing a causal link between abnormal immunity 
and CFS has not been found, the alterations are secondary to an undefined underlying disease 
process or co-factor. 
Numerous other immune system abnormalities have been reported in CFS patients, including 
functional deficiency in natural killer cells (Caligiuri, 1987). This has been referred to as 
chronic fatigue immune deficiency syndrome and is characterised by fatigue, remittent fever, 
and lowered natural killer cell activity. 
2.2.3 Psychiatric Disorders 
Some authors believe that CFS is predominantly a depressive disorder (Greenberg, 1990) and 
is best treated with antidepressive drug therapy. Both fatigue (physical and mental) and 
muscular pain are prominent symptoms of depressive disorders (Stoeckle & Zola, 1964), so 
that CFS patients' symptoms are sometimes difficult to distinguish from those of depressive 
disorder patients (Wessely & Powell, 1989). The evidence suggests that the depressive 
disorder accounts for the symptoms and disability attributed to CFS in some cases (Lane et 
al, 199 1). 
A link has been established between fatigue and psychological distress. A large community 
survey found that 20 % of women and 14 % of men complained of significant fatigue and that 
about 50% of these also had symptoms of depression (Chen, 1986). David (1991) reviewed 
thirteen published reports, which had recorded psychiatric symptoms and diagnoses in 
chronically fatigued patients. These included depressive, panic and anxiety disorders and 
somatization. Not all of these studies used standard criteria for CFS but Lane et al (1991) did 
use these established criteria in their study of 200 adult patients. The 60 patients with CFS 
had similar likelihoods of current psychiatric disorders, active mood disorders when 
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compared with fatigued control subjects. They concluded that CFS patients have a high 
prevalence of unrecognised, current psychiatric disorders, which often preceded their fatigue 
syndrome. Ray (1991) also found that a significant percentage of patients with fatigue 
appeared to have a psychiatric disorder, with major depression being the most common 
disorder. Several questions arose from her review. The first questioned the appropriateness 
of using standard procedures for determining depression in these patients, since CFS patients 
do not present with depression or a psychiatric disorder as their primary symptom and it may 
be secondary to or be a consequence of the prolonged fatigue. Secondly, there is a possibility 
that a depressive illness may form part of the symptornatology of an organic illness. Also, 
any chronic illness can produce a psychological challenge, and patients who are depressed 
may be so as a reaction to their illness. However, there is evidence that psychiatric problems 
precede the onset of fatigue in some patients. In the patient group studied by Taerk et al 
(1987), 50% had a major depressive episode prior to the development of "neuromyasthemia", 
while Kruesi et al (1989) concluded that psychiatric problems were more likely to predate 
CFS than to follow. Similarly, Lane et al (1991) produced evidence that depression generally 
preceded fatigue or had a simultaneous onset in a group of 60 CFS patients who were also 
more likely to have sornatization disorder and to attribute their illness to a physical cause. 
Wood et al (1991) compared the psychiatric status of CFS patients with a muscle disease 
group and found that 26.5 % of the CFS patients had been treated in the past, before the onset 
of fatigue, for a psychiatric disorder, and that 41 % currently had sufficient symptoms to be 
regarded as suffering from a psychiatric disorder. 
Several of the studies examining the link between psychiatric morbidity and chronic fatigue 
have given rise to conflicting results. Hickie et al (1990) concluded, from follow up of CFS 
patients, that the psychiatric illness was the consequence rather than the cause of fatigue. 
Conversely, Manu et al (1989) concluded, using similar diagnostic techniques, that the 
fatigue was caused by the psychiatric illness in two thirds of the patients. Further studies have 
not lead to more conclusive agreement. A more recent study of 64 CFS patients with a 
relatively short mean illness duration of 20 months found only a 17% prevalence rate for all 
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psychiatric disorders, with a current prevalence of 45%, which is comparable to other 
chronic medical disorders (Shanks & Ho-Yen, 1995). They concluded that CFS patients are 
no more prone to overt psychological illness than the general population arguing against any 
simple theory of psychological causation or maintenance of CFS. In his review of fatigue and 
chronic fatigue syndromes, White (1990), has put forward two suggestions: "(i) an 
independent factor predisposed some individuals to develop both depressive illness and a 
fatigue syndrome as a response to different physical and psychological stresses, (ii) the 
fatigue syndrome was the somatic presentation of a depressive illness in some patients. " 
A lot of the symptoms cited for CFS share considerable overlap with those of depression. 
However, most CFS patients claim that they are not depressed or that depression is not the 
key, although it may be contributory, to their problem. Long term psychological effects have 
been noted following infectious mononucleosis. It has been suggested that this illness can 
have persistent neurological and psychiatric consequences in a minority of cases, and that 
depression here may be organically caused and secondary to nervous system involvement 
(Hendler, 1987). It may also be possible that the depression in post-viral syndromes could 
reflect a neurochemical change induced by the virus (Sachar, 1975). The question arising 
from a lot of the evidence of links between CFS and psychiatric disorders is that, if a person 
is physically ill and depressed, their emotional state could reflect a dispositional tendency to 
depression, or it could represent a symptom of the illness. The depression may just be a 
reaction to the situation and chronicity of the illness. Indeed, in his review, Lishman (1988) 
suggested that "organic" factors are chiefly relevant in the earlier stages but that persistent 
Symptoms are perpetuated by psychological factors. An interesting observation from a study 
by Wood et al (1991) was that those fatigue patients who reported a viral illness at the onset 
of their symptoms were more likely to have a psychiatric diagnosis. They also found that 
32% of the fatigue patients studied reported a major, stressful life event in the six months 
preceding the onset of fatigue. It is perfectly plausible that the chronic fatigue syndrome 
would be likely to give rise to a depressive reaction to the impairment that is involved. 
However, Wessely and Powell (1989) concluded, in their study, that the psychiatric disorders 
in CFS patients were more than just an understandable reaction to a fatiguing illness. It must 
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also be remembered that not all CFS patients meet psychiatric criteria, therefore psychiatric 
disorders cannot be the sole explanation for CFS. 
Depression does, not offer a complete explanation for CFS, since it is found only in between 
one and two thirds of the cases (Sharpe, 1991). It is also worth noting, that there is a group 
making up a quarter of the samples in whom no psychiatric diagnosis was reached (Manu et 
al, 1988). David (1991), therefore, proposed an integrated model that is more likely to 
describe what actually happens in individual cases: 
Fatigue/Disability 
Virus/External Insult Depression/Anxiety 
2.2.4 Psychological Factors 
Attention has also been directed towards the role of cognitive distortions, and the ensuing 
maladaptive behaviour, as mediators of impairment in many illnesses, both physical and 
psychological. With regard to CFS, it is possible that an initial infection may then lead to the 
development of a cycle of attributional and cognitive factors, which can then lead to avoidant 
behaviour. These psychological factors (behaviour, beliefs and attitudes) will have a more 
important effect on how a patient copes with CFS, their rehabilitation and their expectations 
in the eventual outcome. Watts (1982) considered the implications of attributing illness to 
either psychological or organic factors, given the observation that symptoms attributed to an 
external cause are usually less debilitating than symptoms attributed to a personal or 
"internal" cause. Wessely et al (1989) have described the attributions that CFS patients make 
about their symptoms and their role in perpetuating disability. They discuss a state of 
"learned helplessness" that may follow on from the initial symptoms of fatigue and rnyalgia, 
which may become 'potent, aversive and uncontrollable'. This may also exacerbate the mood 
disorder that is found in many CFS patients (Wessely & Powell, 1989). 
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Several researchers have demonstrated a relationship between personality factors and the 
development of a fatigue state or an extended recovery from illness. White (1990) 
summarises the literature on the association between personality and fatigue states. From a 
study on 58 CFS patients, Blakely (1991) found that the largest subgroup was characterised 
by hypochondriasis/hysteria (40%). This group was over-controlled and defensive, denying 
psychiatric symptoms while endorsing CFS symptoms. He concluded that there was 'no 
unique set of psychological characteristics which can be considered as necessary antecedents 
or consequences of CFS', but suggested that high levels of emotionality or neuroticism may 
act as predisposing factors. From anecdotal observations, Abbey (1993) describes CFS 
sufferers as previously having highly productive lifestyles and this plays a more important 
part in maintaining self-esteem than in other patient groups. In this respect, they would be 
particularly susceptible to the psychological impact of disability, as a result of a severe or 
prolonged illness. Lewis (1994) confirmed that CFS sufferers rate themselves higher than 
controls on the "hard driving" and "many outside interests" items of the Bortner type A 
personality scale and they were shown to adopt a more conformational coping style. Also, 
van Houdehowe et al (1995) found that CFS sufferers might possess personality types more 
likely to generate stress than non-sufferers, being high on self-ratings on an "action 
proneness" scale. 
Psychological factors may play a role in acquiring and recovering from infection. Cohen and 
colleagues from the MRC Common Cold Unit, showed that measures of psychological stress 
predicted infection with the common cold virus (Cohen et al, 1991). Also, a Swedish study 
of the outcome of aseptic meningitis, post-infectious fatigability was predicted by premorbid 
psychological status (Muller et al 1958). For an overview of the way in which stress may 
influence the onset and cause of infectious illness see White (1990a). 
One important fact arising from psychological studies on CFS is that it is difficult to consider 
fatigue as being either organic of psychological in origin, since both factors can make 
contributions. Psychological factors may interact with organic factors in producing illness, 
thus playing a contributory role without being causally sufficient. Wessley et al (1989) 
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describe cognitive and behavioural factors which may lead to the development of a chronic 
condition from a possible organic onset. There is also evidence that psychological stress, 
before or at the time of infection, is a powerful predictor of fatigue persisting after viral 
infection (Wessely et al, 1995). Even if all cases of CFS are initially the result of viral 
infection, the secondary consequences, both social and psychological, may be a more potent 
cause of long term disability (Butler et al, 1991). Avoidance of activity and mood disorder 
could sustain symptoms, and create a vicious circle including expectations of failure, a belief 
in the continuation of the original illness, decreased physiological and psychological tolerance 
and feeling of helplessness and loss of control. In this case, the patients' attempts to cope 
with the symptoms, and subsequent avoidant behaviour, may paradoxically perpetuate the 
symptoms. 
2.2.5 Life events / Stress 
Behavioural and cognitive factors have been examined with respect to perpetuation of 
disability in CFS (Wessely, 1995) but less attention has been diverted to the impact of 
psychosocial stressors and non-pathological responses to stress in the development of CFS. 
A relatively small number of studies have examined the implications of stress in the aetiology 
of CFS, mainly in the form of life events. There has been some evidence that stressful life 
events and ongoing situations appraised as stressful may contribute to illness via changes in 
the immune system (Dorian et al, 1986) and/or through the effects on mental health (Brown 
& Harris, 1989). Surawy et al (1995) reported that the onset of illness occurred in 
association with a viral illness in 100 CFS patients interviewed, but that on further 
questioning, patients frequently revealed major psychosocial stressors preceding the onset of 
the illness. Typical examples were chronic relationship or work problems, difficulty in 
adapting to life changes and bereavement. Similarly, Stricklin et al (1990) reported a 
significantly greater severity of stress experienced in a group of 25 patients with epidemic 
neuoromyasthemia, compared to healthy controls in the 12 months prior to the onset of the 
illness, with bereavement being the most common event. They suggested that this was a 
psychological illness precipitated by a combination of stress and an infectious agent. Wood et 
al (1991), also found that 32.4% of a group of CFS patients studied, reported a major, 
15 
stressful life event in the 6 months preceding the onset of fatigue, with job changes and 
moving house being the most common. Conversely, Lewis et al (1994), examined life events 
in the two years prior to the onset of illness in CFS and irritable bowel syndrome patients and 
found that of 42 life events, only two, both of which were related to moving house, were 
more frequently reported by the CFS group. They suggested that any association between 
life events and illness onset may also apply to the IBS group. One difference found was that 
the CFS group perceived significantly less overall support prior to their illness than the IBS 
group and the healthy controls. They suggested that every day minor hassles may predict ill 
health better than major life events and that they may be more related to the onset and course 
of CFS. However, this has yet to be confirmed. Similarly, Bruce-Jones et al (1994) found 
little relationship between social adversity and the development of PIFS in a group of patients 
assessed at onset, two and six months after glandular fever. Surawy et al (1995) has put 
forward a cognitive model to describe the aetiology of CFS (Table 2.1). In this case the 
precipitating factors may be a combination of psychosocial. stress and an acute illness. 
Table 2.1. Aetiological Factors in CFS 
Premorbid personality Hard-worldng & achievement-orientated 
Tendency to "bottle up " feelings 
Events at onset Chronic pressures to perform 
Life events 
Symptoms of acute iUness 
Lewis et al (1994) also examined personality variables, in the form of type A behaviour in 
CFS patients and found that those individuals who were vulnerable to CFS appear to be 
characterised by "hard-driving behaviour and problem orientated, problem-focused coping 
styles", suggesting a self-induced, pressurised lifestyle prior to their illness. CFS patients in 
another study also talked of high achievement orientation, perfectionism, high standards of 
work performance with persistent striving to meet the needs and expectations of others, often 
at the expense of neglecting their own personal needs (Suraway et al, 1995). Indeed, several 
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interviewees in a qualitative study on 50 CFS patients by Ware (1993) spontaneously referred 
to themselves as being type A. 
It must be acknowledged that these studies are, by their very nature, retrospective and recall 
can obviously be affected by illness, but it is also important that premorbid psychosocial 
stressors and personality/behaviour characteristics should not be ignored in the aetiology, and 
thus treatment, of CFS, particularly from the point of preventing relapse. 
2.2.6 Sleep Disorders 
A few studies have shown that factors that disturb sleep, such as psychological distress, 
noxious envirom-nental disturbance, primary sleep disorders, or inflammatory joint disorders 
can contribute to a non-restorative sleep syndrome. Fragmented sleep with periodic limb 
movements (Moldofsky, 1984) or sleep apnoea (Molony et al, 1986) have been found in 
patients with fibromyalgia, which has been shown to share many symptoms with CFS (White, 
1990). Many of the behavioural and somatic features associated with both fibromyalgia and 
CFS, such as fatigue, negative mood and impaired intellectual function, can be induced by 
total or partial sleep deprivation or prolonged wakefulness (Moldofsky, 1986). Other 
symptoms of sleep deprivation include emotional distress, progressive temporal and cognitive 
disorganisation, impaired performance on memory tasks and low concentration (all symptoms 
of CFS) can be reversed with normal slow-wave NREM sleep (Horne, 1988). 
A study comparing CFS patients with normal subjects found that the patient group had more 
difficulty falling asleep, spent less time asleep, had reduced REM sleep and greater alpha 
EEG activity during NREM sleep (Whelton, 1992). Buchwald et al (1994) showed, using 
polysomnography, that 41 % of a highly selected group of CFS patients, had abnormal results 
for a multiple sleep latency test and 81 % had at least one sleep disorder - sleep apnoea (44 %) 
or idiopathic hypersomnia. (12%). They concluded that a potentially treatable sleep disorder 
may coexist with CFS. Other studies have shown that around 60% of patients with CFS also 
suffer from sleep disorders and that these sleep patterns differ from those seen in depressed 
patients (Morriss et al, 1993; Krupp et al, 1993). 
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Similarly, Manu et al (1994) used polysomnography with a group of 30 patients referred for 
evaluation of chronic fatigue. Thirty three percent had a primary sleep disorder and although 
alpha-delta sleep was identified in 26% of the group, this was not more closely associated 
with, fibrornyalgia. or depression. 
A small amount of research has demonstrated a link between certain cytokines and aspects of 
cellular immune function and the sleep-wake cycle and have suggested that a disturbance in 
sleep-wake related immune functions may provide a link to the symptoms of CFS (Krueger et 
al, 1990). Further research is needed to examine a potential link between disruption in 
normal overnight sleep physiology and any associated alteration in immune functions in CFS. 
Sleep disorders are confounding factors in CFS that have not received enough attention 
particularly since they are potentially treatable 
2.2.7 Neuroendocrine abnormalities 
Hypothalamic-Pituitary-Adrenal (HPA) axis 
Due to similarities in symptoms (fatigue, mood and sleep disturbance) recognised between 
Addison's disease, which is caused by a primary adrenal insufficiency leading to 
hypocortisolemia and CFS, some recent research has searched for abnormalities in the HPA 
axis in CFS sufferers, as a potential causative factor. Dernitrack et al (1991) found a blunted 
adrenocorticotrophic hormone (ACTH) release in response to corticotrophin releasing 
hormone (CRH) in CFS patients compared to controls and a decreased 24-hour urinary total 
free cortisol output. These results suggest that patients with CFS have a mild form of 
hypocortisolism, probably due to a deficit in the hypothalamus or above. Cleare and Wessely 
(1996) suggest that this HPA axis perturbation and hypocortisolemia could be a final common 
biological pathway in the perpetuation of CFS, which could be initially be caused by a variety 
of physiological and physical triggers. The possibility exists that a short-lived infection, with 
or without the presence of psychological stress, results in a disturbance of the HPA axis, 
which persists long after the infection has been eliminated. This persistent dysregulation of 
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the HPA impacts on brain functioning. In this respect, neurotransmitter abnormalities in CFS 
are secondary to dysfunction of the HPA axis (National Task Force, 1994). 
2.2.8 Muscle Dysfunction 
At the onset of the chronic fatigue syndrome the primary symptoms tend to be those 
associated with viral infections, as well as headaches, dizziness and general aches and pains. 
A large proportion of the chronic symptoms, experienced by patients, tend to be muscular; 
muscle weakness and tenderness, muscle tremor, profound fatigue (muscular and mental) and 
extreme debility, as well as the psychological symptoms. These persistent and ongoing 
symptoms of weakness, fatigue and muscular pain have led researchers to examine muscle 
tissue and to test muscular function in the search for an underlying cause. The focus has 
been to determine whether the fatigue is central in origin, ie. due to a failure to recruit motor 
units, or peripheral, due to the failure of neuromuscular transmission, sarcolernmal excitation 
or excitation-contraction coupling (Edwards, 1986). 
A reduction of activity of some glycolytic enzymes of skeletal muscle has been found after 
acute febrile infections (Astrom et al, 1976). It is logical to explore the possibility of a defect 
in biochemical pathways responsible for energy exchange. Of 109 patients attending a clinic 
dealing with muscle pain, only a small proportion exhibited an objective abnormality in the 
muscle (Mills & Edwards, 1983). In primary fibrorayalgia, "moth-eaten " Type I fibres 
have been seen in muscle biopsies (Henrikkson et al, 1982), suggesting continuous muscle 
fibre activity, similar to that observed in disorders of postural muscle control. Fatigue with 
dynamic exercise occurs with excessive lactic acid production in patients with mitochondrial 
disorders (Edwards et al, 1982). Muscle pain can also be due to ultrastructural damage and 
associated with large increases in plasma creatine kinase activity (Henrikkson et al, 1982) In 
a large biopsy study on 74 CFS patients, Edwards et al (1993), found morphological 
abnormalities in 81% of the CFS group compared to 32% of controls. However, the clinical 
significance of type I fibre atrophy is uncertain and they observed no overall tendency 
towards fibre atrophy. Necrosis was found in both the CFS patients and the control group. 
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None of the abnormalities found were consistent, nor did they reach statistical significance, 
when the two groups were compared. They concluded that CFS is not a myopathy. 
In order to examine some of the metabolic changes potentially associated with CFS, 
Wagenmakers et al (1988) took muscle biopsies from 23 CFS patients, 8 McArdle's disease 
patients and 14 untrained controls and measured the activities of mitochondrial enzymes. 
Cytochrome C oxidase and citrate synthetase activities were reduced to 64 % and 74 % of the 
control levels, respectively. They measured a low mitochondrial content in the majority of 
the CFS patients, while the 6 patients, who performed a cycling test, also exhibited a high 
degree of exercise stress at low intensities, decreased endurance, tachycardia and an increased 
dependence on glycolysis leading to a high lactate production at low exercise intensities. 
However, they suggested that many of the biochemical changes during exercise and many of 
the symptoms of these patients could be a consequence of their reduced habitual activity 
levels. Additionally, they maintained that the decreased levels of activity may have increased 
the proportion of type II muscle fibres with a low capacity for aerobic metabolism, leading to 
a new reduced limit to the amount of exercise that could be done without lactate production. 
Edwards et al (1993) suggested that although mitochondrial abnormalities have been 
described in CFS patients, mitochondrial function tests have been normal or may reflect the 
level of activity of the patients being studied. 
Some later studies again used Phosphorus" Nuclear Magnetic Resonance Spectroscopy to 
examine skeletal muscle bioenergetics in CFS patients during and after exercise. Wong et al 
(1992) found that PCr, Pi and pH all reached peak values more rapidly in CFS patients who 
also had lower concentrations of ATP at fatigue, which occurred earlier, when compared to 
normal subjects. They suggested that this signified a defect in oxidative metabolism with a 
resultant acceleration of glycolysis in working skeletal muscle of CFS patients. However, 
Barnes et al (1993) found, in 46 CFS patients following a standard handgrip protocol, no 
evidence of mitochondrial defect nor a consistent abnormality in pH regulation, concluding 
that there was no consistent bioenergetic abnormality in CFS patients that could explain the 
prominent symptom of fatigue. 
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Byrne and Trounce (1987) used electron microscopy to examine muscle biopsy samples from 
CFS patients and showed no definite abnormalities in the biochemical analysis of a range of 
glycolytic and mitochondrial enzymes. These findings are consistent with the absence of a 
major deficit in intermediary energy metabolism in muscle. Evidence from unreplicated 
EMG studies showed increased jitter, but this could not adequately explain the symptom of 
excessive fatigue (Jamal and Hansen, 1985), since several sites are required to function to 
cause reduced motor performance, it is possible to have muscular fatigue when the muscle 
itself is not impaired. 
One possible explanation put forward for the prolonged symptoms of excessive fatigue in 
CFS is the persistence of "low-frequency fatigue", which is thought to arise from a failure in 
excitation-contraction coupling and is associated with the need for greater central drive to 
overcome the likely reduction in force per impulse (Newham et al, 1983). Stokes & Young, 
(1984), found no evidence to support this explanation since no difference was found between 
CFS patients and controls in the force/frequency curve or the rate of force decline. Since 
neither low frequency fatigue nor failure of neuromuscular transmission (or failure of 
sarcolemmal excitation) could adequately explain the symptom of prolonged fatigue, Edwards 
et al (1993) concluded that it was not due to muscle abnormalities or muscle disease. 
Similarly, Kent-Braun (1993) found no evidence of excessive acidification, abnormal 
metabolism or increased muscular fatigue on intermittent or sustained muscle contraction tests 
Nor did they find evidence of abnormal muscle membrane function or excitation-contraction 
coupling in 7 CFS patients compared to healthy, sedentary controls. However, patients 
generated less force than controls and had a greater added force with tetanic stimulation, 
suggesting the presence of central fatigue and a possible psychological component to CFS. 
Because profound muscle fatigue, precipitated by minimal physical activity, is one of the 
most prominent complaints amongst patients with PIFS and CFS, several studies have 
examined muscle performance, in an effort to determine the site of the disturbance. Muscle 
fatigue is defined as the loss of ability to generate force and it can be central or peripheral 
(Jones, 1989). Friman (1985) examined the effect of acute infectious disease on human 
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isometric muscle endurance (anaerobic work). Previously, he had observed reduced 
isometric muscle strength in patients convalescing from infectious diseases (Friman, 1978). 
He studied 32 male patients suffering from various acute infectious diseases. Isometric 
endurance was measured immediately after the fever, 1 and 4 months after, and 
measurements after one year were taken as control values. The subjects' endurance capacity 
was reduced to 82-87% of the control, and impairments were still evident at 4 months. No 
loss in isometric endurance capacity was observed in healthy controls confined to bed for the 
same period. He proposed that reduced glycolytic capacity, mediated by reduced glycolytic 
enzyme activity, may have been partly responsible for the reduced endurance as well as the 
possibility of muscle hypotrophy. 
Lloyd et al (1988) measured maximal isometric strength before, during, and after a series of 
maximal contractions of the elbow flexors and found that the maximal isometric torque 
(force) was not significantly different between 20 patients with CFS compared to 20 controls. 
However the patients did show a significant impairment in recovery of maximal isometric 
strength after the endurance sequence, whereas the controls did not. They suggested that this 
may result from an inability to generate a maximal motor command from the central nervous 
system (CNS) and it is unlikely that the muscle is the ma or site of dysfunction in patients 
with CFS. Their conclusion implied that the abnormality is in the perception of muscle force 
and effort rather than of actual force production, that leads to the fatigue associated with 
CFS. However, the lack of twitch interpolation, to control for central inhibition, meant that 
this conclusion was uncertain. 
In their later paper, Lloyd et al (1991) examined the subjective perception of effort during 
prolonged submaximal isometric exercise in 12 male CFS patients compared to 13 healthy 
controls. This type of exercise resembled the demand put on the muscle in usual daily 
activities. They found no significant differences between the relative torque produced by 
either voluntarily or electrically stimulated contractions, when comparing patients and 
controls throughout the test, nor did they find any significant difference in perceived exertion 
between the two groups. This suggested that failure of the link between motor drive and the 
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metabolic mechanisms of the muscle is not the site of the pathophysiology producing fatigue 
in CFS Patients. They also refuted the significance of excessive intracellular acidosis in some 
CFS patients observed by Arnold et al (1984) and Yonge (1988). Arnold used Phosphorus" 
Nuclear Magnetic Resonance Spectroscopy to report an abnormal rapid decline in PH in 
active forearm muscle during handgrip exercise in a single patient with post-viral fatigue 
syndrome, but they did not control for the effects of rest. In arguing against the significance 
of these results, their conclusions suggested that the critical pathophysiological abnormality 
responsible for the prominent subjective fatigability associated with this condition must 
therefore lie within the central nervous system, above the level of the motor cortex. They 
believe that this also ties in with the prevalent psychological symptoms. Central fatigue is 
thought to be important in limiting activity, as signals from the skin, joint and tendon 
receptors feed back to the central nervous system, allowing both conscious and unconscious 
mechanisms in the perception of fatigue (Jones, 1989). 
Further efforts to detennine whether the fatigue associated with CFS was central or 
peripheral in origin were made by Stokes et al (1988). Central fatigue was examined by 
testing the exercise capacity of the whole body and the strength of the quadriceps femoris on 
voluntary movement, and peripheral fatigue was examined using stimulation of the adductor 
pollicis to test strength and fatigability in the absence of volitional control. Any 
abnormalities in performance occurred only during voluntary activity, whereas the contractile 
strength and recovery of muscle after the exercise, were both normal in the CFS patients. 
This suggested an impairment of central mechanisms, which could be due to a lack of 
motivation or fear of pain, or possibly due to a reflex inhibition by afferent activity arising 
from damaged painful joints (Stokes and Young, 1984). A similar technique of percutaneous 
stimulation was used in twitch superimposition of the quadriceps muscle by Rutherford and 
White (1991). They measured maximum quadriceps isometric (MVC) strength, activation 
and fatigability (repeated contractions at 60% MVC) in 11 fatigued patients following a 
corroborated viral infection and compared them with healthy controls. Two of the patients 
could not fully activate their muscle but allowing for this (with stimulation) the group mean 
strength was 104% of the predicted normal muscle strength for their height and age. There 
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was a remarkable trend for the patients to show less muscle fatigue than the healthy controls 
on the endurance test. They concluded that the feelings of fatigue and weakness by these 
patients could not easily be interpreted as either physiological muscle fatigue or lack of effort. 
However, they did acknowledge that the single limb model used in this study did not 
simulate normal daily movement patterns that these type of patients have difficulty with, and 
they may actually be limited in activities involving larger muscles, where more stress is 
placed on the cardiovascular and respiratory systems. 
2.2.9 Cardiovascular deconditioning and physical inactivity 
A few groups have examined cardiovascular and aerobic capacity in patients with PIFS or 
CFS. One of the earlier studies compared the exercise response between effort syndrome 
patients and patients with anxiety states and healthy controls on a five minute submaximal 
cycling test (Jones et al, 1946). The effort syndrome and anxiety states showed similar 
significantly higher heart rates, peak blood lactate levels and oxygen uptake values in the 5 
minute post exercise period when compared to the control group. Montague et al (1989) 
examined resting cardiac function and exercise performance in 41 CFS patients compared 
with age and sex-matched controls on a supine cycle ergometer test. The CFS patients had no 
evidence of underlying mechanical or electrical abnormalities at rest or during 24-hour 
ambulatory ECG measurements. Only 13% of the CFS patients could continue the graded 
exercise test to the target heart rate of 85 % of age-predicted maximum, compared to 63 % of 
controls. The CFS patients stopped due to fatigue whereas the controls were more likely to 
stop because they had reached their target heart rate. The CFS patients terminated the test 
at a mean peak heart rate of 124 beats per minute whereas the mean peak heart rate reached 
in the control group was 152 beats per minute. There were also significant difference in test 
duration, with the CFS patients continuing for only 9 minutes and the control group 
continuing for 12 minutes. This study highlights a marked limitation in exercise capacity in 
this group of CFS patients but, in this case, the size of the peripheral effect appeared greater 
than the size of the cardiac effect. Despite a low heart rate, it is possible that the reduced 
aerobic capacity at the muscular level prevented continuation of the exercise test. 
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Another study by Riley et al (1990) compared the aerobic capacity of 13 CFS patients with 
that of a 13 matched normal controls and 7 irritable bowel syndrome patients. All 
participants performed a symptom limited Bruce walking test on the treadmill with continuous 
measurements of heart rate and expired air analysis. Blood samples were taken at rest, at 
peak exercise and during recovery and analyzed for lactate, phosphate, glucose and creatine 
kinase activity. The CFS patients had a reduced exercise time on the treadmill, higher heart 
rates and peak blood lactate levels and higher ratings of perceived exertion on the Borg scale 
compared to both other groups tested. The CFS patients had an altered perception of their 
degree of exertion and also of their premorbid level of physical activity. They concluded that 
there was no evidence for a deficient cardiovascular response or peripheral muscle function 
besides that which might be expected as a result of deconditioning. A more recent study by 
Gibson et al (1993) measured maximal isometric quadriceps strength at rest and following an 
incremental cycle test to exhaustion in twelve CFS patients and compared them to sedentary 
controls. No differences were found in exercise duration, heart rate/work rate relationships, 
or in muscle function. However, peak heart rates and blood lactates were lower in the CFS 
patients and they had raised perceived exertion scores during the exercise. The CFS patients 
showed a linear increase in effort perception with increasing intensity whereas the control 
subjects showed a threshold in effort perception at about 20-30% of maximum capacity 
followed by a linear increase. They suggested that CFS patients have a lower threshold for 
sensation during exercise or that they have an additional perception of fatigue at rest over and 
above that experienced during exercise, and they concluded that central fatigue was limiting 
exercise capacity in these patients. The pathological mechanism of muscle disuse and the 
resultant complications of weakness, atrophy and diminished endurance is most likely similar 
to the disuse phenomenom, which has been extensively studied and described in other groups 
of patients who have neuromuscular lesions and/or lead sedentary lives (Kottke, 1966). 
Disuse and inactivity have a harmful effect on muscle, respiratory and cardiovascular 
function (Greenleaf and Kozlowski, 1982). Whether the initial cause is physical or 
psychological, the ensuing reduced activity level, will unavoidably lead to deconditioning. If 
physical conditioning is considered as general training to improve aerobic fitness, muscle 
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strength and endurance, then the effect of extended periods of inactivity would be expected to 
reverse these improvements, a deconditioning; response. A mean reduction in maximum 
oxygen uptake of 28 % was observed in 5 healthy males after 20 days of bedrest (Saltin et al, 
1968). Similarly, a decrease of 15 % in mean peak oxygen uptake values (25.8 to 21.9 
n-ils. kg-. miff' ) was observed in sedentary individuals after only 10 days of bed rest (Hung et 
al, 1983). This is largely caused by the decreased cardiac output and stroke volume (29%) 
and left ventricular function associated with inactivity and bed rest (Taylor et al, 1949; Vetter 
et al, 1971). Inactivity reduces the stroke volume and perhaps the efficiency of the circulatory 
regulation during exercise. The margin between aerobic demands of daily activities and the 
maximum aerobic power becomes narrower and, sooner or later, this will create symptoms. 
In addition, inactivity is associated with changes in body composition in the form of increased 
body fat and loss of lean body mass resulting in decreased muscle strength but these effects 
can be counteracted through a programme of active muscle use (Deitrack et al, 1948). The 
slow twitch muscle fibres seem particularly sensitive to disuse and changes in their function 
would also be expected to result in significant reductions in stamina and capacity for physical 
activity. When no tension is exerted throughout the day (as in bedrest), loss of strength 
occurs at the rate of approximately 3% per day (Kottke, 1966). 
Much of the observed low exercise tolerance in CFS patients may be a result of dramatically 
reduced activity levels, complete inactivity and bedrest. The resultant deconditioning in turn 
can lead to further avoidance of activity and further reductions in exercise tolerance. 
2.2.10 Sununary 
The heterogeneous nature of chronic fatigue syndrome was noted by Swartz (1988), who 
stated that it is likely to have multiple psychosomatic and somatic causes, making the 
aetiology somewhat inconclusive. Several studies have identified viral triggers in CFS, with 
EBV, Coxsackie B and Herpes viruses all being implicated. However no one viral cause, 
positive in all cases, has been identified and therefore, serological tests for these viruses 
cannot be used as a diagnostic test for CFS. Additional infectious agents including bacteria, 
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parasites and other viruses have been hnplicated as triggering agents in CFS, although, thus 
far, no convincing evidence for a direct causal relationship has been established. 
Links between psychological stress, physical activity, depression and the immune system 
have been well established (Calabrese et al, 1987; Dorian & Garfinkel, 1987), which 
probably explains the immune abnormalities reported in association with CFS. Some studies 
have found evidence of relatively minor abnormalities in a proportion of patients, but no 
consistent picture has been established nor has an association of immune status and clinical 
state been determined (Buchwald & Komoroff, 1991). 
A large proportion of CFS patients meet criteria for a psychiatric diagnosis, with depression, 
anxiety and panic disorders being the most common. It is unresolved whether the depression 
is a reaction to the chronic fatigue state or whether a preceding psychiatric disorder leads to 
the development of CFS. Both muscle pain and fatigue are prominent symptoms of 
depression such that the symptoms of CFS patients are commonly difficult to distinguish from 
those of patients with depressive disorders (Wessely & Powell, 1989). However, since 
depression is only found in one to two thirds of CFS patients with one-third of CFS patients 
having no psychiatric diagnosis, it cannot be offered as a sole cause in all cases, and the 
possibility of depression as a reaction to prolonged fatigue cannot be ruled out, in some 
cases. Those who advocate a cognitive model in the aetiology of CFS suggest that the 
symptoms associated with CFS (fatigue, poor concentration, muscle pain), result from the 
physiological changes accompanying chronic emotional distress and inactivity, which act as a 
perpetuating factor (Surawy et al, 1995). Therefore, once the illness is established, 
cognitive, behavioural, emotional, physiological and social factors may perpetuate it, once the 
combination of a minor acute illness and psychosocial events act as precipitators. 
It has also been suggested that psychological factors, such as cognitions, attitudes and 
behaviours, can interact with both physiological and psychiatric disorders to perpetuate the 
symptoms associated with CFS (Wessely et al, 1989). Certain personality types may be more 
susceptible to the development of a chronic fatigue condition, and consequent avoidant 
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behaviour and inactivity can lead to a vicious circle of low expectations of eventual outcome 
and decreased physical and psychological tolerance (Magnusson et al, in press). 
The symptoms of weakness, muscle pain and disproportionate fatigue have lead researchers 
to examine muscle tissue and test muscle function in search of a physical explanation. No 
consistent metabolic or biochemical abnormalities have been discovered other than those 
explained as a consequence of reduced habitual activity levels (Wagenmakers et al, 1988). In 
exercise studies, normal muscle strength and fatigability, a decreased exercise tolerance and 
an altered perception of exertion have been measured (Riley et al, 1990; Rutherford & White, 
1991). This has lead researchers to look away from peripheral (muscular) causes and to turn 
towards central impairment as a cause for the fatigue. Perhaps as a consequence of the 
muscle pain and weakness and fatigue, CFS patients tend to have low habitual activity levels. 
The detrimental effects of inactivity on muscle, cardiorespiratory function have been 
documented and this will undoubtedly play an important role in perpetuating the symptoms of 
chronic fatigue. 
Laboratory abnormalities have been detected in the immune, endocrine, muscular and central 
nervous systems in a variable minority of patients (Blondel-Hill & Schafen, 1993). A lack of 
consistent or highly prevalent abnormalities is the rule. Not one but several causative factors 
have been proposed for CFS, some possibly precipitating and some more perpetuating in 
nature. There may be several causes but the search will still continue for an organic cause of 
fatigue that predisposes patients to psychiatric illness (Greenberg, 1990). 
2.3 Treatment 
2.3.1 Anti-viral 
Studies on the treatment of CFS have been relatively limited to date although recommended 
guidelines have been prolific. A recent book devoted only six out of seventy-five chapters to 
treatment, all of which were studies using immunological therapeutic agents (Hyde et al, 
1992). 
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If CFS is associated with a persistent virus, an improvement would be expected with effective 
anti-viral treatment. Amantadine, which is used to provide protection against Influenza A, 
has been reported to reduce fatigue symptoms in a placebo-controlled study of multiple 
sclerosis patients (Rozenberg, 1988). It would be expected that it could have a beneficial 
effect in CFS but no clinical trial has been conducted. Epstein Barr virus is also widely 
implicated in the pathogenesis of CFS, and Acyclovir, an anti-viral drug, which inhibits DNA 
replication, that is active against herpes viruses (including EBV), has been used in a clinical 
trial with no greater effects than placebo in CFS patients (Straus et al, 1988). 
2.3.2 Immunotherapy 
Presuming that the virus initiates an immune system response that can lead to chronic 
activation of the immune system, several treatments have been devised to modulate this. 
Some CFS patients were found to have specific Ig subclass deficiencies or a decrease in 
antibody-dependent cell-mediated cytotoxicity such that intravenous and intramuscular 
immunoglobulin was administered (Gantz & Holmes, 1989). Lloyd et al (1990) advocated the 
use of intravenous immunoglobulin in CFS patients following a 43 % response (symptom 
improvement) compared to 12% on placebo in a group of 49 CFS patients, whereas Peterson 
et al (1990) observed no objective therapeutic advantage in immunoglobulin therapy versus 
placebo, in 30 CFS patients, with 25% of patients in each group reporting some 
improvement. Inftision of antibodies active against Coxsackie viruses, which have been 
described in the aetiology of CFS, using plasma exchange (to remove the circulating immune 
complexes) and fresh frozen plasma, produced only a mild and very temporary subjective 
improvement (Behan & Behan, 1988). No evidence of improvement was observed using 
immune system stimulants such as, interferon, interleukin-2, transfer factor or immunovir 
which was also the case with immunosuppressive treatment (Behan & Behan, 1988). There 
also appears to be no advantage from treatmenit with thymic hormones (to stimulate T cell 
production) or inosine probanex/Immunovir (a drug also having weak anti-viral properties) 
(National Task Force, 19944). Although the role of immunoglobulins has not been resolved, 
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the current recommendations, based on expense, tolerability and available efficacy data, is 
that its use in CFS is not routinelY justified (Straus, 1990). 
2.3.3 Essential fatty acids 
Behan et al (1990a) has proposed that the post viral fatigue syndrome is triggered by the 
effects of a viral infection on essential fatty acid (EFA) metabolism, leading to a general 
reduction in EFA levels, making it more difficult for the host to eliminate viruses, an 
increased risk of ongoing infection and persistence of the syndrome. In a3 month, placebo 
controlled trial, 85% of PVFS patients on Efamol Marine, a combination of 80% evening 
primrose oil and 20% fish oil, rated themselves better than baseline compared to 17% of the 
placebo. Behan et al (1990b) reported a 74% improvement over baseline after one month of 
Efamol marine treatment compared to 23% of controls, with significant changes in essential 
fatty acid levels measured in the red cell membrane phospholipids. However, the results of 
these studies have not been replicated and an unpublished, 6-month randomised, double-blind 
trial of Efamol Marine in 98 CFS patients failed to show any difference in symptom rating 
between the treated and placebo group (Riley et al, 1993). 
2.3.4 SIeep disturbance 
Sleep disturbance is also a common symptom of CFS, and several neurotransmitters are 
involved in the regulation of sleep, including serotonin, acetylcholine, gamma-aminobutyric 
acid and catecholamines (Jouvet at al, 1983) some treatment has focused on regulation of this 
symptom. Conventional drugs used in the treatment of sleep disorders, such as 
benzodiazepines, do not appear to correct the sleep abnormalities in CFS (McClusky, 1993). 
However, Goldenberg et al (1986) have had some success with tricyclic antidepressants such 
as amitriptyline or imipramine, acting as sleep modulators in fibrornyalgia patients. 
2.3.5 Neurally mediated hypotension 
A recent study found evidence of neurally mediated postural hypotension (assessed as an 
abnormal response to an upright tilt test) in 22 out of 23 selected CFS patients compared to 4 
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out of 14 controls (Bou-Holaigah et al, 1995). Following therapy to increase the blood 
volume through increased dietary sodium or fludrocortisone, 9 patients reported complete or 
near complete resolution of CFS symptoms. These patients were selected and the treatment 
was open, without a placebo comparison. 
2.3.6 Neuroendocrine 
If hypocortisolernia is of causal importance in some or all of the symptoms of CFS, then 
treatment with hydrocortisone therapy could be of benefit. This hypothesis is currently being 
examined by a double-blind, placebo-controlled trial (Cleare & Wessely, 1995). 
2.3.7 Psychiatric and Psychological 
Most other studies have approached the treatment from the psychiatric or psychological 
aspect. Whether the cause or the consequence of CFS, an emotional disorder can be a source 
of fatigue and disability (Wessely & Powell, 1989), but it can be effectively treated, both 
pharmacologically, or with cognitive behavioural therapy (CBT) (Hawton, 1989). CBT 
focuses on the theory that the disability seen in CFS patients is aggravated by cognitive 
distortions and is perpetuated by maladaptive behaviour. Butler et al (1991) observed a 
clinically significant improvement in symptoms and functioning, using CBT, in 69 % of a 
group of 50 severely disabled CFS patients and this was maintained at follow-up. Cox and 
Findley, (1994) used a combination of CBT and occupational therapy in a pilot study with a 
group of 28 CFS in-patients and observed 57 % of the patients had an improved activity level 
six months following discharge. Patients in both of these studies were also offered traditional 
antidepressant therapy. A more recent study compared CBT to normal medical care and 
found a 60% patient rated improvement compared to 23% of controls with subsequent 
improvement in daily function and Karnofsky score, one year after starting treatment (Sharpe 
et al, 1995). 
Pharmacological approaches have included the use of antidepressants. Tricyclic anti- 
depressants have been shown to be beneficial in a controlled trial of fibromyalgia, which is 
closely associated with fatigue (Goldenberg, 1986). Vercoulen (1996) carried out a 
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randomised controlled trial of fluoxetine, known to have fewer sedative and autonomic 
nervous system effects than tricyclics. After 8 weeks of treatment, a 20mg daily dose of 
fluoxetine was found to have no superior effects to placebo on any symptoms characteristic of 
CFS. There is little evidence from controlled trials on anti-depressants as a treatment for 
CFS and one study reported that only 4 out out 55 patients felt "greatly improved", while 13 
stated that they had been "made worse" (Sharpe et al, 1992). 
2.3.8. Exercise and activity 
Only a few studies have attempted to treat the effects of deconditioning and inactivity in CFS. 
This may be due, in part, to the lack of agreement on the physical aetiology of the 
syndrome, as well as the resurgence of symptoms observed after activity in these patients, so 
that those dealing with this particular group may have found it 'safer' and less contradictory 
to recommend rest and relaxation. Rest has commonly been the mainstay of this treatment, 
with work and physical activity approached with caution (Archer, 1987). Patients are 
frequently told to rest until symptoms subside or to modify their lifestyle and live within their 
own individual limits (Dowsett et al, 1990). 
However, it is well documented that exercise has beneficial effects, both physically and 
mentally for healthy individuals (Eiseman, 1985), and also several studies have indicated that 
exercise may be useful as an antidepressant (Doyne et al, 1983, Martinsen, 1990). 
Conversely, it has also been shown that inactivity can have adverse psychological effects 
(Baekeland, 1970). Various community and clinical studies have indicated that individuals 
from a range of age groups with physical disorders, who are completely inactive, are at a 
greater risk of psychiatric disorder than are healthy ones (Weyerer, 1990). Patients who feel 
chronically fatigued and lethargic, but who do not show any signs of depression should, 
likewise, benefit significantly from an exercise programme (Taylor, 1985). Sheehan (1989), 
describes the human body as a complex machine whose proper maintenance requires regular 
exercise, and referred to such chronically fatigued patients as exhibiting an "exercise 
deficiency". 
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Edwards and colleagues have demonstrated the benefit and objective improvement with 
physical fitness training, on an individual basis, in an open, uncontrolled study of patients 
with "effort syndrome" (Newharn and Edwards, 1979). They describe both progressive 
(beginning from a supine position) and constant work rate test on a cycle ergometer, with 
measurements of heart rate, blood pressure, power output and blood samples taken at regular 
intervals. The exercise programme consisted of two to four half hour cycle ergometer 
sessions per week, aiming at a daily progression. Supplementary exercises were also 
included. On repetition of the same exercise test one or two weeks later, patients already 
showed lower exercise and recovery heart rates, lower blood pressure and an increased work 
capacity. Graded exercise would seem to be a logical approach to the treatment of CFS and 
could rarely be contra-indicated in most disease populations. However, several current 
reviews on CFS do not mention exercise, possibly since it is not considered to have a curative 
effect (Gantz & Holmes, 1989; Blondell-Hill & Shafran, 1993). Gantz and Holmes do 
recommend moderate exercise to maintain muscle tone and endurance, primarily to 
counteract the effects of inactivity. However, they caution against excessive exercise, 
commenting that this may result in exacerbation of symptoms. A review by Sisto (1993), 
does mention that exercise programmes can help CFS, but only by giving patients a sense of 
control over their condition. 
McCain et al (1988) has shown improvement in subjective measurements of pain with a 20 
week cardiovascular fitness training programme in patients with fibrositis/fibromyalgia 
syndrome. Thirty-four patients were assigned to either heart-rate elevated training on the 
cycle-ergometer, three times per week, or a programme of flexibility only exercises. As well 
as improvements in rnyalgia, the exercise group showed a significant increase in peak work 
capacity, and neither of these improvements were observed in the group doing flexibility 
work only. Similarly, Mengshoel et al (1992) reported reduced feelings of muscular tension 
and an improved general feeling of well-being with a programme of low-intensity dynamic 
endurance training in fibromyalgia patients. A group of 18 patients formed a training group 
that did two one-hour aerobic exercise sessions per week for twenty weeks. The group 
improved their upper-extremity dynamic endurance capacity and showed a reduction in 
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exercise induced pain that was not seen in the control group who did not change their 
exercise habits for the duration. 
Fatigue is a multifactorial problem with contributory causes in the areas of physiology, 
biochemistry, psychology and environmental sciences and therefore, improvement in several 
factors could decrease the liability to fatigue (Shepherd, 1974). 
2.4 Benefits/Effects of Exercise 
2.4.1 PsYChological effects of exercise 
Depressed patients tend to be inactive and have a low physical working capacity compared to 
non-psychiatric controls (Eisemann, 1985; Aaoro & Brekke, 1983). The few studies that have 
used exercise intervention in the treatment of depressed patients have given positive results 
(Martinsen, 1990). One of the earlier studies compared the effects of ten weeks of 
psychotherapy and ten weeks of running, three times per week and found that the runners has 
at least as much improvement as the other treatment group on SLC-90 depression scores 
(Greist et al, 1979). Other studies reported that, compared to either no treatment or 
relaxation training, aerobic exercise produced significant reductions in depression scores 
(Doyne et al, 1983; McCann & Holmes, 1984). Klein et al (1985) found 12 weeks of either 
running, meditation or psychotherapy to be equally effective in reducing depression. Other 
studies compared a combination of exercise plus counselling, with either treatment given 
alone and achieved the most significant reductions in depression scores as a result of the 
combination treatment (Reuter et al, 1982; Asberg et al, 1978). Freemont (1983) expanded 
on Reuter's study and compared cognitive therapy, running and a combination of both, and 
found that all treatments had equal effects on Beck depression inventory (BDI) scores. 
Aerobic exercise seemed to be more effective than no treatment, but was not significantly 
different from other forms of exercise treatment, and a combination treatment was most 
effective. Exercise programmes have also been associated with significant increases in self- 
esteem, particularly with those patients who are initially low in self esteem (Sonstroem, 
1984). 
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With regard to the type or intensity of the exercise, Sexton et al (1989), found walking and 
jogging programmes to be equally effective in relieving depressive symptoms and state 
anxiety. They suggested that "regular light or self-selected exercise, 30 minutes three times 
per week" is adequate for benefit and resulted in a minimal dropout. Moses et al (1989) also 
reported that moderate exercise is preferable to higher intensity exercise in reducing tension- 
anxiety and that psychological benefits may not be directly related to improvements in 
maximal aerobic capacity. Lower levels of exercise may have greater psychological effects 
by avoiding the potentially negative effects of demanding exercise and a higher drop-out. 
Mutrie (1986) compared the effects of eight weeks of aerobic exercise, strengthening and 
stretching exercise and being on a waiting list. After four weeks, those in the aerobic group 
had reduced BDI scores, whereas the strengthening and stretching group and the control 
group showed no reduction. After eight weeks both exercise groups had decreased 
depression, more positive moods and were physically fitter. 
It appears to be the participation in the exercise itself, rather than any improvements in 
physical fitness, that lead to psychological gains, as both aerobic and anaerobic exercise have 
shown similar effects with and without increases in functional capacity. Patients themselves 
evaluated physical fitness training as the most important element in the comprehensive 
treatment programmes (Martinsen and Medhus, 1989). By placing more emphasis on the 
physical side of their treatment, patients might be taking the focus away from the stigmatized 
psychological aspect of their illness. Additionally, it could be that the social environment 
may be as important on psychological outcome as the activity itself. Exercise could also 
provide a distraction that could, in turn, reduce state anxiety (Morgan, 1985). It is, as yet, 
unclear how the exercise mediates these effects. Some studies suggest that this antidepressant 
effect may result from the release of an endogenous endorphin, which has known analgesic 
and euphoric effects similar to morphine (Cronan & Howley, 1984). Other suggestions are 
that the exercise leads to an increase in the concentrations of monoamines in the brain 
(Ransford, 1982), or that it may be due to the reduced catecholamine levels after exercise 
(Cousineau, 1977). Since increases in serotonin (5-HT) levels in the brain can result in 
fatigue and sleepfulness, an increase in the concentration of 5-HT in certain areas of the brain 
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might be associated with a high rate of neuronal firing, which could then increase the 
sensitivity to fatigue (Newsholme & Castell, 1996). It is also possible that regular exercise 
could decrease the sensitivity of the 5-HT receptors. DeVries (1981) reported reduced EMG 
recordings of muscle tension after exercise, which may indicate a mechanism for reported 
decreases in anxiety and tension levels after exercise. Increased capacity for work may also 
assist the individual in coping with stress (Schafer, 1978). It could also be a combination of 
several of these or even other factors that mediates the psychological benefits associated with 
the exercise training. 
The corollary of this is that inactivity has detrimental psychological effects, with the 
immediate emotional response to limitation of activity being similar to that in other situations 
of stress (Kottke, 1966). Anxiety, hostility, tension, complaints of discomfort and changes in 
pattern of sleep may all occur to varying degrees as a response to inactivity, depending on the 
individual's personality. 
2.4.2 Physiological effects 
Exercise has been shown to have numerous benefits, including increased longevity, and a 
number of profound physical changes. Aerobic exercise is associated with increased stamina 
and endurance, usually associated with an increased maximum aerobic capacity (VO, max), 
and a greater cardiovascular efficiency, leading to a reduced heart rate at a given oxygen 
uptake (Astrand & Rodahl, 1986). Subsequently, improvements in aerobic fitness lead to a 
decreased risk of all causes of mortality. The other well-documented effects of exercise 
include increased high density lipoprotein levels (Wood, 1985), increased vagal tone, stroke 
volume, cardiac output and blood pressure at submaximal exercise intensities (Seals et 
al, 1984), all of which contribute to a decreased risk of heart disease (Haskell, 1984; Pate et 
al, 1995) 
Regular exercise also increases insulin sensitivity, myocardial hypertrophy, blood volume and 
haernoglobin levels, but decreases platelet aggregation. At the muscular level, increased 
capillarisation and number and density of mitochondria. lead to increased removal of the by- 
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products of exercise, particularly lactic acid, from the tissues and a reduced lactate production 
at a given exercise intensity (Astrand & Rodahl, 1986). Improved fitness also leads to a 
more efficient fuel usage, conserving the body's more limited glycogen reserved by using 
increased ability to use fatty acids as a fuel (gluconeogenesis)(Saltin et al, 1983). 
Exercise also leads to an increase in the metabolic rate both during and after the exercise 
bout and a general increase in energy levels (Astrand & Rodahl, 1986). 
Several chronic medical, conditions involve considerable bedrest and inactivity, whether 
during the rehabilitation from a condition or as a consequence of a long-term illness. 
Exercise therapy has been increasingly advocated for treatment of several chronic diseases, 
such as coronary artery disease, peripheral vascular disease, chronic obstructive pulmonary 
disease, rheumatoid arthritis, osteoporosis and chronic pain syndroms. It has been postulated 
that physical activity would stimulate the formation of collateral vessels, reduce the pain of 
claudication and increase exercise tolerance in patients with peripheral vascular disease 
(PVD)(Ekroth et al, 1978). After a training programme of 3x 30 minute walking sessions 
per week and a general increase in daily activity for 4 to 6 months, 40% of patients with 
PVD could walk continuously for more than 1 kilometre, an increase of 234%. Another 
group reported results suggest increased peripheral blood flow following exercise training, in 
which maximal walking time and time to claudication pain increased (Skinner & Strandness, 
1967). A recent prospective randomized controlled trial of patients with chronic obstructive 
pulmonary disease compared rehabilitation in the form of a package of breathing and joint 
mobility exercises, interval training, treadmill walking, upper body exercises, using both 
supervised and at home routines, with conventional community care (Goldstein et al, 1994). 
The treatment group improved their physiological fitness (6-minute walk distance and 
submaximal cycle time) and both emotional function and dyspnoea index after 24 weeks. 
Patients with rheumatoid arthritis have also been reported to benefit from an exercise 
programme consisting of I hour of supervised aerobic exercise every second week and 
recommendations for home exercise on a bicycle ergometer (Nordemer et al, 1981). At the 
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completion of the study, the treatment group were 3 times more physically active than the 
control group, had less joint stiffness, received fewer intra-articular joint injections and oral 
steroids, and spent less days in hospital. Preliminary work with cystic fibrosis patients 
suggests that exercise may improve respiratory functions and physical work capacity (Zach et 
al, 1982), while in a group of post-polio patients with apparent disuse weakness, several 
showed significant improvements in strength in response to a carefully supervised exercise 
programme (Feldman, 1993). In patients with osteoporosis, although high intensity physical 
activity can cause fractures, walking, mobility exercises and certain other low-level exercises 
have been shown to prevent bone mineral loss and increase bone density (Smith et al, 1981). 
The ultimate goal of exercise conditioning of patients with coronary artery disease (CAD) is 
to increase life expectancy and to increase the quality of life through increased physical work 
capacity and decreased depression and anxiety. A review by Shepherd (1983) concluded that 
subjects allocated to exercise programmes had a 25 to 35 % mortality advantage over those in 
control groups. 
The exercise prescription, with respect to frequency, duration and intensity varies 
considerably in all studies with the chronically ill, depending on the level of disability. 
Previous guidelines by the American College of Sports Medicine (1978) "for developing and 
maintaining cardiorespiratory fitness and body composition in healthy adults" recommended 
15-60 minutes of exercise, 3-5 days per week at 50 - 85% of maximum oxygen uptake. 
While these guidelines were meant for healthy adults, they formed the basis of exercise 
prescription for coronary rehabilitation, initially, and several other conditions. These 
guidelines have been revised taking into account that the quantity and quality of exercise 
needed to obtain health-reIated benefits may differ from what is needed for fitness benefits 
(ACSM, 1990). It may be more important to promote an increase in activity volume (duration 
and frequency) at a moderate intensity than to increase intensity above a moderate level 
(relative to a person's capacity (Haskell, 1994). This provides support for the value of low to 
moderately intense activity, especially for the chronically sedentary, overweight individuals, 
other patients and the elderly. The new guidelines also imply that performance of a number 
of short bouts of activity throughout the day, if they total 30 minutes or longer, will provide 
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significant health benefits, and this type of approach can be far more manageable for such 
individuals. 
2.5 Tests for assessment of Physiological Capacity 
There are many ways to assess the different aspects of fitness, and the methods chosen need 
to reflect the reason for undertaking the assessment. Tests on elderly, ill or disabled 
individuals should be more related to those factors that are important for health, well-being 
and independence. 
The purpose of exercise testing is to determine whether there is a normal response to the 
challenge of continuous exercise. Clinical applications may include diagnostic, functional and 
therapeutic objectives. Functional exercise testing is used to determine exercise capacity. It 
provides information on an individual's current physical condition which can then be used to 
set appropriate training loads, as well as providing initial data for comparison, so that the 
effects of an exercise programme can be monitored. Improvements can be measured 
quantitatively, while also giving feedback and motivation to the patient. Because of the 
diversity of symptoms associated with CFS, the initial assessment of functional capacity needs 
to include both aerobic capacity, since CFS patients complain of abnormal fatigue during and 
after exercise, and muscle strength since they also complain of muscle weakness. In addition, 
other measures pertinent to good health should be included in order to obtain a more 
comprehensive assessment of the patients overall general health. 
2.5.1 Measurement of aerobic fitness 
Aerobic fitness is associated with a person's capacity to undertake prolonged forms of 
activity, ranging from daily tasks such as walking, cleaning and shopping to other more 
obvious forms of physical exercise. A clear link has been established between the 
enhancement of an individual's aerobic capacity and their ability to cope with the demands of 
their lifestyle (Bird, 1993). 
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An individuals aerobic capacity is dependent on several inter-related factors, the most 
important of which is the efficiency with which they utilize oxygen. A clear link exists 
between oxygen consumption and cardiorespiratory fitness, since oxygen delivery to tissue is 
dependent on lung and heart function. The maximum oxygen uptake (VO, Max) is the 
maximum rate at which oxygen can be taken in, distributed and used by the body in the 
performance of work. This maximum rate represents an individual's physiological limit and 
the V02 max represents the single most commonly used indicator of an individual's capacity 
for oxidative metabolism and exercise capacity. V02 max is related to heart rate through the 
Fick equation and is a product of maximum cardiac output and the maximal systemic 
arteriovenous oxygen difference, such that a linear relationship exists between heart rate and 
oxygen use during exercise (Astrand & Rodahl, 1986). Normally, as the work rate or 
intensity increases, the rate of oxygen uptake and the heart rate increase up to a plateau, after 
which further increases in work rate show no further increases in VO.. In older, sedentary 
individuals, V02 commonly does not reach a plateau because of a limiting symptom or sign 
that causes a person to cease exercise before reaching it, such as fatigue, bluffed vision or 
angina. In this instance, the peak V02 measurement represents a limiting condition rather 
than a physiological limit. This determination is often referred to as a symptom-limited V02 
max or functional capacity. Aerobic capacity, measured before and after an exercise 
programme is one of the best methods for assessing physical fitness improvement (Karlsson 
et al, 1967), although the use of a single measure to describe the level of physical and 
physiological fitness has been criticized (Ricci, 1967). For this reason, several additional 
measures should be made, when possible. Various factors can limit V02 max and these can 
vary in different individuals and may well be different in CFS patients compared to healthy 
individuals. Also, the limiting factors may change for any given individual as a result of an 
exercise training programme, or the onset of disease (McCully, 1993). Determination of peak 
V02 represents a relatively simple and practical means of measuring general exercise capacity 
and assessing the results of intervention in patients with CFS. The extensive published 
information on human oxidative capacity provides a broad frame of reference for interpreting 
results and treatment strategies. 
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2.5.2 Blood lactate and exercise 
Energy sources in the muscle vary as exercise intensity increases. The ventilatory response 
reflects both changes in the substrates used and the amount of aerobic and anaerobic 
metabolism. During low intensity activity, free fatty acids are oxidised aerobically as the 
primary source of fuel. As the level of exertion increases, more carbohydrates are 
metabolized, as aerobic processes can no longer meet the demand for oxygen, resulting in 
lactate production and accumulation. Increased capacity for lactate clearance in trained 
individuals prevents, or minimizes lactate accumulation and lactic acidosis at higher exercise 
intensities. After maximal exercise, or exercise to an individual's perceived maximum level, 
at which stage the glycolytic processes will be the sole fuel source, blood lactate continues to 
rise, reaching a peak 3 to 5 minutes after exercise cessation. An accumulation of protons can 
be the factor that causes fatigue and will thus be a contributing factor in termination of an 
exercise test (Astrand & Rodahl, 1986). There is good evidence that a muscle lactic acidosis 
which causes intramuscular pH to decline to approximately 6.4, will interfere with excitation- 
contraction coupling and lead to muscle fatigue in strenuous exercise (Brooks, 1987). An 
individual's ability to tolerate the rising blood lactate concentration will influence the 
duration of exercise and their capacity to continue exercise during a maximum aerobic 
capacity test. 
Measurement of peak blood lactate levels following a maximal exercise test will give a good 
indication of individual tolerance levels. The peak level of lactate will reflects the individual's 
"pain" threshold and therefore, their motivation to continue. Since regular exercise improves 
the metabolic efficiency of the muscles, having a glycogen sparing effect, blood lactate levels 
at submaximal workloads will also decrease and measurement of blood lactate levels before 
and after training provides a basis for comparison of exercise capacity and lactate tolerance. 
This reduced lactate accumulation that is associated with regular aerobic exercise occurs 
through decreased production (Holloszy & Coyle, 1984), increased clearance (Donovan & 
Brooks, 1983) and increased intramuscular buffering capacity (Parkhouse & McKenzie, 
1984). Conversely, a lactacidosis occurs at low workloads in unfit individuals and has also 
been shown in patients with "vasoregulatory asthenia" (Jones et al, 1975). 
41 
2.5.3 Perceived exertion rating 
It has been shown that the heart rate is linearly related to exercise intensity and can be used as 
a predictor of aerobic capacity (Astrand & Rhyming, 1954). The subjective rating of the 
intensity of exertion has also been shown to be a good indicator of the physiological work 
being done (Borg, 1970). The scale that was developed, based on this relationship, shows 
correlations of between 0.77 and 0.9 between heart rate, physiological indicators of fatigue 
such as oxygen consumption, blood lactate and ventilation, and a subjective rating of 
perceived exertion (RPE) (Pandolf, 1983). Borg's original 15 point RPE scale, has values 
ranging from 6 to 20, with verbal anchors at each odd integer ranging from "very, very light" 
to "very, very hard" (Borg, 1970). It is intended to correspond to each individual's mental 
tabulations of his/her own individual physiological responses 
Many factors, such as pain threshold, individual sensory acuteness, experience of the activity 
and the overall level of conditioning affect the individual's estimate of their effort expenditure 
(Carlton & Rhodes, 1985). It is dependent on both central and peripheral contributions and 
the size of the muscle mass involved. During low intensity exercise, the physical strain in the 
working muscles is the primary stimulus for effort perception, while at higher intensities, 
above a critical threshold, the central input also contributes to effort perception (Robertson et 
al, 1979). Eston et al (1987), concluded that RPE was a good predictor of metabolic demand 
during exercise. Generally, it is agreed that local factors (blood lactate levels and muscular 
strain) dominate the individual's perception of exertion (Mihevic, 1981; Pandolf, 1983), 
particularly at low to moderate intensities. Central factors (ie. heart rate, oxygen uptake, 
ventilation) may serve as amplifiers to local factors relative to aerobic demand (Caferelli, 
1977; Robertson, 1982). This implies that central factors would mainly dominate at higher 
intensities; ie. unless a physiological response is highly activated and provides input for 
conscious awareness, it is unlikely to have a significant impact as a perceptual cue. 
Since it is well documented that the metabolic cost of submaximal exercise is reduced 
following an aerobic training programme (Kilbom, 1971), it would be expected that this 
should be perceived as involving less effort; ie. at any given submaxiinal workload, RPE 
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should be reduced following physical conditioning (Carlton & Rhodes, 1985). Ekblom and 
Goldbarg (1971), recorded decrements in RPE after six weeks of aerobic training in a group 
of rheumatoid arthritis patients and Kilborn (1971) also showed reduced submaximal RPE 
levels after seven weeks of bicycle training at 707OV02 max. Similarly, Hagberg et al (1989) 
found that endurance training reduced RPE for a given percentage of maximum oxygen 
consumption for a sample of individuals aged 70 to 79 years, whereas resistance training had 
no effect. 
Evidence suggests that rather than a single primary cue, multiple sensory inputs of local and 
central origin are integrated and weighted by the individual to arrive at an evaluation of 
overall perceived exertion. Therefore, the use of the RPE scale in conjunction with other 
measures of physical fitness provides a link between physiological indicators of stress (heart 
rate) and a psychological indicator (subjective perception of bodily sensations), which can 
also be used as a measure of adaptation to training. 
2.5.4 Strength measurement 
In order to carry out normal daily activities successftilly, muscles must possess an adequate 
degree of strength, a lack of which may reduce the individual's physical capacity to perform 
specific movements and limit the ability to undertake certain physical tasks. It is related to 
other aspects of an individual's capacity, and should not be considered as an isolated 
component. Muscle strength can be discussed in terms of a continuum from maximal 
strength to strength endurance and local muscle endurance. The maximal strength refers to 
the maximum amount of force that a muscle or group of muscles can generate in a single 
maximal contraction. This may determine whether they are capable of lifting or moving a 
heavy object. The ability to repeat or sustain muscular contractions over a set period will 
affect an individual's ability to carry out normal activities such as walking, carrying objects 
or climbing stairs. The strength of a muscle can be. determined by using various types of 
muscular contraction. Muscle strength can be measured isometrically, isotonically or 
isokinetically, each of which has inherent limitations but also specific uses. It is well 
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documented that muscle strength decreases with age, but it has also been difficult to 
disentangle the effects of ageing from the decreased physical capacity that accompanies it 
(Bassey, 1978). 
The maximum voluntary isometric force of the quadriceps is a measurement commonly made 
in both in clinical and experimental studies (Rutherford et al, 1986; Edwards et al, 1977). 
Testing of maximal strength requires a high level of motivation in the subject, which may be 
inhibited by fear of pain or pain itself. As a result, weakness and low recorded strength 
values can be due to submaximal activation of the muscle rather than muscle atrophy 
(Rutherford & White, 1991), due to an inherent inhibition of the expression of maximal 
muscular strength in humans. Also, low frequency fatigue can be attributed to impaired 
excitation-contraction coupling, whereby the action potential fails to release the normal 
amount of calcium such that fewer cross-bridges are available for force generation. To 
produce a maximum contraction, a high stimulation rate and a high ATP turnover are 
essential. Therefore, central inhibition, neurornuscular junction failure and impaired 
excitation of the sarcolemma, could result in reduced muscle performance (Edwards, 1982). 
Whether inactivity results in decreased activity of the sarcolemma, through alteration in 
calcium release or ATP turnover remains to be shown. In this respect muscle weakness can 
occur in the presence of normal muscle mass, if the patient has impaired central activation or 
neuromuscular transmission. The causes of fatigue are therefore regarded as being located 
centrally or peripherally. A technique has been developed, for use in the clinical situation, 
that can be used to distinguish between central and peripheral causes of weakness (Edwards et 
al, 1977; Rutherford & Newham, 1986). This technique involves percutaneous electrical 
stimulation of the quadriceps during maximal voluntary isometric contraction and is useful for 
identifying inhibition in the absence of pain or an inability to fully activate the muscle. 
2.5.5 Resting lung function 
Pulmonary function testing can exclude or confirm a suspected disorder or assist in 
quantifying the respiratory impairment. Resting lung function tests were included to 
determine that patients and subject had no underlying airways obstructions that might impair 
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their exercise response. The forced Vital Capacity (FVC) represents the maximal amount of 
gas that can be expelled from the lungs following a maximal inspiration and measures 
restrictive lung problems. Forced Expired Volume in 1 second (FEVI) is useful in 
determining if there is any airways obstruction. The maximal flow rate is limited by the rate 
by which the respiratory muscles are able to transform chemical energy into mechanical 
energy and also by a rising flow resistance. 
2.5.6 Body fat percentage 
Body composition is a better guide for determining the desirable body weight than the 
standard height-weight-age tables. Changes in activity patterns and diet, such as the changes 
associated with chronic illness, can have a profound effect on an individual's body 
composition. In this respect, prolonged inactivity can lead to large decreases in lean muscle 
tissues with or without gains in body fat levels, leading to loss of muscle strength and ability. 
A high level of body fat increases the energy demand of normal activities such that 
overweight individuals find it increasingly difficult to remain active. Measurement of body 
fat levels can, therefore, give an indication of body composition outside the desirable ranges 
for healthy individuals. Body fat was assessed to determine if, potentially as a result of their 
altered and inactive lifestyles, CFS patients had body fat levels outside or above desirable 
levels. It would also be possible to measure whether this changed at all during the course of 
the study as a result of increased activity levels. 
2.6 Psychological Assessment 
Accurate definition and measurement is also essential in psychological medicine, although 
this task is somewhat more difficult than in physical medicine. The instruments available 
consist of a range of validated, condition or disease specific questionnaires, rating scales and 
structured interviews. The development and refinement of these questionnaires, whereby 
patients themselves assess their symptoms, is leading to the increasing use of such 
instruments. For any psychiatric assessment, reliability is essential. This signifies that the 
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various items should demonstrate a reasonable degree of internal consistency. As a rule, a 
phenomenon is measured by a minimum of 6 items. The psychiatric evidence of the 
reliability of the scale (internal consistency) is often expressed by a correlation coefficient, 
wgich indicates the degree to which the selected items are positively correlated. 
Two main type of scales are used in psychiatric measurement: 
1. Likert scales consist of a number of categories (symptoms), each of which is rated in terms 
of severity, often on a five-point scale (0-4) (Likert, 1952). in this type each item on a 
symptom scale is characterized by means of a "quantitative" scale, e. g. 0= not present, I= 
questionably or slightly present, 2= present to a mild/moderate degree, 3 present to a 
moderate/marked degree and 4= present to a marked/extreme degree. 
2. Visual analogue scales (VAS) combine a straight line, usually 10cm in length, with verbal 
cues, whose two end points represent the extremes of the scale, e. g. "definitely not present" 
and "present to an extreme degree". The rater/patient places a mark on the line to indicate 
where they lie on the dimension of severity at that moment. The rating score is then the 
distance measured from the left extreme (not present) to the marked point, in millimeters. 
Some statisticians claim that the use of VAS is preferable to the categorizing scales, since 
they provide more complete information since, by use of a limited number of response 
categories, some information is lost (McCormack et al, 1988). 
Questionnaire formats may vary from single-item questions, to batteries of questions, to 
complete surnmative scales. These will incorporate the response formats described above. 
2.6.1 Self-report scales in psychological assessment 
For the purpose of any study measuring quality of life among patients as an outcome measure 
of treatment provided, a decision must be made on whether to use a diagnostic screening tool 
or a self-report symptom questionnaire or a combination of both. Psychiatric screening 
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instruments can be used to provide a categorical psychiatric diagnosis, whereas self-report 
questionnaires yield mainly dimensional data. For assessment of health outcomes, self- 
reported feelings (e. g. anxiety and depression) and self-reported and observed role 
functioning and behaviour are sufficient indices of psychological morbidity and severity. 
With self-rating scales, the patient is allowed to make their own judgement of severity, using 
phrases like "a little" or "a great deal" because self-rating scales have to speak the patient's 
own language as a priority and most patients have their own lay experience on which to base 
their judgement. In this way a specific psychiatric screening tool may be used to diagnose and 
thus to highlight any conditions that would exclude a patient from entering a specific 
treatment programme. Self-report symptom functioning and behaviour scales will then be 
useful to measure change as a result of treatment. To be used in this context, a scale must 
have validity in terms of criterion, concurrent or predictive aspects, in that it measures what 
it is supposed to be measuring. Criterion validity implies that there is agreement between the 
scale scores and some external criterion - usually done by testing a scale against expert 
clinicians global judgements of severity as recorded on a numerical scale varying from 3- 11 
observations. For concurrent validity, the scale is tested against already established 
instruments. Predictive validity defines that the scale is designed to predict the outcome of a 
particular treatment. All of the rating scales used in this study have been chosen to be valid 
measures for the particular aspect being assessed. 
A very wide range of self-report scales exists for the measurement of psychiatric and 
psychological variables. In addition to the more obvious symptoms of physical and mental 
fatigue, CFS has been linked with depression, sleep disorders and general feelings of poor 
health and vitality. Appropriate self-rating scales must be selected to measure changes in 
these parameters over time and a number of scales that have previously been employed in 
studies with CFS patients. Some rating scales are designed to measure changes in symptoms, 
whereas others focus on long-term trend. The most important function of symptom scales is 
that of measuring changes in symptoms over the course of the treatment period. By using the 
same scale before and after treatment, the effect of the individual's symptoms can be 
evaluated separately. When assessing emotional status, it should be noted that most scales 
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employed for this include symptoms that can be a manifestation of physical illness (National 
Task Force, 1994). The Hospital anxiety and depression scale was specifically designed to 
avoid such symptoms. It is a validated scale that measures both anxiety and depression in 
patients who have physical diseases, in order to bypass the confounding effects of mood 
disturbance on physical symptoms, for example, sleep disturbance, weight loss and energy 
levels (Zigmond & Snaith, 1983). The Pittsburgh sleep quality index (PSQI), a validated 
scale to measure symptomatic sleep disturbance (Buysse et al, 1988). This is a useful 
measure in CFS patients since sleep deprivation has been shown to have a detrimental effect 
on perceived exertion levels during submaximal activities (Myles, 1985). The MOS-36 
(SF36) is a short form from the Medical Outcomes Studies Measures, and comprises brief 
scales for physical functioning, role lin-fitations due to physical problems, role limitations due 
to emotional problems, social functioning, bodily pain, general mental health, vitality and 
general health perception (Ware & Sherbourne, 1992). A number of scales designed to assess 
fatigue have been developed. The visual analogue fatigue scale has been validated as a 
measure of both physical and mental fatigue in patients suffering from post-infectious fatigue 
syndromes (White et al, 1995). The Wessley fatigue scale has been validated as a measure of 
global subjective fatigue in patients with CFS (Chalder et al, 1993), and the Barsky scale has 
been validated as a measure of somatic symptoms amplification in various patient populations 
(Barsky et al, 1988). The clinical global impression scale is a valid and reliable scale , and 
has been used in the area of psychopharmacology, to measure overall change in conditions 
and symptoms (Guy, 1976). 
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CHAIlrER THREE: METHODOLOG 
3.1 Screening 
Ethical approval was obtained from the District (East London and the City) Health Authority 
Research Ethics Committee. Test procedures and all requirements of involvement were 
explained in detail to each patient by the senior physiologist and a qualified psychiatrist. 
Patients were then asked to carefully read through and sign the consent form (Appendix B). 
Chronic Fatigue Syndrome subjects 
Only those chronic fatigue syndrome patients fulfilling the Oxford criteria (Table 3.1) were 
eligible to take part (Sharpe et al, 1991). Full physical screening was carried out or, where 
appropriate, full recent records were obtained from the referring doctor. The purpose of this 
was to exclude any patients with potentially causative organic disorders. Patients with 
disorders known to cause fatigue were excluded from entry into the study. These included 
thyroid disorders, multiple sclerosis, symptomatic sleeping disorders, sleep apnoea, abnormal 
electrolytes and calcium disorders. All CFS subjects were outpatients. A full psychiatric 
history was also documented for each CFS subject, using the Structured Clinical Interview 
(SCID)(Spitzer et al, 1990). In addition to those major psychiatric disorders excluded by the 
Oxford Criteria, patients with all other DSM-III-R psychiatric disorders (Diagnostic and 
Statistical Manual for Mental Disorders- 3' revised edition) (American Psychiatric 
Association, 1987), apart from simple phobias, were excluded, as well as those who reported 
significant symptomatic sleep disorders because of it's separate effect on fatigue. A type of 
fatigue does exist whereby patients complain of fatigue with accompanying hypersomnia, but 
who do not fulfil criteria for CFS or any psychiatric disorder (White et al, 1995). In this 
respect, patients presenting primarily with a sleep disorder may suffer from chronic fatigue 
but not Chronic Fatigue Syndrome. 
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One hundred and sixty seven outpatients attending a hospital chronic fatigue clinic, which has 
been in existence in a department of psychiatry for 11 years, were screened for the study. 
Ninety-six subjects did not meet criteria for the trial for the following reasons: 35 had a 
depressive illness, 23 had a generalised anxiety or panic disorder, 3 had significant insomnia, 
16 had another psychiatric disorder, 9 had a medical exclusion, 5 were too well, 5 were too 
incapacitated and received inpatient treatment, 5 patients refused to participate in the trial. 
Those that were considered too well had recovered significantly from the CFS symptoms and 
no longer fulfilled the criteria. All potential subjects with CFS, and either a psychiatric 
disorder or sleep disturbance, were offered appropriate treatment for their co-morbid 
disorder. If treatment of the co-morbid disorder was successful, but they still met criteria for 
CFS, they were recruited into the study. Seventeen percent (11/66) had had a major 
depressive disorder at initial screening; 6 (9 %) initially had a generalised anxiety disorder. 
Ten (15 %) subjects with sleep disturbance were successfully treated by cessation of caffeine 
and/or a low dose of a sedative anti-depressant given at night, and entered the study. 
Seventy-one subjects met criteria for the trial, of whom 5 declined. Sixty six subjects gave 
valid, informed consent and were recruited into the study. 
TabIe 3.1 Symptom criteria for chronic fatigue syndrome 
CHRONIC FATIGUE SYNDROME (Sharpe et a], 1992) -"Oxford criteria" 
A syndrome characterised by fatigue as the principal symptom 
A syndrome of definite onset that is not life long 
The fatigue is severe, disabling and affects physical and mental functioning 
The symptom of fatigue should have been present for at least 6 months during which time it was present for 
more than 50 % of the time 
" Other symptoms may be present, particularly rayaIgia, mood and sleep disturbance 
" Certain patients should be excluded from the definition, including: 
a. patients with established medical conditions known to cause chronic fatigue 
b. patients with a current diagnosis of schizophrenia, manic depressive illness, substance abuse, eating 
disorder or proven organic brain disease 
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Healthy Sedentary Controls 
Healthy sedentary controls were recruited through posters and personal referral from staff 
and their colleagues at St Bartholomew's Hospital and Medical College. Prior to entry into 
the study, all volunteers were required to complete an activity questionnaire (Appendix C) 
describing in detail the number of occasions they took part in a physical activity in the 
previous three months; the number of times they took part in strenuous, moderate or mild 
activity in the average week as well as determining their attitude to activity, i. e. whether they 
considered themselves adequately active or sedentary. Only those considered as truly 
sedentary, on the scoring system, were accepted for entry into the study, i. e. they took part in 
no strenuous activity and exercised moderately less than once per week. 
For the baseline inter-group comparison, 33 healthy sedentary controls and the 66 CFS 
patients, underwent the complete physiological and psychological assessment, as described 
below. The 66 CFS patients were those recruited for the treatment study, while the control 
group subjects were assessed on one occasion only. The control group and the depressed 
group were age, weight and gender matched with the CFS patient group. 
In addition, a small group of ten outpatients with major depressive disorders were recruited 
by the supervising consultant or by referral from other consultants within the Department of 
Psychological Medicine at St Bartholomew's Hospital. As with the control group, the 
depressed patients went through all of the assessments during one visit. Their results on the 
same physiological and psychological tests were compared with those of the CFS patient 
group. 
3.2 Psychological and symptomatic assessment 
On the initial assessment a structured psychiatric interview, the Structured Clinical Interview 
for DSM - IIIR (SCID, American Psychiatric Association, 1987), was carried out by a 
qualified psychiatrist. The use of SCID requires clinical experience in and knowledge of 
DSM-Ill and DSM-III-R (Diagnostic and Statistical Manual for Mental Disorders). The 
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structured clinical interview (SCID) is constructed to start with questions about demographic 
data and the major complaint of the patient. The order of questions has been arranged to 
correspond to the differential diagnostic reasonings in DSM-111. The SCID provides current 
diagnosis of mental disorder according to the DSM-111-R as well as lifetime diagnosis and can 
be used reliably to differentiate major depression from generalised anxiety disorder in 
outpatients. All subjects then completed a total of six questionnaires to assess depression, 
anxiety, sleep quality, somatic symptom amplification, functional capacity general health 
score and mental and physical fatigue. On subsequent visits (CFS patients only) only the 
SCID and Clinical Global Impression change score (CGI) (Guy, 1976) were carried out by a 
qualified psychiatrist, blind to the treatment group, and the psychological questionnaires were 
completed, again by the patient, at the time of their physiological reassessment. 
A combination of symptom scales and a global rating scale were used in this study. 
Symptom scales contain groups of items, each of which contributes partly, by describing the 
area covered by the scale, e. g. depression, and partly be standardising the measured 
dimension with which the scale operates, e. g. slight, moderate or severe depression. In 
contrast to this, with global rating scales, the contents and standardisation are less precise, 
but they are useful to include to supplement symptom scales and are they particularly useful 
in clinical trials (Bechetal, 1993). 
All symptom scales were completed by the subjects in the same room at each assessment, in a 
relaxed and quiet setting (See Appendix C for scales). The purpose of all tests both 
physiological and psychological was clearly explained. At all stages the symptomatic 
questionnaires were completed prior to the physiological assessments. Every effort as made 
to carry out all re-assessments at the same time of day as the initial baseline assessment, to 
avoid potential time-related changes in mood over the period. This was also important for 
the physiological reassessment due to diurnal variations in physiological parameters. 
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The Hospital Anxiety and Depression Scale (HAD) (Zigmond & Snaith, 1983) 
The HAD scale is a self-assessed mood scale, designed as an instrument to screen for 
clinically significant anxiety and depression in patients attending a general medical clinic. 
Anxiety and depression were selected as the two most common aspects of neurosis presenting 
in hospital practice. It avoids questions about symptoms that might be caused by physical 
disease (such as weight loss or sleep disturbance) and thereby overcomes inflation of 
psychiatric measures by physical diseases. The scale is recognised as a valid measure of the 
severity of these disorders of mood such that repeated administration of the scale at 
subsequent attendances can give useful information about changes and progress. This measure 
was used to assess change in mood with treatment and to assess baseline effects on treatment 
success 
The HAD Scale is a 14 item questionnaire with seven items composing the depression 
subscale and seven the anxiety subscale. There is a choice of 4 responses to each item and 
subjects were asked to complete it in order to reflect how they felt during the previous week. 
The choice of response is time based, with choices of "definitely as much" (3) to "hardly at 
all" (0) to questions such as, "I feel restless as if I have to be on the move" (anxiety) or "I 
still enjoy the things I used to enjoy " (depression). Responses are scored from 0 to 3 and 
separate scores up to a maximum 21 each were obtained for depression and anxiety. For both 
the depression and anxiety subscales, a score of 7 or less is a non - case, scores or 8- 10 are 
doubtful cases and scores of 11 or more are definite cases. 
Validity of the HAD was assessed by comparison with the Montgomery-Asberg Depression 
Rating Scale (MADRS) (Montgomery & Asberg, 1979) for depression and the Clinical 
Anxiety Scale (CAS) (Snaith et al, 1982) for anxiety. In a subsample of patients with a 
definite mood disorders, the correlation coefficient of the depression scale with the MADRS 
was 0.77 and the correlation of the anxiety scale with the CAS was 0.67. Internal 
consistency of the two scales was examined by calculating correlations (Spearman) between 
each item and the total score for the remaining items of the subscale. These correlations 
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ranged from 0.76 to 0.41 for anxiety (p < 0.01) and from 0.6 to 0.3 for depression (p < 0.02) 
(Zigmond & Snaith, 1993). 
Yhe Fatigue Questionnaire (Chalder et al, 1993) 
Fatigue is a difficult symptom to define and many attempts have been made to measure 
fatigue objectively and subjectively. Fatigability, as an objective inability to sustain power, 
can be measured electrophysiologically, but it is not necessarily related to the subjective 
sensation of fatigue (May & Kline, 1988). The Fatigue Questionnaire contains a list of 
fourteen questions to assess physical and mental fatigue and can be used in the assessment of 
symptom severity, the detection of fatigue cases in epidemiological studies, and as a valid 
estimator of change. This scale was used to measure the severity of subjective fatigue of 
patients and to assess change with treatment. 
Four response options are given for each item and Likert-type scoring was used to assign 
weights to each position with "0" being better than "3". A total fatigue score (up to a 
maximum of 42) is obtained by adding up all the items. The scale is subdivided into two sets 
of items relating to physical fatigue (questions 1- 8) and mental fatigue (questions 9- 14). 
Examples of typical questions are "do you start things without difficulty but get weak as you 
go on" - physical fatigue and "do you have difficulty concentrating" - mental fatigue. The 
Cronbach's alpha scores for internal consistency of the total fatigue scale range from 0.88 - 
0.9 calculated for all items, with scores of 0.85 and 0.82 for the two sets of items for 
physical and mental fatigue, respectively (Chalder et al, 1993). 
Relative operating characteristics (ROC) analysis was used to assess the discriminating ability 
of the scale across the total spectrum of morbidity, using area under the curve, giving an 
ROC value of 0.85 (Chalder et al, 1993). This demonstrates the ability of the scale to 
discern between "cases" and "non- cases". The more sensitive the scale the greater the area 
under the curve, where 1= total agreement. The fatigue scale has been shown to have good 
face validity and reasonable discriminant validity as an estimator of change evaluated on an 
open treatment trial (Butler et al, 199 1) 
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7he Visual Analogue Fatigue Scale (Mite et al, 1995) 
The status of fatigue as a physiological response, psychological perception, or a symptom of 
physical or psychiatric disorders remains unclear. Individuals can experience physical fatigue 
independent of mental fatigue, mental fatigue as distinct from physical fatigue or both 
together such that it becomes difficult to distinguish the exact nature of the fatigue. A visual 
analogue self-rating scale has been devised that allows patients to distinguish between mental 
and physical fatigue and also both exertional and persistent forms of these. It has previously 
been found that physical fatigue, particularly after exertion is more significantly severe in 
fatigue states than psychiatric disorders and therefore would allow us to differentiate pure 
fatigue disorders. The complaint of physical fatigue, especially post-exertional, may be 
important in differentiating post viral fatigue states from psychiatric disorders. The Visual 
Analogue Fatigue Scale was devised originally with CFS and depressed patients and therefore 
provides a useful tool for assessment and comparison with other similar groups (White et al, 
1995). These measures were used to assess the different responses of the different types of 
fatigue to treatment. Subjects were required to score four 0 to 100mm visual analogue scales, 
where 0 stands for optimally healthy or non-existence of the symptom and 100 stands for a 
severe or strong prevalence, by placing a mark on the line at the point most applicable to how 
they felt in the previous week. The four lines were used to measure the principle components 
of fatigue - "persistent mental", "persistent physical", "exertional mental" and "exertional 
physical" fatigue. A score of fifty represents a normal value with high scores indicating 
excess fatigue. 
VAS scales have been shown to have good discriminating and social validity for repeated 
measures (May et al, 1986). The validity of the VAS fatigue scale has been demonstrated its 
use with different diagnostic groups (upper respiratory tract infections and glandular fever), 
although very little analytical data exists as of yet. White et al (1995) found self-ratings of 
fatigue to be significantly higher in those with fatigue states and psychiatric disorders, than in 
those who were well. At 2 months after onset, subjects with fatigue states had significantly 
more persistent fatigue than those with psychiatric disorders (62 vs 54, p=0.001) and more 
physical fatigue (74 vs 56, p= 0.0001). The total physical fatigue shown to be significantly 
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higher in fatigue state subjects (p=0.0001) The data demonstrates that the VAS scale can 
discriminate between fatigue related to psychiatric disorders and a fatigue state. Persistent 
physical fatigue can be used to differentiate those with fatigue states from those with 
psychiatric disorders. The internal consistency of the VAS fatigue scale has not been assessed 
to date. 
Two scales were used to measure fatigue since fatigue is the main symptom of this syndrome 
and it was important to assess it comprehensively and accurately. Some patients respond 
better to a Likert-type scale and others to a visual analogue scale, so using the two types 
allowed for greater certainty of assessing this symptom according to paientsindividual 
preferences. 
7he Pittsburgh Sleep Quality Index (PSQI) (Buysse et al, 1989) 
Sleep quality is also complex and difficult to define quantitatively and objectively. Poor sleep 
quality can be an important symptom of many medical disorders and complaints about sleep 
quality are common. They are particularly associated with Psychiatric disorders, and 
frequently accompany anxiety and stress in the general population (Karacan et al, 1983). 
Sleep disorders are also common in patients with chronic or unexplained fatigue (Buchwald et 
al, 1994; Manu et al, 1994). The PSQI was devised to provide a reliable, valid and 
standardised measure of subjective sleep quality and quantity, to discriminate between good 
and poor sleepers, and to provide a brief, clinically useful assessment of a variety of sleep 
disturbances that might affect sleep quality. It can also be useful to study the association 
between sleep disturbance and other disorders, such as age, gender, health status and medical 
and psychiatric variables. Subjective sleep disturbance was measured in order to examine its 
confounding effect on exercise treatment, and to exclude those patients with significant 
subjective sleep disturbance. Sleep quality includes quantitative aspects of sleep, such as 
sleep duration, sleep latency or number of arousals, as well as more purely subjective aspects, 
such as "depth" or "restfulness" of sleep. 
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The PSQI assesses sleep quality during the previous month. The scale consists of 19 self- 
rated questions to assess a wide variety of factors relating to sleep quality, including estimates 
of sleep duration and latency, and the frequency and severity of specific sleep-related 
problems. This includes questions such as, "during the past month, have you had trouble 
sleeping because you - (a) cannot get to sleep within 30 minutes or (b) wake up in the middle 
of the night or early morning". Response choice range from "not during the past month" to 
"three or more times per week", with grades in between. These 19 items are grouped into 7 
component scores sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep 
disturbance, use of sleeping medication, daytime dysfunction - each weighted equally on a 
scale of 0 to 3. Sleep efficiency and number of hours sleep per night are also rated from a0- 
3 point scale. The seven components are added together to yield a global PSQI score ranging 
from 0-21, with higher scores indicating poorer sleep quality. 
The seven component scores had an overall reliability coefficient (Cronbach's alpha) of 0.83, 
indicating a high degree of internal consistency. This implies that each of the 7 components 
appears to measure a particular aspect of the same overall construct, i. e. sleep quality. Test- 
retest reliability gave no significant differences on paired Wests, with the questionnaire 
completed on 2 occasions, 28 days apart with no intervention in between. Validity was 
determined by comparing PSQI estimates of sleep variables with those obtained by 
polysonmography. T-tests showed no difference between PSQI estimates and laboratory 
findings for sleep latency (r = 0.33, p< 0.001). A global PSQI score >5 provided a sensitive 
and specific measure of poor sleep quality, relative to clinical and laboratory measures as well 
as by comparison of healthy subjects with those with known sleep disorders. (Buysse et al, 
1989) 
Barsky Amplification Scale (Barsky et A 1988) 
Somatosensory amplification refers to the tendency to experience somatic sensations as 
intense, noxious or disturbing. It can involve either a heightened attentional focus on bodily 
sensations or a tendency to select out and concentrate on some relatively mild and infrequent 
sensations. Amplification encompasses a wide range of somatic stimuli and bodily states, and 
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is not necessarily limited to those sensations symptomatic of disease. In this respect some 
individuals can also be more inclined to recognise and report both psychological and somatic 
symptoms, such that they amplify all forms of distress, verifying the close relationship 
between psychological symptoms of emotional distress and somatic symptoms of bodily 
distress. Somatosensory amplification can be measured with this self-report questionnaire to 
assess the tendency of an individual to amplify a broad range of bodily sensations, which has 
been shown to have associations with anxiety, depression and hostility and to be a predictor 
of impairment of functioning (Barsky et al, 1988). This scale was used to assess whether 
"somatization" alters treatment efficacy or changes with treatment. The amplification scale 
consists of five self-report questions. Patients or subjects were asked to rate how 
characteristic each of the items was of them on a five point scale from 0, ("not at all") to 4, 
("extremely"), giving a maximum score of 20. The questions relate to sensations of pain, 
noise, hunger and cold/heat. Intra-scale reliability (internal consistency) was 0.72, according 
to the Cronbach's alpha method. The test-retest reliability was assessed by re-admistration of 
the scale to 52 patients over periods from 1.5 to 5 weeks and this gave a coefficient of 
reproducibility of 0.85. Evidence of its predictive validity was obtained from a high 
correlation (r = 0.58, p=0.0001) with DSM-II hypochondriasis scale (Barsky et al, 1988).. 
Short Form 36 (SF36) Health Survey Questionnaire 
Traditional measures of morbidity to assess the effects of different health care interventions 
that can influence a wide range of variables, such as physical mobility, emotional well-being, 
social life, and overall well-being, are generally agreed to be to restricted (Brazier et al, 
1992). General health measures can be used to examine the relative burdens of different 
diseases and the relative benefits of different treatments, in a different way than disease 
specific or treatment-specific measures. The SF 36 is a short form of the Medical Outcomes 
Survey (MOS) questionnaire, and is a standardised, comprehensive and brief, self-rated 
measure of how people perceive their health and capacity (Ware & Sherboume, 1992). The 
Health Survey Questionnaire represents the health concepts most frequently included in health 
surveys - physical, social and role functioning, mental health, and general health perceptions 
- as well as two additional concepts - bodily pain and vitality. Each of the eight health 
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concepts were scored separately, from 0 to 100, with low scores indicating poorer health and 
capacity. 
Physical functio was assessed with 10 items, ranging from less demanding functions like 
bathing and dressing, up to the most vigorous activities of running, lifting heavy objects and 
strenuous sports, with walking, climbing, bending and moderate sport falling in between. 
Low scores indicated a lot of limitation in all physical activities, and high scores indicated 
that all types of physical activities could be performed without limitations due to health. 
Three choices of response were given for each activity, from "limited a lot" to "not limited at 
all". The first of two function scales physical rol , was constructed from questions about 
health-related limitations in the type or amount of work. Low scores indicated problems with 
work or other daily activities as a result of physical health and high scores indicated no such 
problems in the previous 4 weeks. This included 4 questions, such as "due to health, have 
you accomplished less than you would like to" with yes/no responses for each. Bodily pai 
assessed the frequency of bodily pain or discomfort and the extent of interference with 
normal activities because of pain using 2 questions. The answers ranged from "not at all" to 
"extremely" A low score indicated very severe and extremely limiting pain, and a high score 
implied no pain or limitations due to pain in the previous 4 weeks. General health perception 
used 4 questions using 5 response choices ranging from definitely true to definitely false on 
questions such as, "I am as healthy as anybody I know". Low scores indicate a belief in 
poor personal health that is likely to get worse and high scores, a belief in excellent general 
health. A four-item measure of vitali was used to assess subjective well-being, using 5 
response choices from "all of the time" to "none of the time". The scores ranged from 
feeling tired and worn-out all the time (low) to feeling full of pep and energy all of the time 
(high) in the previous 4 weeks. A typical question would be "Do you feel worn out" or "Do 
you have a lot of energy". The social functio item assessed health related effects on social 
activity using a5 choice scale ranging from "not at all" to "extremely". The questions 
enquired as to what extent or how much of the time physical or emotional health interfered 
with social activities, such as visiting friends. High scores indicate that physical and 
emotional problems have not interfered with normal social activities in the past 4 weeks. The 
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second function scale assessed role limitations because of emotional problems fLQ_IC 
emotiona ) with 3 questions and a yes/no response choice to questions asking to what extent 
emotional health has caused them to, "accomplish less than you would like". Low scores 
indicate problems with work or other daily activities as a result of emotional problems while 
high scores indicate no problems in these areas. The mental health scale includes one or more 
items from each of the four major health dimensions (anxiety, depression, loss of behavioural 
or emotional control and psychological well-being). Typical questions would be "Have you 
felt down-hearted and blue" or "Have you been a happy person". The response choices 
ranged from "all of the time" to "none of the time". Low scores indicated feelings of 
nervousness and depression all of the time and high scores indicated feeling peaceful, happy 
and calm in the past 4 weeks. 
The item total correlation coefficients for the 36 items within the 8 health scales ranged from 
0.55 to 0.78 and Cronbach's Alpha exceeded 0.8 on all eight scales, ranging from 0.80 to 
0.92. both providing evidence of internal consistency. Clinical validity (construct) was 
shown by clear differences in self reported health between the general population and patients 
with four common conditions and by a high level of agreement between SF36 scores and 
general practitioners' perceptions of symptom severity (Garratt et al, 1993). 
Clinical Global Change Scale (Guy, 1976) 
The main outcome measure in the treatment study was the Clinical Global Impression 
change scale (CGI). Global rating scales are extremely simple instruments, which require 
little time for assessment and recording, but they do not provide the same details as 
symptom rating scales. Therefore it is generally recommended that global rating is used in 
conjunction with symptom rating scales (Bech at al, 1993). The CGI is a frequently used 
and validated self-rated measure of severity of illness or overall change since admission 
into a study or compared to treatment onset. Global scales of change are bipolar scales, in 
that they use, for example, the following categories: 3= marked improvement, 2= 
moderate improvement, 1= slight improvement, 0= no certain improvement, -1 = slight 
deterioration, -2 = moderate deterioration, -3 = marked deterioration. For ease of use 
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and for scoring purposes, the numerical values tend to shift so that the scale ranges from 1 
marked improvement/very much better to 7= marked deterioration/ very much worse. 
The use of scales for change requires a good retrospective and global memory and is 
therefore most appropriate for short-term therapeutic studies, such as this one (Guy, 1976). 
The span for global improvement is "since admission into the study" and not from the last 
rating period. This nature of global scales makes them relevant and meaningful in 
evaluation of therapeutic effect. Due to the lack of definition of the scales and 
standardisation studies, they have played only a modest role in many scientific 
investigations within clinical psychiatry. The validity can be verified by its use in several 
trials (Ahlfors et al, 1980; Heikkila at al, 1981). Provided that the assessor is a trained 
clinician who is familiar with the medical aspect of the illness, the scale by definition 
becomes valid, since global assessment of a disease condition is part of traditional 
psychiatry. Under these conditions, the reliability becomes very good, generally better than 
symptom rating scales (Bech et al, 1993). 
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3.3 Physiological Assessment 
Visit On 
All physiological assessments were carried out at the exercise physiology laboratory at the 
National Sports Medicine Institute. Full explanations given of the test procedures and trial 
requirements were again given prior to the assessment. Lifestyle details were taken by the 
senior physiologist including questions on smoking and drinking habits, duration and initial 
onset of illness, premorbid and current activity levels and any activity that they found 
particularly difficult. Patients were asked to refrain from eating for at least one and a half 
hours Prior to their appointment for comfort to eliminate any potential adverse effects of the 
exercise or anxiety about the tests on digestion, and they were instructed to bring comfortable 
walking shoes and loose clothing. 
Body composition 
The percentage of body fat was measured using a Harpenden skinfold calliper. Three 
skinfold measurements were taken at each of four sites - triceps, biceps, subscapular and 
suprailiac - according to the method by Durnin and Wormersley (1974). The average of each 
of the four site measurements was added to give a total four site skinfold score in millimetres. 
This measurement was used to assess baseline body fat levels in relation to general population 
norms and to monitor any changes in body fat levels during the course of the treatment 
Resting lungfunction 
Forced Vital Capacity (FVC) and Forced Expired Volume in I second (FEV1) were 
measured using a Vitalograph Spirometer (Buckingham, England). Holding the tubing and 
mouthpiece patients were instructed to take a deep breath and then to exhale completely and 
forceftilly into the machine until they felt their lungs were completely empty. They were 
required to repeat this test three times in their own time and the best score was taken. This 
gave a measure of FVC (litres/minute), FEV1 (litres/minute) and the ratio of FEV1 to FVC. 
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This was to assess basic lung mechanics in terms of ability to expire forcefully and to discern 
that there were no underlying airway obstructions that might hinder exercise performance. 
Isometric quadticeps strength 
Voluntary and stimulated isometric maximal voluntary contraction (MVC) was measured in 
the quadriceps femoris muscle of the dominant leg. Patients were seated in a specially 
adapted rigid, straight back chair. The back was adjustable to alter the seat length such the 
lower limb below the knee was allowed to hang freely at 90 degrees. Patients were held in 
position by a large strap around the pelvis. An inextensible strap was attached around the 
ankle Oust proximal to the malleoli) which was attached to a strain gauge and amplifier at the 
back of the chair. The distance from the strap to the strain gauge was again adjusted to 
maintain the 90 degree knee flexion. Two large pad electrodes (8 cm x 12 cm) were strapped 
over the proximal and distal portions of the anterior aspect of the thigh for percutaneous 
twitch stimulation. The two pad electrodes were attached to a Digitimer electrical stimulator 
driven by a Digitimer Trigger Generator such that 200-350 volt impulses and 50 usec 
duration were initiated at lHZ frequency. Trial stimulations were applied at rest with the 
subjects asked to rate on a scale of 1 to 10 whether they found it painful or uncomfortable. 
Maximum voluntary contraction (MVC) was measured when the patients were asked to push 
against the ankle strap with as much force as possible holding for approximately 3 seconds. 
Verbal encouragement was given for each trial and 15 seconds rest was allowed between 
contractions. They performed five repetitions, with twitch stimulations added on trials 2 and 
4. 
During a truly maximum contraction no extra force is generated by the stimulation in addition 
to the voluntary force. This technique was used to ensure maximal activation of the 
quadriceps muscle by over-riding any central inhibition and has been used previously with 
patient groups (Rutherford et al, 1986; Gibson et al, 1993). In the original protocol for this 
technique, where extra force is generated by stimulation, the true maximum can be estimated 
from the height of the extra force recorded, relative to the height of the twitch before the 
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voluntary contraction. The development of any additional twitch force on the stimulated trials 
reflected a submaximal contraction. 
However, the equipment available for the current study could not allow for accurate 
measurement of the height of the extra force generated by the stimulation relative to the 
height of the twitch unstimulated (i. e. voluntary maximal contraction). Results for the MVC 
were measured in Newtons (N) as well as recording whether the highest MVC was achieved 
with or without twitch interpolation. This is an adaptation of the twitch interpolation 
technique described by Edwards et al, (1977) whereby it is only possible to determine the 
subject's ability to maximally contract their quadriceps voluntarily, i. e. without stimulation. 
In this respect the stimulation was used to determine if there was a central inhibition, and by 
adding extra stimulation to over-ride this, a closer representation of the muscles maximal 
capacity could be gained. This peak force was recorded as well as whether this was achieved 
with or without stimulation, so that we could then record the number of subjects who could 
reach their highest value voluntarily, or with the addition of electrical stimulation, to more 
fully activate the muscle. 
Treadmillfamiliarisation 
To relieve any anxiety about the test and treadmill exercise, all CFS patients were thoroughly 
familiarised with the test procedure on visit one, prior to performance of the walking test on 
visit 2. The control and depressed groups did all of the tests in one visit. They were 
introduced to walking on a Powerjog M30 Medical Treadmill (Sport Engineering Ltd) at 
increasing speed up to the test speed of 5 kilometres per hour (km. h-), with a mouthpiece in 
place. Instruction was also given on how to step off the treadmill when the subject needed to 
stop and on the use of the Rating of Perceived Exertion (RPE) scale (Borg 1970). The 
procedures for the fingertip blood sampling for lactate analysis were also explained as well as 
the incremental progression of the test and the requirements from them. 
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Visit Two 
Visit two was approximately one week after visit one and subjects were again requested to 
refrain from eating for one and a half hours before their appointment. Height was recorded 
(in metres) with a Seca stadiometer and weight (in kg) using a calibrated Seca scales. These 
were used to calculate the Body Mass Index (BMI) from the formula weight (kg) divided by 
height (m)'. Thumbprick capillary blood samples (approximately 20 microlitres) were taken 
with the patients seated for determination of resting blood lactate concentration (in 
mmol/litre) using a GM7 automated blood analyser (Analox Medical Instruments). The 
analysis is based on the conversion of lactate and 02 to pyruvate and H202 catalysed by 
lactate: oxygen oxidoreductase. The maximum rate of oxygen consumption is directly related 
to the lactate concentration in the sample. Samples were analysed in duplicate 
Three electrodes were placed on the chest, one on each side at the base of the sternum and 
one in the clavicular area. Heart rate was recorded throughout the test using a 3-lead ECG 
(Hewlett Packard 40120A) which gave a continuous display of heart rate and V5 wave. The 
ECG recording was also interfaced with the on-line gas analyser and was displayed on the 
print-out throughout the test. Expired air was analysed continuously using an on line Jaeger 
EOS Sprint gas analysis system (Erich Jaeger UK Ltd). Patients breathed through a low 
resistance lightweight valve (Jakemen & Davies, 1979) attached via lightweight tubing to the 
EOS sprint system. Minute ventilation was measured by a pneurnotachograph. The 
percentage of oxygen (02) and carbon dioxide (CO2) in the expired air were sampled from the 
collection bag and analysed every 30 seconds by a Zirconium 02 analyser and a paramagnetic 
Infrared C02 analyser, respectively. This enabled continuous monitoring of oxygen 
consumption and carbon dioxide production in litres per minute and millilitres per kg per 
minute. Test procedures and requirements were again explained to the patients. 
The treadmill speed was gradually increased to the test speed of 5km. h"l and the test began 
when the subject appeared comfortable, which took about 1-2 minutes. Slope was increased 
every 2 minutes from zero to 5% initially, and then in 2.5 % increments. Subjects were asked 
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to rate their perceived exertion using an unmodified Borg scale (Borg, 1970) in the last 30 
seconds of each 2 minute stage. When they indicated an RPE of 14 (between "somewhat 
hard" and "hard"), on the scale, a fingerprick capillary blood sample was taken for blood 
lactate analysis. Patients were encouraged to continue to volitional exhaustion or symptom 
limited maximum. The test was terminated as soon as they stepped off the treadmill and 
recovery heart rate was recorded for 5 minutes. Peak V02 and heart rate were recorded as 
well as percentage of age predicted maximum heart rate reached, calculated from the formula 
210 - (age x 0.65) (Jones, 1988). Aerobic capacity was measured in absolute (I. min-') and 
relative (mI. kg-1. min7) terms. A final blood sample was taken 3 minutes after the test for 
determination of peak blood lactate concentration. 
Before leaving the laboratory the CFS patients were given an activity diary to record their 
habitual activity pattern during a normal week. They were also given instructions on how to 
record their pulse rate and asked to record their resting pulse rate over the week. 
Calibration 
The EOS Sprint system was calibrated 30 minutes prior to each test and again no more than 
10 minutes prior to the test. Calibration of the analysers was done in two stages by passing a 
sample of a known certified gas mixture through, at a controlled flow rate of I litre per 
minute. The first "zero point" gas, containing 100% nitrogen and no oxygen or carbon 
dioxide, was used to set the baseline by checking that the analyser recorded a zero gas 
concentration for this mixture. As soon as the zero point was stable, the 021C02 mixture was 
automatically let through. The second calibration gas contained a mixture of approximately 
5% C02 and 15 % 0... This mixture was used to set a second reference point at values close 
to those expected during physiological assessment. The computer would then use the two- 
point calibration to calculate an actual regression line. The pneumotachograph was calibrated 
by passing a2 litre volume of ambient air through ten times (20 litres) using a 2L syringe. 
Using the expected and actual value a correction factor was automatically calculated by the 
computer. 
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The treadmill was calibrated once a month. This was done by first measuring the belt length 
using 4 separate measurements. A mark was placed on the belt so that the number of 
revolutions of the belt could be counted as it passed a set point on the side. The treadmill was 
then run at set speeds from 4 to 20 km. h-' and the calculated belt speed derived from the 
formula: 
Belt sPeed = Belt length(m)/1000) x No. revolutions(n)/time for no. lal2s(s) 
3600 
Belt speed = 14.616 
t where 4.06 m= belt length 
n= no. of laps timed 
time for n laps in seconds 
The polar heart rate monitors that were given to subjects for recording of home exercise 
sessions were calibrated prior to use. This was done manually while also showing them how 
to record pulse at the wrist or carotid artery in the neck. With the subjects seated and relaxed 
and with a stable pulse, beats were counted for 15 seconds and multiplied by 4 to give heart 
rate in beats per minute, which was compared with the value recorded on the polar monitor. 
Values were also compared with the pulse count automatically measured by the 3- lead 
ECG. 
Randomisation - USpatients only 
Prior to the study sixty-six pieces of paper were coded with either an E (Exercise Group) or 
an F (Flexibility Group), 33 in each group. The papers were then placed in envelopes coded 
1 to 66, the order of envelopes being determined by random number tables. Once a patient 
completed the initial screening and assessment, the next envelope was opened by an 
independent staff member, not connected to the study. This allowed for random allocation of 
all 66 CFS patients into the two treatment groups. 
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The psychiatrist who conducted the psychiatric retesting was not informed about the treatment 
group of the patient. Patients were informed that both groups involved a form of treatment, 
which was explained to them, and that the researchers were not aware whether one was better 
than the other. 
2.4 Treatment 
Exercise group 
Exercise treatment followed the basic principles of exercise prescription (ACSM, 1990) 
adapted to the subjects current capacity. Patients attended the Exercise Physiology Laboratory 
on a weekly basis for twelve weeks for exercise, flexibility and relaxation sessions and to 
receive the following weeks exercise prescription. All weekly sessions were supervised by a 
qualified exercise physiologist. Exercise intensity and duration was individually tailored but 
most patients began at an intensity of 40% of their maximum aerobic capacity which equated 
to approximately 50% of their individual heart rate maximum reached in the walking test. 
Progression was determined by individual ability. 
The initial aim was to establish a regular pattern of exercise, without over emphasis on the 
duration to start with, such that patients were encouraged to exercise daily, at least five days 
per week. Patients were encouraged to make their exercise session a part of their daily 
routine, setting aside the time and planning in advance, particularly with regard to the best 
time of day to exercise. Sessions initially lasted 5 to 15 minutes and were progressed by 
increasing the duration by I-2 minutes per week up to 30 minutes and then by increasing the 
intensity to 50% and then 60% of their maximum aerobic capacity. Target heart rates for the 
exercise sessions were calculated for each individual and they were given portable heart rate 
monitors (Polar Favour Sports Testers) to monitor and record the intensity during their 
prescribed exercise sessions, and to ensure that they reached, but did not exceed, their target 
heart rate. They were also taught how to measure their heart rate manually to give them a 
better understanding and for longer term application. 
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Other exercise devices were also introduced during the programme and patients were also 
encouraged to use other modes of exercise at home, such as stationary and outdoor cycling 
and swimming. On the laboratory visits patients exercised on the treadmill and the cycle, and 
occasionally the rower or stepper, within their target range for up to 30 minutes. They were 
also given instructions sheets to include some simple stretching exercise at the beginning and 
end of their exercise session. They were taught the basics of passive stretching and given a 
selection of exercises for each of the main muscle groups to be stretched. This included 
exercise for the upper and lower leg, the anns and shoulders, the chest and upper back and 
the neck. 
Subjects were advised not to exceed prescribed activity levels during a good phase of the 
illness. If they reported fatigue in response to a new level of exercise, they were advised to 
remain at the same level for an extra week and to increase the exercise when the symptoms 
regressed. Stretching and relaxation was included in this group in order to establish correct 
exercise habits and to allow comparison of similar treatments on all aspects except the aerobic 
exercise. 
Flexibility Group 
Patients in this group also attended the laboratory on a weekly basis for twelve weeks for 
flexibility and relaxation sessions. Each subject was taken individually through a stretching 
routine by the exercise physiologist and given an instruction sheet with diagrams of exercises 
that they should perform at home. As described above this involved a selection of passive 
stretching exercises for all the major muscle groups, with alternative and with a wider range 
of exercises added through the programme. The general instructions involved holding each 
position for a minimum of 15 seconds and repeating each exercise twice. Exercises were 
included for the upper and lower leg, the arms and shoulders, the chest and upper back and 
the neck. Relaxation sessions were carried out in a quiet, darkened room led by the exercise 
physiologist and involved controlled breathing, progressive muscular contraction and 
relaxation followed by mental visualisation aided by appropriate music. 
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Patients were encouraged to set aside 10 minutes each day for stretching or relaxation. The 
time was increased up to 30 minutes per day, 5 days per week, as more exercises were 
added. They were told to avoid any aerobic activities that were not already being 
undertaken. This was explained as any strenuous activity that caused them to get out of 
breath, that noticeably increased their heart rate for more than a few minutes, or caused them 
to sweat/perspire, i. e. brisk walking, jogging, swimming, cycling. 
Activity Diaries 
All patients kept a weekly activity diary (Appendix D), recording details of the type and 
duration of exercise, time of day and how they felt during and afterwards. This was discussed 
with each individual at the beginning of each weekly visit before deciding on the each week's 
treatment. 
3.5 Reassessment and follow-up 
Reassessment after treatment 
After twelve weeks, all patients attended the laboratory for physiological and symptomatic 
reassessment, as performed previously except that all tests were carried out in one session. 
Prior to the physiological testing, each patient completed the six self-rated questionnaires. 
Resting lung function, total skinfold measurement, isometric quadriceps strength, and 
treadmill walking were carried out as in the initial assessment. Capillary blood samples were 
taken again when they indicated an RPE of 14 and also at the same stage as the original blood 
sample if the RPE ratings had altered. During the same week patients also attended the 
psychiatrist for a SCID interview and to complete a CGI change score. 
Crossoverfrom Rexibility to Exercise 
Following their reassessment, patients in the flexibility group were given the option of 
continuing into the exercise treatment group. Exercise sessions were carried out exactly as 
for the group doing the exercise treatment first, involving a weekly progression of duration 
and intensity of exercise, with activity diaries maintained throughout. After twelve weeks on 
this treatment, patients were reassessed physiologically and symptomatically, as described 
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above. In this respect, the patients who crossed over to the exercise treatment after the 
flexibility programme did not have a3 month follow-up after flexibility alone. This allowed 
us to assess whether a combination of treatments, or a gradual introduction to aerobic or 
more strenuous exercise, via stretching, was more effective. It also allowed a ftirther 
assessment of the exercise treatment to ascertain whether a second group on the same 
treatment but with a different initial phase would have the same response, but ideally an 
assessment at three months after completion of the flexibility programme would be desired. 
77iree Months Follow-up 
After the post-treatment assessment (at 12 weeks), all patients were given instructions on how 
to continue and progress with exercise. Some instructions on simple upper body muscle 
conditioning and modified circuit exercises were included at this stage. Patients were also 
permitted to contact the exercise physiologists or to join in an occasional exercise sessions 
with another patient on the programme should they feel the need to. Three months after the 
end of treatment reassessment, all patients returned for a full physiological and symptomatic 
reassessment as before. This was in order to determine if any improvements achieved during 
either or both treatments were being maintained. 
One Year Follow-up 
Approximately one year after the three month reassessment (i. e. 18 or 21 months after 
baseline assessment for the exercise and flexibility groups, respectively, a letter was sent to 
all patients. This enquired whether they were still exercising, whether they had returned to 
work or study and/or premorbid activity levels. They were also asked to complete a visual 
analogue fatigue scale and a Clinical Global Impression Scale. 
3.6 Outcome measures 
The CGI change scale is a self-rated measure of overall change, compared to study onset, 
with seven possible scores from "very much worse" (7) to "very much better" (1). Subsidiary 
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outcome measures included assessments of strength and fitness, symptoms and functional 
capacity, as described above. 
Analysis 
The first stage of analysis involved exploration of the distribution of the data using a one- 
sample Kolmgorov-Smimov test. This goodness of fit test allows for testing the degree of 
agreement between the distribution of an observed set of values with a specified theoretical 
distribution. The resulting K-S value enables the determination of the use of parametric or 
non-parametric tests for comparison of the means. Given the sample sizes involved in the 
current study, a K-S value above 0.2 implied that parametric tests should be used for the 
comparison, and non-parametric test should be used on any distributions with a K-S value 
below this. If the data had a normal distribution, t-tests were used for comparison of the 
means of unmatched samples, applicable to both interval or ratio data. The aim of these tests 
was to compare the amount of variability due to predicted differences in scores between the 
two groups as against the total variability of subjects' scores. In any cases where the data was 
not normally distributed, the non-parametric equivalent of the t test, the Mann-Whitney test 
was used. This test puts the 2 groups of scores together and rank orders all of them, and then 
checks whether one group has mostly low scores, while the other has mostly high scores. 
Therefore baseline and post-treatment comparisons between groups used either t tests or 
Mann-Whitney tests, depending on the distribution. If the data was normally distributed then 
mean and standard deviation is shown in the tables, whereas, if not normally distributed, the 
median and interquartile range are shown. For comparison of the same group before and after 
treatment, i. e. matched pairs analysis, the Student's t test (parametric) and the Wilcoxon test 
(non-parametric) were used depending on the distribution. In all cases aP value of 0.05 or 
less was considered to be significant, so as to reject the null hypothesis. However, higher P 
values are shown in some cases to display a "trend" towards significance. 
The CGI change score was analysed categorically, with a score of 1 or 2 ("very much" or 
"much" better) considered a clinically important improvement, versus CGI scores of 3-7 ("a 
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little better" or worse than that). We compared the proportions, rating themselves as better 
after three months of each treatment, in those who completed treatment as well as by the 
intention to treat, using a Chi-Square (with continuity correction) test for two independent 
samples. This test allows a comparison of the proportion of scores from each group falling 
into the various categories. We also compared all outcome variables within each group, 
before and after treatment. The effects of the two treatments on the sub-maximal responses to 
the treadmill test were compared by examining the mean heart rate and RPE against sub- 
maximal treadmill test stages in the middle third of the walking test between 6 and 12 
minutes, both at baseline and at the end of treatment. At three months follow up, the 
proportion making a significant improvement, as well as and other outcome measures, were 
compared to the onset of treatment. The cross-over group, who received flexibility and 
relaxation training, followed by exercise therapy, provided an immediate re-test of the 
efficacy of this treatment. They were followed up in the same way as the original exercise 
group with the same outcome measures. At one year follow-up, we reported the proportion 
feeling better after completing exercise treatment. 
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CHAPTER FOUR: RESULTS 
4.1 Comparison between patient and subject groups at baseline 
4.1.1 Healthy sedentary controls and CFS patients 
A total of 30 healthy sedentary controls were recruited into the study for comparison on 
physiological and symptomatic measures with the CFS patient group. 
At presentation to the department, all potential CFS subjects with psychiatric disorder or 
sleep disturbance were offered appropriate treatment. If the treatment was successful, but 
they still met criteria for CFS, these patients were recruited into the study. Seventeen percent 
(11/66) initially had a major depressive disorder and 9% (6/66) initially had a generalised 
anxiety disorder. All 17 were successfully treated for these psychiatric disorders before 
entering the study. Fifteen percent (10) subjects with sleep disturbance were successfully 
treated by cessation of caffeine and low-dose sedative anti-depressants at night, and then 
entered the study. The 66 patients screened and recruited for the baseline comparison formed 
the two groups for the treatment study. 
The main characteristics of the CFS and control groups are given in Table 4.1. Groups were 
matched for age, weight and gender, and there were no significant differences between 
groups in any other characteristics, except for height, whereby the CFS patients were 
significantly taller (p=0.04). Despite being very inactive, all subjects fell within the optimum 
range for BMI of 20 - 25 kg/M2 with both groups having a very similar total skinfold 
measurement. Thirty-two (48%) of the 66 CFS patients were taking medication at the time of 
assessment, with 20 taking full-dose antidepressants, 10 taking antidepressants at hypnotic 
doses, and 2 were on other medication. 
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In all of the results tables, if the data was normally distributed then mean and standard 
deviation is shown in the tables, whereas if not normally distributed, the median and 
interquartile range are shown. 
Table 4.1. Characteristics of healthy sedentary controls and CFS patient groups. Values 
are mean and standard deviation (SD) if normally distributed (K-S > 0.2), or median 
interquartile range (IQR), if not normally distributed (K-S < 0.2). 
* signifies a significant difference (p < 0.05), comparisons are otherwise non-significant 
Characteristic CFS Patients (n = 66) Sedentary Controls (n=30) 
Age (years) 37.2(10.7) 36.8(11.1) 
Height (cms) 169.5 (162.9-176.1) 163.3 (158.7-167.9)* 
Weight (kgs) 65.0 (53.9-76.1) 64.7 (54.8-74.6) 
Body Mass Index (kg/m) 22.9 (20.2-25.7) 23.4 (29.8-26.0) 
Total skinfold (mm) 52.6 (36.8-68.5) 50.6 (38.4-62.8) 
Female/male 49/17 22/8 
Physiological compatison 
Results of the physiological assessments for the CFS patients and healthy controls are shown 
in Table 4.2. There were significant differences between the groups in all measures, except 
in resting lung function measures, with the CFS patients having a lower aerobic capacity, 
indicated by the lower relative and absoluteVo2peak and maximum ventilation. In the CFS 
group, the meanV02 peak was 28.2 (6.9) and 37.5 (8.1) mls. kg". miff' for females and 
males, respectively and in the control group mean values were 31.7 (5.8) and 40.5 (5.3) 
mls. kg-'. miri7'. The CFS group terrainated the test at a significantly lower maximum heart 
rate, representing 91.6% of their age predicted maximum heart rate compared to 97.6% in 
the control group. This reduced exercise capacity was also indicated by the significantly 
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lower peak blood lactate and test duration, whereby the control group continued exercise for 
almost 3 extra minutes (2 further gradients). Maximum isometric leg strength was also 
significantly reduced in the CFS patients (461 vs 336 Newtons). These were taking the 
highest values recorded in both groups, with 65 % of the CFS group and 80 % of the control 
group reaching this without stimulation, i. e. their own voluntary maximum level. There were 
no differences between groups on any measures of resting lung function. Recovery heart rate 
taken 3 minutes after the treadmill test was higher in the control group than in the CFS group 
(117 vs 110 BPM). 
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Table 4.2 Physiological variables of healthy sedentary controls and CFS patient groups 
Values are mean (SD) or median (IQR); p>0.05 is not significant (ns). 
Variables CFS patients 
(n=66) 
Sedentary controls 
(n=30) 
Significance 
V02 peak (ml. kg-. min7') 30.6(8.3) 34.1(6.8) 0.05 
V02 peak (I. min-1) 1.9 (1.6-2.2) 2.1 (1.7-2.5) 0.04 
Ventilation max (I. min-1) 69.8 (56.7-82.9) 82.4 (66.4-98.5) 0.05 
Heart rate max (BPM) 171(18) 181(14) 0.004 
% predicted max HR 91(8.8) 97(5.2) <0.001 
Recovery heart rate (BPM) 110(17) 117(17) 0.05 
Test duration(minutes) 10.0(3.6) 12.8(3.1) <0.001 
Total RPE 69(21) 80(19) 0.01 
Blood lactate at RPE 14 
(mmol. l-') 
2.8 (1.6-4.0) 3.5 (2.2-4.8) 0.001 
Peak blood lactate (mmol. l-') 5.4(2.2) 6.7(2.1) 0.005 
FVC (I. mirf') 3.9(0.8) 3.9(l. 1) ns 
FEVI. (I. mirf') 3.1(0.7) 3.1(0.8) ns 
FEVI/FVC ratio 79.8(8.0) 80.2(8.2) ns 
MVC (Newtons) 336(118) 461(114) <0.001 
Oxygen uptake and perceived exertion rating at submaximal stages of the treadmill test are 
shown in Figures 4.1 and 4.2, respectively. As can be seen, perceived exertion scores were 
significantly higher (p < 0.02) on all submaximal stages of the test between 2 and 12 minutes, 
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in the CFS patients compared to the control group with the control group indicating a lower 
perceived rating of exertion at all levels. Comparisons at 16 and 18 minutes on any of these 
measures were not done as the represented maximal, rather than submaximal levels of 
exertion for those who continued the test to for this duration and the numbers in either group 
continuing the test to these stages were small. Differences in submaximal oxygen uptake were 
significant only at 6 (p=0.05), 8 (p=0.04) and 14 (0.02) minutes. Submaximal heart rate did 
not differ between the two groups on any stage of the test. 
Symptomatic comparison 
Table 4.3 shows the results of the symptomatic measures of the two groups. There were 
highly significant differences between groups on all measures of fatigue, both visual analogue 
total, physical and mental fatigue and the Chalder fatigue scales. In addition the CFS patients 
scored significantly lower on measures of general health and well-being, as indicated by a 
lower SF36 total score and lower scores on physical function and role, bodily pain, vitality, 
social function, mental health. The implications of these will be discussed later. The CFS 
group also showed a significantly higher level somatosensory amplification (Barsky score). 
However, there were no differences between the patient and control groups in emotional role 
as measured by the SF36, HAD depression and anxiety, or PSQI sleep quality total score. 
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Table 4.3. Symptomatic variables in healthy sedentary controls and CFS patient groups 
Values are mean (SD) or median (IQR); p>0.05 is not significant 
Variable CITS patients 
(n=66) 
Sedentary 
controls (n=30) 
Significance 
V/A total fatigue 318(47.4) 214(58.1) <0.001 
V/A physical fatigue 168.5 (23.7) 108.4 (26.6) <0.001 
V/A mental fatigue 149.6 (30.7) 105.5 (38.7) <0.001 
Wessely total fatigue 29.5(6.4) 15.3(4.8) <0.001 
SF36 total score 353 (291-415) 643 (576-710) <0.001 
S1736-physical function 45(35-55) 92(83-103) <0.001 
S1736-role physical 0(0-25) 100(0) <0.001 
SF36-bodily pain 41(31-52) 84(74-94) <0.001 
SF36-general health 37(15) 67(17) <0.001 
SF36-vitality 25(15-35) 60(46-64) <0.001 
S1736-social function 38(13-63) 100 (84-116) <0.001 
SF36-role emotional 67(34-101) 100 (83-117) ns 
S1736-mental health 65(14) 73(16) 0.05 
HAD depression 5.0 (2.5-7.5) 6.5 (2.5-10.5) ns 
HAD anxiety 5.0 (2.1-7.9) 7.0 (3.9-10.1) ns 
PSQI total score 6.0 (4.5-7.5) 5.0 (2.4-7.6) ns 
Barsky amplification 9.5(3.9) 7.0(4.4) 0.008 
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4.1.2 CFS patients and a sub-group of patients with depressive disorders 
A small subgroup of 10 depressed patients was recruited for comparison with the CFS 
patients on the same measures. Due to the differences in size between groups, t-tests were 
considered to be more appropriate for this comparison (CFS versus sedentary controls) rather 
than use of ANOVA to compare all three groups. The ANOVA test would allow us to test 
the significance of the differences between 3 or more means but as a parametric test it 
requires normal distributions and acts as a between group and within group variance. It was 
felt that a total of 10 patients in the depressed group was too small a number to justify the use 
of this test. Furthermore, the main interest at this stage was to compare the response of the 
CFS patients and the depressed patients to the given measures. Following on from this thesis, 
we intend to continue recruitment of this patient group for further analysis. 
Table 4.4 Characteristics of CFS patients and patients with depressive disorders 
Values are mean (SD) or median (IQR) 
Characteristic CFS Patients (n=66) Depressed patients (n = 10) 
Age (years) 37.2(10.7) 37.1(10.3) 
Height (cms) 169.5 (162.9-176.1) 172.0 (166.1-177.9) 
Weight (kgs) 65.0 (53.9-76.1) 72.6(9.9) 
Body Mass Index (kg/m) 22.9 (20.2-25.7) 23.6 (20.2-26.6) 
Total skinfold (mm) 52.6 (36.8-68.5) 41.5 (22.8-60.1) 
-ýmale/male 
[ -, mwe/maie 49/17 /4 
All of the patients with depressive disorders were on medication at the time of assessment. 
There were no significant differences in the main characteristics of the 10 depressed patients 
recruited and the CFS patients with respect to age, height, weight, BMI and total skinfold. 
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measurement and, although the gender ratio was 6/4 females to males, this was not 
statistically significant from the CFS group. 
Results on the physiological and symptomatic measures with this group are summarised on 
Table 4.5. There were no significant differences on any of the physiological measures of 
peak oxygen uptake, ventilation, heart rate or blood lactate, nor on test duration, recovery 
heart rate, total RPE or submaximurn blood lactate at an RPE of 14. between the depressed 
and CFS patients. However, there was a tendency in the depressed group towards a higher 
isometric quadricep strength level although the difference was not significant between the 
groups. On submaximal measures, oxygen uptake was significantly lower in the depressed 
patients at 4 (p=0.02), 8 (p=0.004), 10 (p=0.05), 12 (p=0.05), 14 (p=0.003) and 16 
(p=0.003) minutes on the treadmill walking test. There were no differences on submaximal 
heart rate or perceived exertion rating. 
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Table 4.5. Physiological and symptomatic measures in patients with depressive 
disorders. Values are mean (SD) or median (IQR). 
* indicates a significantly higher level (p < 0.05) compared to the CFS patient group 
# indicates a significantly lower level (p < 0.05) compared to the CFS patient group 
Variable Result Variable Result 
VO, peak (ml. kg. min') 30.6(7.7) V/A total fatigue 307.3 (61.1) 
VO, peak (I. min-') 2.2 (1-9-2-5) V/A physical fatigue 147.6 (33.0) 
Ventilation max O. min-') 60.8 (48.6-73.4) V/A mental fatigue 159.8 (32.4) 
Heart rate max (BPM) 171 (19) Wessely total fatigue 33.3(6.8) 
Recovery heart rate (BPM) 111 (26) SF36 total score 358 (289-427) 
Test duration (minutes) 12.3(4.9) SF36 physical function 85 (73-98)* 
Total RPE 84(27) SF36-role physical 50 (62-94)* 
Submaximum blood lactate 
(mmol. l-') 
2.5 (2.1-2.9) SF36-bodily pain 51 (38-64) 
Peak blood lactate 
(mmol. 1-1) 
4.60.9) SF36-general health 43(23) 
FVC (l. min-1) 3.6(0.6) SF36-vitality 20(9-31) 
FEVI (I. min-) 3.0(0.6) SF36-social function 38(22-54) 
FEVI/FVC ratio 81 (8) SF36-role emotional 0 (0-16)* 
MVC (Newtons) 420(128) SF36-mental health 32 (15)# 
HAD depression 13 (11.3-14.8) 
HAD anxiety 12 (9.3-14.8) 
PSQI total score 9(4-14) 
Barsky amplification 8.3(3.2) 
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On the symptomatic measures, the depressed group scored significantly higher on SF36 
measures of physical function and role and significantly lower on emotional role and mental 
health. They also had higher levels of depression and anxiety on the HAD scale. 
4.1.3 Discussion of baseline measures (no intervention) 
The National Task Force for CFS, PVFS and ME (1994) reports a peak incidence of CFS in 
the 20 - 40 year age range with a slight female predominance and a strong representation 
from teachers and the health professions. Previous studies with CFS patients have found a3 
:1 female to male predominance with a mean age of 32 - 38 years when assessed. The CFS 
patients recruited into the current study, with a mean age of 37.2 years and a 74 : 26% 
female to male ratio, were typical of those previously studied. Previously reported illness 
duration ranged from 6 months to 20 years with a mean of about 47 months (Wessely & 
Powell, 1989; Wood et al, 1991; Wong et al, 1992; Gibson et al, 1993; White et al, 1995). 
Those who reported a causal attribution, found a viral illness at onset to be the most 
frequently cited cause, ranging from 53 % (Wood et al, 199 1) and 57 % (Gibson et al, 1993), 
63 % (White et al, 1995) to 66-90 % (Schleuderberg et al, 1992). Illness duration recorded by 
the current CFS patients was 37.4 months with a wide range (6 months to 17 years) with 
67% (44/66) blaming viruses as the cause. Comparison of the above information with other 
studies serves to confirm that the current group of CFS patients are typical and similar to 
previous groups of CFS patients studied, in terms of illness characteristics, age, height, 
weight and gender distribution. This also indicates the feasibility of applying results from this 
trial to CFS patients in general. 
Examination of the physiological results of the control and CFS patients indicates that the 
CFS group score significantly lower on all measures of physical fitness when compared to the 
healthy control group. Careful screening of the control group ensured that those recruited 
were truly sedentary, in that they rarely or never took part in any strenuous activity, or very 
infrequently took part in moderate forms of activity. The mean V02 peak for the control 
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group was lower than the control group assessed by Riley et al (1990), who reported a mean 
peakV02 of 37.9 mls. kg. -'min-, a similar maximum heart rate, but a lower peak blood 
lactate after the test, 5.5 mmol. 1-1, which was a somewhat low level for a test of maximum 
effort. The mean value of 34.1 mls. kg. -lmin7l measured forVo2peak in the controls in the 
current study was below the expected range, for their age, of 36 - 40 mls. kg. -1min7l (McArdle 
et al, 1994). In spite of this, the low level of exercise tolerance and aerobic capacity was still 
significantly higher than results recorded in CFS groups. Separating the peakV02 levels into 
those for males and females and comparing them to UK data from the National Fitness 
Survey (1993) confirms that both groups, CFS patients and the controls, are below the 
optimum levels (45.5 mls. kg. -'mirf' for males and 34.8 mls. kg. -'min-1 for females in the 25z 
34 year age group), with the CFS being lowest. This would indicate that, in the case of the 
CFS patients, these individuals tend to reduce, not only general activity/exercise levels to 
those of sedentary individuals, but must also adapt an even more inactive lifestyle, possibly 
curtailing normal functions (such as socialising, housework or shopping) in order to control 
and minimize their fatigue. There were no differences on measures of body fat (total 
skinfold), body mass index or resting lung functions between the CFS patients and either the 
healthy sedentary controls or the depressed patients. All of these measures were within 
normal expected ranges for healthy individuals, i. e. FEV1/FVC ratio greater than 75 %, and 
body mass index less than 25. Rather than using the total skinfold to estimate the body fat 
percentage of individuals, this was just used to compare differences in the total millimetre 
measurement between groups. This limits the margin of error associated with predictions 
using regression equations. None of the groups has abnormally high total skinfold 
measurements that would indicate any cause for concern. 
Comparing the CFS and control groups on the cardiorespiratory measures, there were no 
differences between the 2 groups in resting lung function, indicating that there were no 
abnormalities in the CFS group at rest that would interfere with lung function during 
exercise. Despite the age similarity in the two groups and, thus, age predicted maximum 
heart rate, the control group pushed themselves to a significantly higher heart rate than the 
CFS patients (181 BPM vs 171 BPM). This, and the lower maximum ventilation and peak 
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exercise heart rate are more in line with an inability to continue exercise to true physiological 
maximum (91.6 % age-predicted maximum heart rate vs 97.6 % in controls). Although many 
factors could affect this, there are two main aspects that are more relevant here. One of these 
factors is that the strength levels, which are below the level be required for normal 
functioning, found in these subjects, would cause them to terminate the exercise due to 
peripheral fatigue in the already weak leg muscles. Another factor is could be their low pain 
tolerance, which could be a consequence of long periods of inactivity, results in termination 
of the test at a peak lactate level of only 5.4 mmol. l-' vs 6.7 mmol. V in the controls. 
However, continuation of an exercise test to almost 92% of predicted maximum heart rate 
does indicate a certain degree of motivation above and beyond just giving up as soon as the 
exercise became a little uncomfortable. Patients did perceive their effort as maximal at the 
end of the test, with all patients reaching RPE levels of at least 17, such that it was more 
likely to be physiological factors, such as weak or fatigued muscles, combined with an 
inability to discern between normal discomfort due to the exercise and abnormal pain or 
fatigue, that prevented them from continuing, rather than a lack of motivation or interest. 
Riley et al (1990) also found a lower peak V02 in their group of 13 CFS patients vs. 13 
controls (31.8 vs. 37.9 mls. kg-'. mirf'), and a shorter test duration (11.2 vs. 14.1 minutes) 
measured on a Bruce test, but no difference in maximal heart rate or peak blood lactate. Both 
these and the current study results are slightly different to the group of 7 CFS patients studied 
by Kent-Braun et al (1993), whose meanV02max of 32.5 mls. kg-'. min-' was reached at 98 % 
of predicted maximum heart rate with a higher peak blood lactate of 7.2mmol. 1-1, but this was 
a relatively small group with a higher proportion of males. 
It must be remembered that it is very difficult for most individuals, other than trained sports 
people, to push themselves to their maximum physiological capacity, or indeed, to even know 
when they have reached that level. Therefore, in studies assessing CFS patients and 
untrained individuals, one would not often observe the criterion blood lactate level of 8 
mmol. 1' or a plateau in oxygen uptake values, that are considered as evidence of a true V02 
max (BASES, 1990). In these studies, it is really a peak V02 that is being measured as the 
individual's perceived functional maximum. 
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Other studies that measured exercise tolerance in CFS patients compared to controls reported 
a2-3 minute shorter test duration in the CFS patients on both cycling or walking tests, as 
was the case in the current study; 10 vs. 12.8 minutes. As in the current study, Gibson et al 
(1993) also found that CFS patients terminated the test at a heart rate that would be 
considered to be below their age-predicted maximum HR. This was significantly lower in the 
CFS patients than in the controls (163 vs. 190 BPM). Montague et al (1989) found that only 
13% CFS patients reached target HR (85% age-predicted max) in a cycle test compared to 
63% of controls, as previously mentioned. However, age-predicted maximum heart rate is 
only a rough guide of an individuals true maximum, which may be higher or lower than this 
level. The CFS patients in the current study terminated the test at 91 % of age-predicted 
maximum heart rate versus 98 % in the controls, which is considerably higher than previously 
recorded in other CFS groups. This was closer to cycle test results with a group of effort 
syndrome patients, who reached a maximum heart rate of 166 BPM (89% predicted 
maximum) compared to the 190 BPM (100% maximum) reached by the control group 
(Stokes et al,. 1988). This is unusual; as untrained individuals tend to terminate a cycle test 
earlier due to local fatigue in the legs prior to attainment of their cardiovascular maximum. 
It could be argued that the fact that the CFS patients reached only 91 % of their predicted 
maximum heart rate, represents a submaximum. effort and that they just did not push 
themselves hard enough. However, a number of factors should be taken into account when 
considering this. Firstly looking at the RPE levels, whereby all patients rated their exertion 
level as 17 or above, i. e. maximum levels, at the end of the test, indicates that they did push 
themselves to the maximum effort that they could achieve. Reaching 91% of the estimated 
maximum heart rate does take a considerable effort, particularly from a group of individuals 
who have not only been leading very sedentary lives, as with the controls, but also whose 
activity level has been reduced to absolute minimum levels, often involving long periods of 
complete inactivity or rest. In some cases this may have involved being bed-ridden or chair- 
ridden. It is not surprising that individuals who have had to adapt to this type of lifestyle 
would find it difficult, in terms of muscle weakness, pain or fatigue to reach their maximum 
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heart rate, or to have any concept of what a true maximum effort feels like. It could also be 
expected that deconditioned. individuals with low leg strength levels would find it difficult to 
reach high or maximum levels before leg fatigue or weakness prevents them from continuing 
with the exercise. It must be pointed out that marathon runners, who also have low leg 
strength levels, do not have difficulty reaching their cardiovascular maximum. However, they 
are well-trained individuals and their leg strength, although disproportionate to their high 
cardiovascular fitness level, is not generally below population norms, as is the case with the 
CFS patients. Therefore, it is reasonable to assume, that the maximum levels recorded by the 
CFS patients in this study represent their maximum level in terms of effort and current 
physical status, which may be different from their true physiological maximum level, but 
which is hindered by functional limitations resulting from a long-term illness. It is possible 
that a regular exercise programme may serve to encourage them to push themselves harder 
and to discover what their body is capable of, while under the supervision of the exercise 
programme. It must be remembered that many barriers are being confronted here, one of the 
most important of which is exercise or activity, such that it is only natural for them to be 
cautious about pushing themselves too hard at the start. 
Another measure, which would reflect pain tolerance, is the blood lactate taken once they 
indicated an RPE level of 14. The CFS patients found the level of exertion to be between 
"somewhat hard" (RPE = 13) and "hard" (RPE = 15), when their blood lactate reached a 
level of 2.8 mmol. V, whereas the control group reached a lactate level of 3.5 mmol. l-' before 
they considered that the exercise had reached this perceived level of intensity. This is 
consistent with speculations about the factors affecting individual perception of exertion, in 
that local factors such as blood lactate and muscle strain dominate at low to moderate 
intensities, with central factors dominating at higher intensities (Mihevic, 1981). 
Further comparisons can be made during sub-maximal stages of the exercise test. Ability to 
exert oneself maximally can depend on motivation and familiarity with exercise, whereas 
measures of physiological demands during sub-maximal exercise are frequently a better 
indicator of actual functional capacity or training status. This is similar to the strong 
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correlation between sub-maximal running economy, rather thanV02 max, and distance 
running performance (Powers et al, 1983). It is interesting that submaximal oxygen uptake, 
but not heart rate, at selected stages, was lower in the control group, showing a greater 
economy of effort in the controls compared to CFS patients. Since a decrease in oxygen 
utilisation, usually a result of a more efficient oxygen extraction and delivery, is one of the 
measurable effects of training of a regular exercise programme, the converse could be 
expected as a result of a lack of exercise or complete inactivity. Although the control group 
were not regular exercisers, a normal daily lifestyle requires a certain amount of ambulatory 
activity, which probably becomes very restricted in the lifestyles of those suffering from 
chronic fatigue syndrome, as they try to conserve their limited energy levels, in order to get 
through the day. This may also entail extended periods of complete inactivity and sitting or 
bedrest. Therefore, at an equal intensity of exercise or amount of work, the CFS patients 
demonstrate a reduced exercise efficiency and a higher demand for oxygen independent of 
effort involved. This again lends support to the concept that the CFS patients are less 
physically fit than a group of healthy sedentary individuals. 
Differences in perceived exertion throughout the test were significantly lower in the controls 
than with the CFS patients, indicating a higher feeling of exercise stress at all intensities 
below maximum. Previous research has shown the RPE during exercise is reduced following 
a regular training programme (Ekblom & Goldberg, 1971), which would also suggest that, 
conversely, deconditioning and inactivity would have a negative effect on RPE, leading to an 
increase in effort perception during exercise. Since the CFS patients had lower than optimal 
levels of muscle strength and a reduced aerobic capacity, local factors (physical strain on the 
working muscles) would lead to the increased RPE at lower exercise intensities, while at 
higher intensities, central factors would dominate (HR, oxygen uptake and ventilation) 
leading also to a higher RPE in the latter stages of the test, and an earlier rating of maximum 
RPE levels. This is consistent with research on the factors affecting perception of exertion 
during exercise (Milievic, 1981; Pandolf, 1983). 
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Other exercise studies with CFS patients have also measured this tendency towards a higher 
perception of exertion at submaximal. levels (Riley et al, 1990; Montague et al, 1989), but 
this was associated with a higher heart rate than in the control group. In contrast to the 
results in the current study, Riley et al (1990) found a higher heart rate, but not oxygen 
uptake at submaximum. stages in their CFS group compared to healthy controls. They 
suggested that physical deconditioning could partially account for the excess fatigue and 
deficient cardiovascular response, but also speculated that sleep disturbance could alter the 
sensory threshold for pain afferents coming from the active muscles and joints, leading to the 
greater perception of effort. However, in the current study we also found higher RPE levels 
throughout the walking test, despite no disturbances in sleep, and is therefore unlikely to be 
the sole explanation. Montague et al (1989) also found abnormally high RPE rating, as well 
as heart rates, in relation to workload in a group of 41CFS patients. Only 33% of these 
patients reached their target heart rate compared to 66% of controls. The higher submaximal 
oxygen uptake measured in the current study agrees with the findings of Wagenmakers et al 
(1988) of a high exercise stress at low exercise intensities and potentially an increased 
dependence on glycolysis. These could all be considered as predicted adaptations to reduced 
habitual activity, which appears to be the case in a large proportion of CFS patients. 
Therefore, we can see that perceived effort rating is consistently high at submaximal exercise 
intensities in all studies of exercise tests with CFS patients. However, pure physiological 
responses, as opposed to RPE as a psychophysiological measure, tended to show varied 
results between normal or slightly raised heart rates and oxygen uptake levels, and it would 
be difficult to determine whether the peripheral effect, i. e. a dysftinction in the working 
skeletal muscle, was greater than the cardiac effect in reducing exercise capacity in these 
patients, since inactivity and deconditioning will have an effect on both. 
The same measure of isometric quadriceps strength was included in the 1991 National Fitness 
Survey (1992) and an optimum of 75% of body weight was set as the ideal level for knee 
extensor isometric strength, with the lower limit of normal defirted as 50% of body weight. 
If peak force is less than 50%, the individual will find it difficult to support the full body 
weight with both feet on the ground and rising from sitting unaided becomes difficult. This is 
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based on original standards set by Edwards et al (1977), who recommended that an adult's 
predicted "normal" MVC (in kg force) is about 75 % of their body weight and the lower limit 
of normal is approximately half their body weight (regression equation: y (MVQ = 7.91 x 
(weight) - 3.77). The MVC for the sedentary controls almost reached the 75% body weight 
(485 Newtons), whereas the CFS patients were only just above the minimum level of 50% 
body weight (325 Newtons), implying that they would have difficulty with activities, such as 
climbing stairs, as was frequently reported by them. Gibson et al (1993), also measured 
quadriceps isometric strength in a group of 12 CFS patients compared to matched controls, 
and found only small and non-significant differences between groups (443N vs 476N), 
although individuals did show a weakness related to body weight and a positive response to 
twitch interpolation, even though 60% of patients attained an MVC without twitch. 
However, the CFS patient group studied were 50% male, which may explain their results 
being somewhat higher than those of the current study. 
Rutherford and White (1991) and Stokes et al (1988) also used the same measure of strength 
with smaller groups of CFS patients, and found that differences compared to controls were 
not significant, and those who did not produce a maximal effort voluntarily, reached normal 
ranges with twitch interpolation. They suggested that this indicated a submaximal effort, 
rather than any intrinsic weakness. The highest force recorded out of the 5 trials was taken 
as the MVC for each subject and for 65% of the CFS patients this highest effort was on a 
trial without stimulation, compared to 80% of controls. This difference between the two 
groups is not significant. This would indicate that a large proportion of the CFS patients were 
not subject to a central inhibition that prevented them from producing a maximal contraction, 
that could be overcome by artificially stimulating a greater proportion of the muscle. It must 
be pointed out that, due to limitations in the equipment available, the use of the twitch 
interpolation technique in the current study lacked in its ability to determine the amount of 
extra force added by the twitch, as was explained in the methods. Interestingly, 20% of the 
control group reached their highest level recorded on a trial with stimulation of the muscle 
implying that a moderate amount of normally active individuals, in terms of lifestyle, may not 
be able to fully activate their muscle. This MVC level reached in CFS patients, with or 
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without stimulation, was still below the expected range for their body mass. In their review, 
Edwards et at (1993), found that most patients examined, who had effort syndromes, post- 
viral fatigue or CFS, had been able to generate normal force using several different muscle 
groups, with or without verbal encouragement, and that those who could not, did so with 
twitch interpolation. The increased force produced on stimulation implies that central factors, 
such as low motivation or fear of pain, could be the cause of low recorded strength levels in 
some patients. However, the fact 65% of the CFS patients in the current trial, whose highest 
level was reached on an unstimulated trial, did not indicate a lack of motivation. 
The detrimental effect of inactivity on cardiovascular capacity has already been well 
documented and discussed, but it is also true that inactivity has negative effects on strength. 
Indeed, Kottke (1966), proposed that, if maximum tension exerted each day is less than 20% 
of the maximal strength of the muscle, then strength decreases, and when no tension is 
exerted throughout the day, loss of strength occurs at a rate of approximately 3% per day. 
Reports from patients in this and other studies suggest that many of them do considerably 
reduce the time spent on their feet, sometimes reverting to bedrest, so that significant losses 
in muscle strength would be expected. The measured low aerobic capacity and muscle 
weakness were most likely responsible for the shorter test duration in the CFS patients, both 
or either of which would prevent them from continuing the exercise. Smith et al (1996), 
found a mean isometric leg extension in a group of 81 - 90 year old women to be 217N 
which again was below the 50% of body mass level (289N) that would be required for 
normal and independent function. More interestingly, they found a positive correlation 
between this measure and walking speed, functional reach and ability to reach varied and 
increasing step heights. These ftinctional activities, which the current group of CFS patients 
also expressed difficulties with, could, at least partly, be attributable to their below optimum 
leg strength. Therefore, speculations on the underlying mechanism responsible for the low 
functional capacity and strength measured in selected groups of CFS patients compared to 
healthy controls, have varied from peripheral fatigue (Montague et al, 1989) to central/effort 
perception (Gibson et al, 1993; Riley et al, 1990), with little general agreement and evidence 
for both. With the added data, it would be reasonable to accept that there is a contribution 
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from both since both are susceptible to the detrimental effects of detraining or inactivity, and 
the CFS patients studied were both unfit and weak. 
Symptomatic measures 
As would be expected there were significant differences between the CFS patients and the 
sedentary controls on all measures of both physical and mental fatigue since this is the 
primary complaint with this condition. Similarly, other measures indicative of this symptom 
are physical function, vitality and physical role scores on the SF36 scale, all of which were 
significantly reduced in the CFS group. It appears also the overall feelings of increased and 
abnormal physical fatigue has a consequential effect on social function, general, and mental 
health. It is probable that sufferers are forced to curtail their normal social activities due to 
fatigue and this loss of social contact and in some cases, a feeling of isolation, leads to the 
decrease in general health perceptions, frustration and stress. Without the distraction from 
regular social contact, an individual with such symptoms as muscle weakness, pain and 
fatigue may then tend to focus unnecessarily or excessively on these sensations, which could 
increase their fear and frustration even more. A significant intergroup difference in the 
Barsky amplification score was found, which is indicative of a heightened awareness of, or 
increased tendency to amplify bodily symptoms and is actually influenced by disruption of 
daily social or other routines (Barsky et al, 1988). There were no differences between groups 
on the HAD depression and anxiety scores, neither of which reached case level, since those 
with psychiatric disorders were excluded prior to entry. However, the lower scores on the 
SF36 mental health scale in the CFS group, indicated that, although not necessarily clinically 
depressed, they felt downhearted, low, unhappy and nervous. The reduced scores on these 
scales measuring physical, mental and social function were also not due to sleep disturbances 
since those with significant sleep disorders were excluded prior to testing, confirmed by the 
similarity between the groups in the Pittsburgh sleep quality score. 
Therefore, the profile that emerges of the CFS patients is of a group of individuals who are 
not clinically depressed but who are suffering the psychological side effects of continued and 
prolonged fatigue. The longer this illness continues, it must be true, that the effects of this on 
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social function and lifestyle become worse, which would ultimately be linked to a low 
perception of their general health and a loss of self-esteem. 
CFS patients compared to depressed patients 
We chose to examine any similarities and differences on both the physiological measures on 
CFS patients with a small group of depressed patients, since CFS can and has been diagnosed 
as purely a depressive illness. The depressed patients were not offered any exercise 
treatment. There has been a relatively small number of studies on the physiological capacity 
of patients suffering from depression, but generally, patients, with either anxiety or 
depressive disorders are less fit than the general population and, this is usually due to 
inactivity (Martinsen, 1990). Similarly the depressed patients in the present study, although 
only a small group, had low fitness levels, comparable to those of the CFS patients on 
measures of maximum aerobic capacity, exercise tolerance and strength. We did not record 
activity levels in the depressed group of patients, but results of a recent unpublished 
ambulatory study with CFS patients revealed that they do have significantly lower activity 
levels than sedentary controls (Dash, personal communication). Taking this into account, it 
would appear that depressed patients also have similarly low daily levels of activity, which is 
consistent with their low fitness levels. However, the differences on some of the 
symptomatic measures reveal that the depressed patients perceive that they can do more 
physically, and they do not see themselves as having a reduced or restricted physical 
function. The CFS patients, on the other hand, perceive that they are restricted physically 
and therefore, avoid activity as the feared stimulus that could worsen symptoms. The low 
scores of mental and emotional health and the high scores on the HAD scale in the depressed 
group, could reveal more of a mental than physical restriction to them being more active, due 
to lack of interest or motivation. 
This puts forward a strong argument for the use of exercise in treatment programmes with 
these patients (Martinsen, 1993), since the psychological benefits of regular exercise have 
been previously well documented (see review section 2.4.1). Martinsen (1990) assessed the 
physiological capacity on a group of 90 depressed patients and found that they had normal, or 
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slightly higher than predicted values for resting lung function, but lower than predicted values 
for V02 max and physical working capacity, indicating that they had no restrictions to 
exercise other than a lack of fitness. They stopped before reaching age-predicted maximum 
heart rate, but reached a peak RPE of 18 and peak blood lactate of 10mmol. I '. Similarly, the 
depressed patients in the current study recorded significantly lower levels fOrVO2 peak, 
(when compared to either US or UK norms, as discussed previously). They continued the 
walking test to similar high RPE levels as the CFS group with the same, relatively low, peak 
blood lactate levels, which was considerably lower that peak blood lactate levels measured by 
Martinsen (1990). The depressed patients, on the whole, appear to be equally as unfit or 
deconditioned as the CFS patients, implying that they also restrict their activity levels, 
possibly for different reasons. They choose not to exercise, with lack of motivation and 
depressed mood having a significant effect. However, they do not perceive that they have 
any physical restrictions to participation in activity and this sets them apart from the CFS 
patients. 
It is interesting that the depressed group of patients showed a tendency towards higher values 
and greater leg strength than the CFS group. Many CFS patients become bedridden at various 
stages of the illness, and this may be responsible for the low levels of strength, whereas 
individuals suffering from depression, although not very physically active, may be less 
inclined to spend such extended periods in bed. This may also explain why they had a better 
submaximal exercise tolerance with significantly lower oxygen uptake levels on all stages of 
the walking test. 
The fact that there were similarities in the physiological results between the CFS and 
depressed patients, but that there were considerable differences in the 
symptomatic/psychiatric measures, reveals a clear distinction between the two groups. This 
suggests that the fatigue, low fitness level, and poor exercise tolerance of CFS patients are 
most likely due to reduced activity levels. This fatigue is not just due to depression and poor 
motivation or lack of interest in the activity, as there are significant differences on measures 
of mood and mental health compared to depressed patients. Fatigue associated with 
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depression (mainly mental fatigue) would be expected to be different than the extreme 
physical fatigue and weakness associated with CFS. Restriction of daily living activities can 
be a cause and a consequence of a depressive illness and may have important consequences. 
The current results are similar to those of pure (not yet chronic) fatigue syndrome patients 
measured 6 months after upper respiratory tract infections (White et al, 1995b). Those with 
fatigue syndrome, in the absence of psychiatric disorder, had greater physical fatigue and felt 
socially incapacitated compared to healthy controls. However, their total scores on the 
visual-analogue scale of 239 was somewhat better that the 318 found with the chronic fatigue 
group, indicating that the longer duration of a fatigue syndrome is likely to worsen this 
symptom. They also separated out those with psychiatric disorders, found no differences in 
the HAD depression and anxiety scores, between fatigue syndrome and controls, as in this 
study. Few other studies with CFS patients excluded those with psychiatric disorders such 
that it is difficult to delineate those with pure fatigue syndrome from those with fatigue that 
can be a consequence of psychiatric disorders. Exclusion of those with psychiatric disorders 
enabled the examination of the effects of the fatigue syndrome itself on physical, mental and 
social function. 
Kottke (1966) suggested that the immediate emotional response to limitation of activity, is 
similar to that in other situations of stress, and can lead to a person showing traits of 
insecurity, anxiety and dependency. Therefore, in the long-term, as activity is ftirther 
reduced and the condition becomes chronic, emotional problems could be expected to 
worsen. Anxiety, hostility, tension, complaints of discomfort and changes in pattern of sleep 
also occur depending on the personality of the individual, particularly as they are forced to 
rely on others for simple tasks, then independence and self-esteem decrease. 
These results indicate that there are clear and significant differences on all measures of 
fatigue, which appear to have effects on other psychological symptoms, but are independent 
of the effects of depression, anxiety or other psychiatric disorders. Poor mental and general 
health in CFS patients could also have an effect on sufferers ability to cope with the long term 
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effects and their ability or motivation to seek treatment, particularly any form of physical 
treatment. 
4.1.4 Summary 
This baseline study which has assessed both physiological and psychological parameters in a 
large group of CFS patients confirms, and adds to, previous results on smaller groups. These 
revealed a decreased aerobic capacity, a reduced exercise tolerance, generally associated with 
an inability to continue to physiological maximum capacity and an increased perception of 
exercise at submaximal levels. Contrary to other studies, a low maximum isometric 
quadriceps strength was also measured. This is the case when compared to either a sedentary 
control group or expected normal ranges. In addition, the CFS Patients differed from 
healthy, non-fatigued individuals on all symptomatic measures of physical and mental fatigue 
and function, and social function which was not a result of a psychiatric disorder. However, 
they were no different from depressed patients on all physiological measures, representative 
of another patient group with very low reported activity levels, but the differences between 
these two groups on certain psychological measures, again confirms that this fatigue is not 
just as a result of depression. However, the CFS patients, in contrast to the depressed group, 
have more of a perceptual problem of low functional capacity and physical restrictions that 
could cause them to reduce their activity levels. It is plausible that much of the reduced 
physiological capacity and exercise tolerance are a consequence of the inactive lifestyles 
adopted by these patients, due to perceived physical restrictions, resulting in physical 
deconditioning. This is also associated with a fear of persevering with any form of activity 
that might be harmftil or lead to a relapse. If this fatigue is largely centrally mediated, as 
Edwards et al (1993) have suggested, then the importance of perceptual, and possibly other 
psychological factors in perpetuating this condition, cannot be ignored. As discussed, 
exercise has been used successftilly in the treatment of several chronic conditions as well as 
depression and anxiety, and these results would justify the case for a trial of graded exercise 
therapy with this group of CFS patients, with a view to improving both physiological and 
psychological symptoms. 
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4.2 Examination of physiological and symptomatic treatment effects 
4.2.1 Between groups: exercise vs flexibilitY and relaxation at baseline 
The main characteristics of the two subject groups are given in table 1. Subjects randon-fly 
allocated to either the exercise or flexibility treatment groups were well matched for age, 
height, weight and gender but subjects in the exercise group had a significantly longer 
duration of illness (p = 0.03) (Table 4.6). 
Table 4.6. CFS patient characteristics at baseline. All results are mean (SD) or median 
(IQR), n (%). * indicates a significant difference between groups (p < 0.05); comparisons 
otherwise are not significantly different 
Characteristic Exercise Group (n=33) Flexibility Group (n=33) 
Age (years) 37.9(9.3) 36.6(12.0) 
Height (cms) 169.5(7.6) 168.4(7.3) 
Weight (kgs) 69.2(18.3) 67.3(12.1) 
Body Mass Index (kg/m) 23.9(5.1) 23.7(4.1) 
Total skinfold (mm) 55.6(22.6) 61.6(22.6) 
Illness duration (years) 3.8 (2.4 - 3.2) 2.0 (0.8 - 3.2)* 
Female/male 23/10 26/7 
Smokers 5(15%) 6(18%) 
All patients were asked several standard questions with regard to lifestyle and habits at the 
initial assessment session (baseline). Fifteen and eighteen per cent of the exercise and 
flexibility group, respectively, smoked. Sixty four percent (21) and 49% (16) from the 
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exercise and flexibility group,, respectively, considered themselves regular exercisers prior to 
the onset of the illness. The most frequent activities were walking, swimming, aerobics/gym 
work, tennis and cycling. With regard to those working or studying, in the exercise group 8 
were working full-time, 4 part-time and in the flexibility group 5 were still working full-time 
and 8 part-time. The remainder, 21 (32%) and 20 (30%) in the exercise and flexibility 
group, respectively, had given up work or study completely, due to the illness. 
Fifteen (45 %) of the subjects in the exercise group were taking medication, 8 were taking 
full-dose antidepressants, 5 were taking antidepressants at hypnotic doses at night and 2 were 
on other medication (anti-convulsant or HRT). In the flexibility group, 17 (51 %) were on 
medication, 12 were taking full-dose antidepressant drugs and 5 were on antidepressants at 
hypnotic doses. There were no significant differences between the groups in type and number 
on medication. Subjects were told to maintain any medications unchanged throughout the six 
or nine months of treatment and follow-up. 
Viral illnesses were the most common subjects' attribution of cause, with 9 out of 66 patients 
believing the cause to be glandular fever, and 35 blaming other viruses. Other perceived 
causes were vaccination (2/66), other infections (8/66), miscellaneous (5/66) (nerve palsy, 
post-natal haemorrhage, severe vomiting, generalised fatigue, recent divorce) and 7/66 did 
not identify any cause. There were no significant differences between groups in cause 
attribution. 
The physiological test results at baseline for the two groups are presented in Table 4.7. No 
significant differences were observed in any measures of cardiovascular capacity or exercise 
response between groups. The FEVl/FVC ratio was a slightly higher in the flexibility 
group, but mean values for both groups were within normal ranges (ie. >75%) for this 
variable. Mean maximum aerobic capacity (VO, peak) was below the average range for both 
groups for this age group in the general population (McArdle et al, 1994). Taking the male 
and female results separately, since about 2/3 of both groups were female, gave a mean of 
36.1 (8.0) and 29.7 (6.4) ml. kg-'. mirf' for males and females, respectively, in the exercise 
100 
group. Values in the flexibility group were 39.4 (8.5) ml. kg-'. mirf' for males and 27.0 (7.3) 
nýfl. kg-'. mirf' for females. Therefore it was mainly the females in both subject groups who 
were below the expected range for females between 30 - 39 years, of 34 - 38 ml. kg-l. milf'. 
The males in the study group were within (flexibility) or marginally below (exercise group) 
the normal range of 38 - 42 mls. kg-. mirf'. Results from the National Fitness Survey (1992) 
reported a meanV02max of 34.2 for females and 45.5 for males in the 35 - 44 age group, 
indicating that both males and females measured were also below the UK population norms. 
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Table 4.7. Physiological variables of both groups at baseline. 
VaIues are mean (SD) or median (IQR); p>0.05 is not significant (ns) 
Variables Exercise Group 
(n=33) 
Flexibility Group 
(n=33) 
Significance 
VO, peak (ml. kg-. miif') 31.8 (26.8-36.8) 28.2 (23.4-33.1) ns 
i -') V02peak (I. min 1.9 (1.4-2.4) 1.9 (1.6-2.2) ns 
Ventilation max (I. min-') 71.2 (52.6-89.7) 68.7 (62.0-77.5) ns 
Heart rate max (BPM) 170(18) 171(19) ns 
Recovery heart rate (BPM) 109(18) 111(17) ns 
Test duration(minutes) 10.5(3.7) 9.5(3.6) ns 
Total RPE 73(21) 64(21) ns 
Submaximum blood lactate 
(mmol. l-') 
2.6 (1.4-3.8) 2.3 (1.4-3.4) ns 
Peak blood lactate (mmol. V) 4.9(l. 9) 5.8(2.5) ns 
FVC (I. min7') 3.9(0.8) 3.9(0.7) ns 
FEVI (I. min-) 3.0(0.7) 3.2(0.6) ns 
FEVI/FVC ratio 77(9) 83(5) p=0.05 
MVC (Newtons) 339(144) 340(105) ns 
All patients continued the walking test until they reached their perceived maximum capacity, 
which occurred at 91 (8%) and 92 (9%) of their age predicted maximum heart rate in the 
exercise and flexibility group, respectively. The test duration at baseline ranged from 2.5 
minutes to 20 minutes. The mean duration of 10.5(3.7) and 9.5(3.6) minutes was reached at 
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a gradient of 12.5% and 10% on the treadmill in the exercise and flexibility group, 
respectively. 
With verbal encouragement 61% (20/33) of subjects in the exercise group and 67% (22/33) 
of patients in the flexibility group produced a maximum isometric contraction without twitch 
interpolation, which was applied an two of the five trials. As an observation the peak MVC 
was recorded on the first trial in a large proportion of the patients. The total RPE score was 
taken as the sum of each RPE rating indicated by the patients at the end of each stage of the 
walking test and there were no significant differences between groups. The slightly higher 
RPE (73 (21) vs 64 (21)) in the exercise group was due to a longer exercise time in this 
group (10.5 (3.7) vs 9.5 (3.6) minutes), but these differences did not reach statistical 
significance. When RPE was analysed as the total score divided by the test duration, the 
baseline values, 7.3 (1.3) (exercise) and 6.9 (0.9) (flexibility), were similar between groups. 
Self-reported symptomatic measures (Table 4.8) revealed significant differences only in total 
physical fatigue as measured by the visual analogue fatigue scale (combining exertional 
physical fatigue and persistent physical fatigue) and vitality on the SF36. There were no 
significant differences in total fatigue, perceived physical or functional capacity or other 
symptomatic measures. 
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Table 4.8. Symptomatic variables in both groups at baseline. Values are mean (SD) or 
median (IQR); p>0.5 is not significant 
Variable Exercise Group 
(n=33) 
Flexibility 
Group (n=33) 
Significance 
V/A total fatigue 312.1 (49.6) 324.6 (45.0) ns 
V/A physical fatigue 161.1 (27.7) 176.5 (16.4) p=0.02 
V/A mental fatigue 151.0 (26.0) 148.1 (34.3) ns 
Wessely total fatigue 28.8(7.1) 30.5(5.6) ns 
SF36 total score 341(84) 336(73) ns 
SF36-Physical function 48(22) 46(18) ns 
S1736-role physical 0(0-25) 0(0-25) ns 
S1736-bodily pain 41(30-51) 41(30-52) ns 
SF36-general health 39(14) 37(16) ns 
S1736-vitality 37(25-50) 22(17-28) p=0.03 
S1736-social function 42(28) 38(24) ns 
S1736-role emotional 52(61-98) 84(50-117) ns 
S1736-mental health 69(60-78) 64(60-68)) ns 
HAD depression 5.0 (1.5-8.5) 5.0 (2.5-7.5) ns 
HAD anxiety 5.8(3.6) 5.7(4.0) ns 
PSQI total score 6.4(2.4) 6.5(3.5) ns 
[Esky 
amplification 9.0(3.9) 9.7(3.6) ns 
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4.2.2 Between groups : exercise vs flexibilitY and relaxation after treatment 
The main outcome measure, the self-rated clinical global impression (CGI) scores, of subjects 
completing the study is shown in Table 4.9. As can be seen, 55 % (16/29) of those receiving 
the exercise treatment rated themselves "much better" or "very much better" (CGI I and 2 
combined) compared to 8/30 (27%) of the flexibility group (Yeats continuity correction = 
3.9,1 DF, p=0.03). Twenty-four per cent more of the exercise group subjects rated 
themselves "very much better", which was significant (95% ci = 5,43%). Four subjects in 
the exercise group and three in the flexibility group did not complete the 12 weeks of 
treatment. In the exercise group, reasons given included: a friend dying, financial crisis, 
ovarian cystectomy and felt worse due to corroborated depressive illness. In the flexibility 
group reasons given included treatment making her worse and two subjects gave no reason 
for non-attendance at sessions. 
Table 4.9. Self-rated CGI change score after completing exercise or flexibility treatment 
Rating score Exercise Flexibility 
(n = 29)(%) (n = 30)(%) 
1: very much better 9(31) 2(7) 
2: much better 7(24) 6(20) 
3: a little better 11(37) 18(60) 
4: no change 1(3) 3(10) 
5: a little worse 1(3) 0 
6: much worse 0 1(3) 
7: very much worse 00 
Analysing by intention to treat 52% (17/33) improved in the exercise treatment group, 
compared with 27% (9/33) in the flexibility group, (Yeats continuity correction = 4.06,1 
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DF, p=0.04; analysing all 33 in each group) (Table 4.10). Intention to treat analysis is useful 
to identify how many of the patients could be effectively treated with the intervention and 
includes all patients who started the treatment, in the analysis. A negative outcome, i. e. no 
improvement, is accepted for those who dropped out, whose results are not available. Only 
one subject in each group rated themselves worse after treatment; both were suffering from a 
major depressive illness when re-assessed after treatment. 
Table 4.10. Self-rated CGI change score with intention to treat 
CGI Score Exercise Group (n=33) Flexibility Group (n=33) 
I or 2 17(52%) 9(27%) 
3-7 16(48%) 24(73%) 
Yeats Continuity Correction = 3.1,1 DF, p=0.04 
A comparison of the physiological parameters in the two groups following 12 weeks of 
treatment are shown in Table 4.11. There were greater improvements with exercise in both 
absolute (p<0.05) and relative V02 peak and maximum minute ventilation (p<0.05), 
indicated by the significant intergroup differences on retest. Test duration tended to be greater 
in the exercise group (p=0.08) and total RPE tended, as a consequence, to be less in the 
flexibility group (p=0.07). When this measure was analysed as RPE total divided by test 
duration, no significant difference was observed between groups at baseline or post treatment. 
However a greater per cent change was seen in the exercise group, where the RPE/test 
duration decreased by 26 % (7.3 vs 5.5), compared to a 21 % decrease in the flexibility group 
(6.9 vs 5.4 ), but this did not reach statistical significance. 
Submaximal. heart rate and RPE recorded at each stage of the treadmill test are shown in 
Figures 4.3 and 4.4, respectively, for the post-treatment conditions. Since there were no 
differences between the groups at baseline this data is not shown for reasons of clarity There 
were no significant differences at baseline between the groups for heart rate and RPE, 
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whereas heart rate at 4 (p=0.04), 6 (p=0.04), 8 (p=0.01), 10 (p=0.002) and 12 (0.04) 
nýinutes, and RPE at 6 (p=0.03) and 8 (p=0.005), 10 (0.003) and 12 (p=0.02) minutes 
were significantly reduced in the exercise group compared to the flexibility group on test 2. 
We compared submaximal cardiovascular response to exercise between exercise and 
flexibility groups at baseline and after 3 months by comparing the area under the curve for 
heart rate versus treadmill stage reached. Peak heart rate did not differ between the 2 groups, 
but cardiovascular response to submaximal exercise was lower in those who had followed the 
exercise programme compared to the flexibility group. Mean heart rate per test stage between 
6 and 12 minutes was 149 (14) beats. min' in the exercise group versus 157 (14) beats. min-' 
in the flexibility group (t=-2.17,57df, p=0.03). The same analysis of area under the curve 
for RPE at submaximal levels (6,8,10 and 12 minutes) showed a greater reduction in 
perceived effort in the exercise group in test 2 (t = -2.06,55 df, p=0.04) 
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Table 4.11. Physiological variables in both groups after 3 months of aerobic exercise or 
flexibility and relaxation. Values are mean (SD) or median (IQR). p>0.05 is non- 
significant but p<1.0 are shown to show a tendency towards significance. 
Variable Exercise group 
(n=29) 
Flexibility group 
(n=30) 
Significance 
I V02 peak (mls. kg-. miif') 35.8 (30.8-40.7) 29.2 (25.1-35.4) p=0.03 
V02 peak (l. min-) 2.2 (1.6-2.8) 1.9 (1.6-2.2) p=0.05 
Ventilation max (I. min-1) 88.6(67-110) 76.1 (64-88) p=0.04 
Heart rate max (BPM) 174(17) 178(14) ns 
Recovery heart rate (BPM) 111(16) 115(15) ns 
Test duration(minutes) 12.5(3.5) 11.0(3.3) p=0.08 
Total RPE 68(18) 52(24) p=0.07 
Submaxium blood lactate 
(mmol. l-') 
2.0 (1.2-2.8) 2.5 (1.6-3.4) ns 
Peak blood lactate (nimol. l-') 6.2(2.5) 6.2(2.5) ns 
FVC (I. mitf') 4.0(0.9) 3.9(0.7) ns 
FEV1 (I. miif') 3.1(0.8) 3.2(0.5) ns 
FEVl/FVC ratio 78(9) 82(4) p=0.07 
MVC (Newtons) 430(182) 378(106) ns 
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Heart Rates during Treadmill Test 
Baseline Exercise (E) & Flexibility Group 
200 
180 
160 
4. d j- 
3.. 140 r 
0 Baseline E Group 
120 a Baseline F Group 
a Retest E Group 
0 Retest F Group 
100 
8 12 16 
Time (min) 
StatisticaUy significant differences denoted as fbHows - 
a, P< 0.05; b, P< 0.02; e, P, < 0.01; d, P< 0.001 
109 
Fio, ure 4.4 0 
RPE during Treadmill Test 
Baseline Exercise (E) & Flexibility Group 
20 a 
C 
13- 18 
C 
C 
0 :E 16 (D X UJI C 
W.. 0 14 
M 
. 
PC 12 
,a 
Baseline E Group 
a) 10 0 Baseline F Group 
M Retest E Group 
IL 0 Retest F Group 
C 
8 12 16 
Time (min) 
Statistically significant differences denoted as follows - 
a, P< 0.05; b, P< 0.02; c, P, < 0.01; d, P< 0.001 
110 
Results of the self-reported symptomatic measures are presented in Table 4.12. Fatigue, as 
measured by the visual analogue total and mental fatigue scales, and Wessely fatigue scores, 
was significantly lower with exercise. Perceived physical function and general health, were 
better in the exercise group, with a trend towards improved physical role (SF36 scale) and a 
significantly greater increase in the SF36 total score. Since the flexibility group were more 
physically fatigued at baseline, we calculated the percent change and showed that exercise 
improved visual analogue scale physical fatigue by 19% (flexibility 12%), but the percent 
differences were not significant. Because the subjects in the flexibility group were more 
physically fatigued before treatment and had a longer illness duration, we used analysis of 
covariance and found that neither baseline physical fatigue (Beta= -0.05, t=-0.37, p=0.71) 
nor illness duration (Beta=-0.10, t=-0.72, p=0.47) covaried with response to treatment. 
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Table 4.12. Symptomatic variables in both groups after 3 months of aerobic exercise or 
flexibility and relaxation. Values are mean (SD) or median (IQR). p>0.05 is non- 
significant but p<1.0 are shown to show a tendency towards significance. 
Variable Exercise group 
(n=29) 
Flexibility group 
(n=30) 
Significance 
V/A total fatigue 253.3 (47.6) 286.0 (67.1) p=0.004 
V/A physical fatigue 130.0 (27.6) 153.7 (34.0) p=0.006 
V/A mental fatigue 123.7 (30.9) 132.1 (39.3) ns 
Wessely fatigue 20.5(8.9) 27.4(7.4) p=0.004 
SF36 total score 479(113) 420(120) p=0.05 
SF36-physical function 69(18) 55(21) P=0.01 
SF36-role physical 25(0-50) 0(0-25)) P=0.08 
SF36-bodily pain 65(20) 54(25) ns 
SF36-general health 46(31-61) 40(25-55) p=0.03 
SF36-vitality 47(31-63) 40(25-55) ns 
SF36-social function 65(25) 56(24) ns 
SF36-role emotional 100 (84-117) 100 (67-134) ns 
S1736-mental health 76(65-87) 76(64-88) ns 
HAD depression 5.5 (2.9-8.1) 4.0 (0.6-7.4) ns 
HAD anxiety 5.5 (3.0-8.0) 7.0 (3.5-10.5) ns 
PSQI total score 5.0 (3.5-6.5) 6.0 (4.1-7.9) ns 
Barsky amplification 8.4(3.4) 8.5(4.1) ns 
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4.2.3 Changes within groups with treatment 
Analysing the data in Tables 4.7 and 4.8 (baseline) and Tables 4.11 and 4.12 shows that there 
were changes in physiological measurements within both groups, but aerobic capacity as 
measured by peakV02only improved significantly (p < 0.04) in the exercise group (by 13 % 
from 31.8 to 35.8 mls. kg-'mirf'). Improvements were observed in both symptomatic and 
functional capacity after both treatments, but the greatest improvements occurred with those 
receiving the exercise treatment. Results for each group were compared separately for 
improvement on each treatment. After the 12 weeks of graded aerobic exercise, significant 
positive differences were observed inV02 peak, both relative (p=0.001) and absolute 
(p=0.0003), maximum ventilation (p=0.0002), test duration (p=0.0002), MVC 
(p<0.0001), blood lactate at an RPE of 14 (p=0.001)(the same test stage at the original RPE 
of 14) and total RPE score (p < 0.000 1). Significant changes (p < 0.05) were observed in all 
of the symptomatic measures of physical capacity and fatigue except the HAD depression and 
anxiety scores, total Pittsburgh sleep score, mental health (SF36) and the Barsky 
amplification score. Subjects in the flexibility group also showed increases in maximum 
ventilation (p=0.001), heart rate maximum (p=0.004), test duration (p=0.0001), MVC 
(p=0.001), total RPE score (p<0.001) and both blood lactate at an RPE of 14 (P=0.006) 
and post-test blood lactate (p=0.002). Symptomatic improvements were observed in total 
fatigue (p=0.02) and physical fatigue (p=0.004) (V/A scale), Wessley physical (p=0.02) 
and mental fatigue (p=0.01) and SF36 vitality (p=0.008), social function (p=0.02) and 
mental health (p=0.03). Larger changes were measured following the exercise treatment 
compared to the flexibility treatment. 
Cross-over group 
Twenty three subjects who began with the flexibility treatment crossed over to the exercise 
treatment after 12 weeks of flexibility and relaxation and followed the same exercise 
programme as the exercise group. Seven subjects chose not to go on to the exercise 
treatment, mainly because of domestic commitments. Results of this group were compared to 
baseline parameters measured on entry into the study. Tables 4.13 and 4.14 show the post- 
exercise data for the flexibility group. 
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On the CGI score 55% (12/22) of patients rated themselves "much better" or "very much 
better" (CGI 1/2), after the exercise treatment and compared to baseline. This was not 
significantly different (p=0.09) to the 27 per cent of this group who had improved following 
the flexibility treatment alone. One patient did not complete the exercise programme due to a 
foot operation. 
Significant increases were measured in absolute and relative V02 peak, maximum ventilation, 
heart rate maximum, total RPE score, test duration, post-test peak blood lactate, MVC with a 
tendency towards a decrease in blood lactate at an RPE of 14 (p = 0.09), compared to baseline 
values. Highly significant changes were observed at all submaximal levels of the walking test 
on heart rate, at 6 mins (p=0.008), 8 mins (p=0.003), 10 mins (p=0.001) and 12 mins 
(p=0.002) and in RPE scores at 6 mins (p=0.000), 8 mins (p=0.004), 10 mins (p=0.04) 
and 12 mins (p=0.02), versus baseline. In the symptomatic measurements a significant 
improvement was observed in physical and mental and total fatigue (V/A scale), Wessely 
fatigue, physical and social function and general health as measured by the SF 36, Barsky 
amplification with a tendency towards increased vitality (p=0.09). In addition to the 
increases observed after the flexibility programme, new significant improvements from 
baseline were observed in VO, peak, strength, physical function and physical fatigue. 
The post-exercise results of the cross-over group were also compared to the measures 
recorded after the 12 weeks of flexibility and relaxation, on all variables, i. e. post-flexibility 
versus post-exercise. This was in order to compare the amount of change resulting from the 
different treatments in the same group of subjects. To avoid complication, these results tables 
are presented in Appendix E and is discussed on page later. 
. 
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Aaivity Diaties 
An analysis of the activity diaries for the two groups is given in table 4.15. The diaries were 
analysed in blocks of 4 weeks giving a mean duration of activity per week for weeks 1-4,4 
-8 and 8- 12. The cross-over group spent a similar amount of time involved in aerobic 
activity as those originally on the exercise treatment, when they crossed over to the graded 
aerobic exercise programme. In both groups, duration of aerobic activity in minutes per week 
increased over the 12 weeks of treatment, and significant differences were observed in 
duration of activity between weeks I-4 and 4-8 (p=0.03), 4-8 and 8- 12 (p=0.0009) 
and weeks I-4 and 8- 12 (p=0.0003) for the whole group while following the aerobic 
exercise programme. 
Table 4.15. Analysis of activity diaries in minutes of activity per week in giving the 
mean of each 4 week block. * denotes significant difference with previous 4 week block. 
Group Activity Weeks 1 -4 Weeks 4-8 weeks 8- 12 
Exercise Aerobic 113(57) 114 9470* 143 (52)* 
Flexibility Stretching 86(38) 91(34)) 99(50) 
11 Aerobic 1 99(46) 
-I 
104(49) I 143 (80)* 
- 
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4.2.4 Post exercise pooled data 
To ftirther examine the effects of the exercise treatment, the physiological and symptomatic 
results of all those who had completed the 12 weeks of exercise were pooled at baseline and 
post treatment. This included the 29 who followed the exercise programme from the start 
added to those who crossed over to the exercise following the flexibility programme. Those 
who dropped out during the first 12 weeks and those who did not cross-over were not 
included in the pooled baseline data. These results are shown in Tables 4.16 and 4.17. 
Highly significant improvements were observed in the total group in all physiological 
measures after exercise treatment, except in recovery heart rate and resting lung function, 
with an II% increase in absoluteVo2max, a 20 % increase in test duration and a 25 % 
increase in leg strength. Significant positive changes were observed in all symptomatic 
measures except mental health and bodily pain (SF36), HAD anxiety and depression and the 
Barsky somatic amplification score, indicating that positive adaptive physiological and 
symptomatic changes were achieved by all those who had completed the exercise programme. 
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Table 4.16. Physiological variables at baseline and post exercise (pooled exercise 
cross-over group). Values are mean (SD) or median (IQR) 
Variable Baseline 
(n=51) 
Post exercise 
(n=51) 
Significance 
V02 peak (ml. kg-l. min-) 31.3(8.1) 33.4(7.3) 0.004 
V02 peak (I. min7') 1.9 (1.5-2.3) 2.1 (1.7-2.5) <0.001 
Ventilation max (I. mirf 1) 71.8 (58.7-84.9) 80.7 (63.2-98.1) <0.001 
Heart rate max (BPM) 172(18) 175(14) 0.05 
Recovery heart rate (BPM) 110(17) 110(13) ns 
Test duration(minutes) 10.0 (8.0-12.0) 12.0 (9.8-14.3) <0.001 
Total RPE 67(54-80) 61(48-74) <0.001 
Submaximum blood lactate 
(mmol. 1-1) 
2.9 (1.7-4.2) 2.2 (1.4-3.0) <0.001 
Peak blood lactate 
(mmol. 1-1) 
5.6(2.1) 6.3(2.2) 0.01 
FVC (I. min-') 3.9(0.8) 3.9(0.8) ns 
FEVI (I. min-1) 3.0(0.7) 3.1(0.7) ns 
FEVl/FVC ratio 79(8) 80(8) ns 
MVC (Newtons) 309 (226-392) 388 (268-508) <0.001 
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Table 4.17. Symptomatic variables at baseline and post exercise (pooled exercise 
cross-over group). Values are mean (SD) or median (IQR) 
Variable Baseline 
(n=51) 
Post exercise 
(n = 49) 
Significance 
V/A total fatigue 320.3 (50.0) 265.4 (54.7) <0.001 
V/A physical fatigue 167.3 (25.6) 138.7 (29.5) <0.001 
V/A mental fatigue 156 (138-175) 120 (100-141) < 0.001 
Wessely total fatigue 29.9(6.6) 22.5(8.3) < 0.001 
SF36 total score 342(88) 460(134) < 0.001 
SF36-physical function 45(29-61) 65(52-72) <0.001 
SF36-role physical 0(0-25) 25(0-75) 0.01 
SF36-bodily pain 48(23) 61(24) 0.08 
SF36-general health 38(15) 50(18) 0.006 
SF36-vitality 27(15) 41(17) 0.007 
S1736-social function 45(22-69) 63(38-88) <0.001 
SF36-role emotional 66(33-100) 100 (87-117) 0.005 
S1736-mental health 65(15) 68(20) ns 
HAD depression 5.0 (2.0-8.0) 6.0 (3.5-8.5) ns 
HAD anxiety 6.0 (3.5-8.5) 5.5(3-8) ns 
PSQI total score 6.8(3.0) 5.7(2.8) 0.02 
Barsky amplification 9.3(4.0) 8.3(4.0) ns 
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4.3 Follow up Results 
4.3.1 Three months post-treatment 
Both treatment (exercise and flexibility) groups were retested physiologically and 
symptomatically three months after completion of the programme. During this period they 
did not have regular supervised exercise sessions but advice was given on how to maintain 
and progress with their exercise sessions and they could remain in contact, mainly by phone. 
Forty seven of the sixty-six subjects recruited attended for reassessment. Seven had dropped 
out before the first retest, 7 had not crossed over from flexibility to exercise therapy after the 
flexibility programme, and 5 could not attend due to leaving the country, change of address 
or exercise unrelated injury. 
The main outcome measure, the CGI score, increased to 69% (18/26) "much better" or "very 
much better", compared to before the onset of treatment/entry into the study, in those who 
received only the exercise programme (Table 4.18). 14/21 (67 %) of these, who had crossed 
over to the exercise, rated themselves as "much" or "very much better". This gave a total 
treatment outcome of 32/47 (68%) who had followed the exercise programme, feeling 
considerably better three months after treatment, compared to baseline. Figure 4.5 shows the 
CGI scores following the initial 12 weeks of exercise or flexibility treatment, after cross-over 
and at 3 months and I year follow-up. 
Table 4.18. Self-rated CGI change score at 3 month follow-up 
Rating score Exercise Cross-over 
(n = 26)(%) (n = 21)(%) 
1: very much better 6(23) 7(33) 
2: much better 12(46) 7(33) 
3: a little better 6(23) 5(24) 
4: no change 2(8) 1(5) 
5: a litfle worse 0 1(5) 
6: much worse 0 
7: very much worse 0 
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cr) CM 
Physiological results 
Compared to baseline, subjects in the exercise only group showed significant improvements 
in V02 peak, both relative and absolute, maximum ventilation, test duration, total RPE score, 
peak blood lactate and MVC (Table 4.19). Subjects who followed the flexibility programme 
prior to the exercise programme also improved significantly, in test duration, total RPE 
score, blood lactate at an RPE of 14 and MVC versus baseline measures (Table 4.13). The 
increase in peak oxygen uptake and maximum ventilation measured after the exercise 
programme were not maintained. Significant changes (p < 0.05) were also observed in 
submaximal heart rate and RPE at 6,8 and 10 minutes for both groups at follow-up, 
compared to baseline, with values of those who had followed the exercise only programme 
reaching a higher significance level. 
Symptomatic results 
Compared to baseline self-rated symptomatic measures revealed a significant decrease in 
fatigue, as measured by the visual analogue scale in total, physical and mental scores and the 
Wessely total fatigue scores, and improved physical function, social function, emotional role, 
and total SF36 score in subjects in the exercise only group (Table 4.20). Subjects who 
followed the flexibility and then exercise programme also showed a decreased total, physical 
and mental fatigue (visual analogue scale), total fatigue, measured by the Wessely scale, 
improved physical function, vitality, social function, and mental health, a decrease in the total 
SF36 score and a decreased score on the Barsky scale (Table 4.14). 
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4.3.2 Yhree month follow-up: Total post-exercise group (pooled data) 
Tables 4.21 and 4.22 show the baseline and follow-up results of only those subjects who had 
completed the exercise programme (see page 8 for group description). There was a 
significant difference between groups in relative V02 peak at 3 month follow-up, so this data 
was not included in the analysis. The results of the 47 subjects who completed full 
physiological and symptomatic reassessment were pooled and analyzed at baseline and 
compared to their follow-up results 3 months after completion of the exercise programme. 
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Table 4.21. Physiological variables in exercise and flexibility group (pooled) at baseline 
and at 3 month follow-up. Values are mean (SD) or median (IQR) 
Variable Baseline 3 month follow up 
(n=47) 
Significance 
V02 peak (ml. kg-'. miff') 30.9(8.0) 32.0(8.6) 0.05 
V02 peak (I. min-') 1.9 (1.5-2.3) 2.1 (1.7-2.5) 0.003 
Ventilation max (I. min-') 71.3 (54.8-87.8) 84.2 (67.8-100.6) 0.002 
Heart rate max (BPM) 172(18) 177(18) 0.01 
Recovery heart rate (BPM) 111(17) 111(17) ns 
Test duration (minutes) 10(8-12) 12.0 (9.6-14.4) <0.001 
Total RPE 67(54-80) 62(49-76) <0.001 
Submaximum blood lactate 
MM01.1-1) 
3.0 (1.8-4.3) 2.4 (1.9-3.0) 0.04 
Peak blood lactate 
(nimol. l-') 
5.7(2.1) 6.8(2.5) 0.002 
FVC (l. min-') 3.8(0.8) 3.9(0.8) ns 
FEVI (Lmin7) 3.0(0.7) 3.2(7.0) ns 
FEVl/FVC ratio 79(8) 81(7) ns 
MVC (Newtons) 308 (224-392) 403 (284-522) <0.001 
Compared to baseline significant increases were measured in absolute V02 peak, maximum 
ventilation and heart rate, and blood lactate at an RPE of 14. Subjects continued for a further 
2 minutes on the treadmill test giving a significant increase in the test duration, a higher post 
test peak blood lactate level and a lower RPE throughout the test (and thus a decrease in the 
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total RPE score). Both heart rate and RPE at 4,6,8,10,12 and 14 minutes were 
significantly reduced (p<0.005) when compared to baseline (Figure 4.6 & 4.7). Inaddition 
oxygen uptake was lower at 4 (p=0.06), 6 (p=0.006), 8 (p=0.001). 10 (p=0.05), 12 
(p=0.02) minutes at follow-up compared to the initial levels (Figure 4.8). 
The symptomatic measures revealed highly significant improvements in all measures of 
fatigue, physical and mental function and general health but not in HAD depression and 
anxiety scores or the Pittsburgh sleep quality score (as would be expected) or the Barsky 
amplification score. 
The combined CGI scores for the 47 subjects indicated that 31/42 (68%) considered 
themselves significantly improved 3 months after following the exercise treatment. 
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Table 4.22. Symptomatic variables in exercise and flexibility group (pooled) at baseline 
and at follow up 3 months after completing the exercise programme 
Values are mean (SD) or median (IQR) 
Variable Baseline 
(n=47) 
3 month follow-up 
(n=47) 
Significance 
V/A total fatigue 319.8 (47.4) 254.7(57) <0.001 
V/A physical fatigue 166.8 (23.1) 133.5 (32.4) <0.001 
V/A mental fatigue 158 (140-176) 110 (88-132) <0.001 
Wessely total fatigue 29.9(6.5) 20.8(8.5) < 0.001 
SF36 total score 340(84) 442(125) <0.001 
SF36-physical function 45(31-59) 70(57-83) <0.001 
SF36-role physical 0(0-25) 25(0-50) 0.01 
SF36-bodily pain 47(23) 62(42-82) 0.003 
SF36-general health 39(15) 51(20) <0.001 
SF36-vitality 26(15) 43(21) 0.001 
SF36-social function 44(19-69) 63(51-76) <0.001 
SF36-role emotional 52(14-89) 100 (67-134) 0.005 
S1736-mental health 64(15) 73(19) 0.01 
HAD depression 5.0 (1.6-8.4) 6.0(3-9) ns 
HAD anxiety 6.0 (3.5-8.5) 6.0(4-8) ns 
PSQI total score 6.8(2.6) 6.1(3.1) ns 
amplification 9.1(4.0) 8.6(5.2) 0.08 
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Figure 4.6 
Heart Rate during Treadmill Test 
Baseline (E+F pooled) &3 month follow-up 
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Statistically significant differences denoted as follows - 
a, P< 0.05; b, P< 0.02; c, P, < 0.01; d, P< 0.001 
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RPE during Treadmill Test 
Baseline (E+F pooled) &3 month follow-up 
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Statistically significant differences denoted as follows - 
a, P< 0.05; b, P< 0.02; c, P, < 0.01; d, P< 0.001 
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Figure 4.8 
Oxygen Uptake during Treadmill Test 
Baseline (E+F) &3 month Follow-up Group 
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Statistically significant differences denoted as follows- 
a, P< 0.05; b, P< 0.02; c, P, < 0.01; d, P< 0.001 
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4.3.3 One yearfollow up 
Forty-seven of the 66 patients replied to the follow-up questionnaires approximately one year 
after treatment was completed. On the CGI score, 76% (32/42) of those who had followed 
the exercise programme rated themselves "much" or "very much better" compared to 
baseline, on entry into the study. Of the 10 who had flexibility treatment alone, 5 replied, 2 
of whom were significantly better, I of whom had done her own exercise programme. 
There was a significant difference (p=0.05) in the number of subjects who were working or 
studying when compared to baseline, with 66% (31/47) working at I year versus 38% 
(25/66) at baseline, combining the figures of those working full- and part-time. When broken 
into respective part- or full-time work/study hours, 40% (19/47) were working full-time at 1 
year follow-up compared to 20% (13/66) at baseline, and 26% (12/47) were working part- 
time at follow-up compared to 18% (12/66) at baseline, with 62% (41/66) not working or 
studying at all. Premorbid employment details revealed that 88% (58/66) were working full- 
time, 4.5 % (3/66) part-time and 7.5 % (5/66) were not working before their illness at all. 
Sixty-eight percent (32/47) had continued with exercise and considered themselves regularly 
active, which is higher than the proportion of subjects who regarded themselves as regularly 
active before they ever fell ill (55%)(36/65), but not significantly so. In addition, the visual 
analogue scores for physical (p<0.0001), mental (p=0.0003), and total fatigue (p<0.0001) 
all increased significantly compared to baseline. We also analysed separately the visual 
analogue scores of those who rated themselves a CGI score of I or 2 (i. e. recovered/much 
better) to determine if their fatigue rating had returned to normal levels. This gave scores of 
119 (35), 114 (37) and 233 (64) for physical, mental and total fatigue, respectively. A score 
of 100 on physical and mental and 200 on total fatigue would indicate no fatigue. There was a 
significant difference (p<0.001) in total fatigue on this scale between baseline (316(48)) and 
follow-up (230 (63)) for all those who had completed the exercise programme. 
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4.4 General Discussion 
A significantly greater proportion of subjects (55 %) rated themselves as "very much better" 
or "much better" after graded aerobic exercise treatment, compared to flexibility and 
relaxation alone (27 %). This was an effect size of approximately 100 per cent compared to 
an active intervention, i. e. 100% more were better with the exercise treatment than the 
flexibility treatment (difference in % of the treatment group getting better divided by the % of 
placebo getting better). Only one subject in each group felt worse after completing treatment 
and both of these had developed a major depressive illness, with the treatment itself not 
responsible. The development of the depressive illness in both cases was consequent on life 
events and not attributed, by the subject, to the treatment. Analysis by intention to treat gave 
similar results, with low drop-out rates. Exactly the same percentage of cross-over subjects 
rated themselves as better after three months of exercise, giving further support to the 
original exercise group results. This also suggests that there is no advantage in beginning 
with flexibility alone and introducing patients to regular activity through a more gradual 
approach, since three months of exercise treatment was as effective as six months of a more 
staged approach of flexibility followed by aerobic exercise. Starting with a3 month flexibility 
programme might alleviate any worries that an aerobic exercise programme might be too 
strenuous, but this approach offered no advantage to the final outcome. This outcome was 
maintained or exceeded at follow-up 3 months post-exercise treatment, by both patient 
groups, regardless of initial treatment, giving a total group outcome, 3 months after 
completion of the exercise programme, of 68 % improved. At one year follow-up, three 
quarters were better, with an accompanying return to pre-morbid levels of physical activity, 
but incomplete return to work. 
The subsidiary outcome measures of fatigue and functional capacity confirmed the superior 
improvement with aerobic exercise. The lack of change in measures of mood, mental fatigue 
and mental health suggests that successful treatment was independent of antidepressant or 
anxiolytic effects. Although a minority of subjects were taking antidepressant medication, this 
was maintained the same throughout the study with no differences between the two treatment 
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groups. Therefore, antidepressants cannot have been responsible for the differences between 
treatments. 
The drop out rate of 11 % is comparable to other exercise studies with similar patient groups. 
A study using exercise with chronic low back pain sufferers (Frost et al, 1995) had a 12% 
drop-out, similarly 12% patients dropped out of an aerobic exercise study with patients with 
chronic respiratory disorders (Goldstein, 1993). Veale et al (1992) had a 25% drop-out rate 
from their exercise programme with depressed patients, which involved a programme of 3 
supervised sessions per week. Interestingly, a recent combined exercise and drug treatment 
trial with CFS patients, which included those with psychiatric disorders, had a much higher 
drop out rate of 29% (Morriss et al, 1996). This may highlight the importance of excluding 
patients with major psychiatric disorders which could affect their participation in and 
adherence to a treatment programme, as well as allowing us to examine the effects of the 
treatment on pure fatigue syndrome, rather than a fatigue syndrome confounded by other 
potential disorders. 
Regular and progressive aerobic activity produced measurable and significant increases in 
aerobic capacity, as measured by a 13 per cent increase in peakV02, an increased maximum 
ventilation and treadmill test duration. These changes in peak aerobic capacity are consistent 
with previous results with a group of healthy sedentary individuals performing low intensity 
training (50% V02max) for 30 minutes, three times per week, in which maximum aerobic 
capacity was increased by 5- 10% after 6- 12 weeks (Blomqvist & Saltin, 1983). Similarly, 
Jette et al (1988), measured a 12 per cent increase in relativeV02 Max in a group of 
sedentary middle-aged males and females who exercised for 30 minutes, 3 times per week at 
60%V02max for twelve weeks. An even larger increase (27%) was measured by Steinhaus 
et al (1990) with a group of 55-70 year old subjects after 4 months of walking or jogging at 
60-65% of theirV02max initially, increasing to 70-85 % max heart rate . The 13 % increase 
observed following exercise in the current study indicates that it is possible to find 
measurable increases with a very low intensity exercise programme in a previously inactive 
group. The main reason for highlighting these studies is to point out that very sedentary, unfit 
or elderly individuals, which would also encompass the typical CFS patient, in terms of 
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baseline physiological capacity, can experience the same magnitude of improvement, in terms 
of a training response, as a more able, fit or healthy individual. This applies even when the 
exercise programme followed is relatively mild in intensity and duration, and quite possibly 
below the threshold intensity that one might consider necessary to stimulate a training effect. 
A clear link has been established between the enhancement of an individuals aerobic capacity 
and their ability to cope with the demands of their lifestyle (Bird, 1993). The positive effect 
of the exercise programme on functional capacity was confirmed by the significant inter- 
group differences in both physiological and functional capacity after three months of 
treatment. This is a relatively short space of time to see measurable training effects, 
particularly considering that the duration of illness ranged from a minimum of 9 months up to 
a maximum of 19 years. However, when working with deconditioned or very sedentary 
groups of individuals, relatively small changes in biological variables can produce substantial 
improvements in functional capacity and thus a positive clinical outcome. Frequently, those 
individuals who start with a relatively low level of fitness improve the most, when expressed 
as a percentage of maximum oxygen uptake and it may be that only a small amount of 
exercise is sufficient to promote positive adaptations. Haskell (1994) and Astrand (1970) 
suggested that more benefit is achieved when the least active persons take up exercise, than 
when more active individuals increase their activity by a similar amount, and he put forward 
a model, showing that, for any given amount of activity, the magnitude of benefit is inversely 
associated with the baseline activity level. The previous results (4.1) confirmed that the 
groups in the study were considered both low-active and unfit compared to normal healthy, 
but sedentary individuals, and therefore, were likely to respond well, with regard to 
improvements in physiological capacity, even with a very moderate amount of activity. 
Indeed some of the CFS patients had spent extended periods in bed or had adapted their 
lifestyles to get through essential daily tasks interspersed with periods of rest or sleep. 
Undoubtedly this would have a detrimental effect on their physiological capacity, to the 
extent that that the addition of even a small amount of physical activity was sufficient to 
initiate a training or exercise effect - physiological or psychological. 
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The chosen low intensity of exercise, particularly at the early stages of the training, and 
indeed the total volume of exercise, may be considered too low for noticeable improvements 
in fitness, as it is considerably below the original American College of Sports Medicine 
(ACSM) recommendations for the amount of exercise necessary for "developing and 
maintaining fitness in healthy adults". (ACSM, 1978). Indeed, the landmark paper by 
Karvonen (1957) suggested that training had to increase the heart rate to above 140 beats per 
minute to cause an increase in VO, max. However, since then, several researchers have tried 
to determine the minimal threshold or intensity of exercise necessary to improve either 
fitness, health or both. Haskell (1992) compared responses to 15 weeks of aerobic activity at 
85% or 45% of maximum aerobic capacity and found that over the shorter term greater 
changes were seen in the 85 % group but over the longer term, a9% increase was also seen 
in the group exercising at 45 %, with a greater adherence and fewer drop-outs in this group. 
Similarly, a 20 per cent increase in VO, max was measured after a 12 week aerobic exercise 
programme at 60% VO, max in a group of previously sedentary middle-aged women 
(Johannessen et al, 1986). 
Lower intensity exercise may encourage greater adherence to exercise programmes, 
particularly for previously sedentary or deconditioned individuals. A study comparing 10 
weeks of high intensity to moderate-intensity aerobic training, attention-placebo control and 
waiting-list control found that only the moderate-intensity exercise group demonstrated 
benefits in variables associated with well-being, in older, sedentary individuals (Moses, 
1989). It appears that moderate intensity activity performed by previously sedentary middle- 
aged and older men and women results in significant improvements not only in aerobic 
capacity but in other health measures, and, for enhancing health, it may be more important to 
promote an increase in the volume, rather than intensity, of activity. This lends support for 
the value of low to moderate intensity activity for the chronically sedentary, overweight 
individuals, patients and the elderly. Low intensity "non-demanding" exercise can also lead to 
greater psychological benefits and increased compliance. Sexton et al (1989) recommended 
that therapeutic exercise should consist of regular, light. self-selected exercise, for 30 
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minutes, several times per week, which is adequate for beneficial effects, whilst minimising 
drop-out. The low intensity of exercise used with the CFS patients in this study was not only 
sufficient to allow adaptive physiological effects, but was also manageable enough to promote 
good adherence, since patients felt able to cope with the demands of the exercise and were 
less inclined to drop out. Those who did drop out in this study did not do so because of the 
demands of the exercise programme, but for more domestic reasons. 
The peak V02 of 30.6 n-A. kg-'. mirf' for the CFS group as a whole (n=66) at baseline was just 
below the average level expected for healthy individuals (36 - 40 ml. kg-1. miff) in the 30 - 39 
year age range (McArdle et al, 1994). This was reached at 91 (8) and 92 (9)% of their age 
predicted maximum heart rate in the exercise and flexibility groups, respectively, indicating 
that the subjects were motivated to continue the test to perceived physiological maximum. 
The issue of whether we can presume that the CFS patients actually pushed themselves to 
maximum has been discussed previously in section 4.1.3. Previous studies have suggested 
that reduced motivation or increased pain are both common problems when testing CFS 
patients, as they report higher perceived effort and pain at any given workload than healthy 
individuals (Riley et al, 1990; Gibson et al 1993). However, it would be expected that any 
new activity would feel more strenuous and/or painful, particularly if associated with a 
greater lactate production, for an individual who has taken part in little or no activity for an 
extended period. The result of this would expectedly be an increased perceived exertion 
rating on the RPE scale, which may be considered inconsistent with the level or intensity of 
exercise they are doing. Following the exercise programme, the mean V02 peak for the 
exercise group increased to 34.8 ml. kg-1. mirf 1 which was closer to the optimum range for 
healthy individuals. When the male and female data was analysed separately, it was found 
that the males were just within the normal range before treatment, whereas the females were 
below this normal range. Following the exercise treatment, mean values for the men 
exceeded the optimum range whereas the females reached the lower end of this range. Some 
of the male subjects in the study had previously been very active participants in sport prior to 
their illness, such that one would speculate that their premorbid V02 peak would have been 
well above the optimum range for the general population. Some men were beginning to 
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incorporate jogging into their exercise programme towards the end of treatment, again 
accounting for the greater increase in peakV02values in males. The significant increase in 
maximum ventilation is consistent with an increased aerobic capacity and is most likely to be 
due to the subjects utilising a greater proportion of their available lung volume after training. 
Badenhop et al (1983) measured increases in maximum ventilation of 10 litres (25%), on a 
low intensity training programme at 30-45%Vo2max, performed 3 times per week with a 
group of elderly deconditioned subjects, which is similar to the 24 per cent increase in 
maximum ventilation measured in the exercise group in the current study. Improvements in 
peak aerobic capacity serve to indicate that it is possible for a group of individuals with very 
low levels of aerobic fitness to follow a programme of regular exercise at a very low intensity 
and to see measurable improvements. In a relatively short space of time, they can reach 
levels expected for healthy individuals in the general population, i. e. levels consistent with a 
normally active lifestyle. However, this is not to say thatV02max is the most important 
determinant of lifestyle activity, but it remains a good starting point from which to assess a 
person's capability. 
The differences between the two groups in the blood lactate response to exercise was not 
significant when re-tested after 12-weeks, but the mean percent change in the exercise group 
(30%) was significantly higher, whereby the blood lactate concentration at the same test stage 
decreased from 2.6 to 2.0 mmol. 1-1 after training, with no change in the flexibility group. 
This indicates a lower blood lactate production for the same exercise intensity after the 12 
weeks of exercise, i. e. a greater metabolic efficiency and a switch to a greater reliance on 
aerobic metabolism. In realistic terms for the CFS patients, this lowered lactate level during 
exercise would allow them do more or continue for longer in any activity without the 
discomfort or pain associated with lactate accumulation in and around the working muscles. 
One of the documented short-term effects of regular exercise is an increase in the capacities 
of the major metabolic pathways to release energy, which ultimately reduces local fatigue and 
discomfort in the exercising muscles, because less lactic acid is produced (Astrand & Rodahl, 
1986). 
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In line with the increased test duration in both groups, there was an increased post-test peak 
blood lactate concentration, potentially indicating an increased ability to tolerate the lactate 
produced as a result of the exercise and implying a higher pain threshold following either 
programme. This may be partly as a result of participation in the programme, which allows 
them to put into a better perspective, the discomfort that can be associated with new or 
increased exercise participation, particularly after a long period of inactivity. When they 
began, this pain or signal to stop the test was probably partly due to fear of activity per se 
and of causing a relapse or of overdoing it, as well as a lack of familiarity with the sensations 
of strenuous levels of exercise. After following an exercise programme, gaining a better 
understanding of exercise and, probably, experiencing a certain amount of pain or discomfort 
in the process, they felt more confident in their ability and more prepared to push themselves 
further. A similar study design (aerobic vs flexibility training) with sedentary, elderly 
individuals, measured an increased aerobic capacity in their flexibility treatment group 
(Steinhaus et al, 1990). The authors suggested that the upper heart rate limit of 100 BPM for 
the flexibility training group was sufficient to allow cardiorespiratory training to occur in a 
group who had previously been very inactive. Since the flexibility group did not wear pulse 
monitors while stretching, we cannot determine whether the heart rate was sufficiently 
elevated to allow some aerobic training effects. Badenhop et al (1983) had previously 
demonstrated that elderly and sedentary individuals can significantly improve their aerobic 
capacity at heart rates of 30 - 40% of maximum. In addition, many subjects in the current 
study noted a reduction in anxiety about tackling physical tasks, during the programme, 
which encouraged them to be more active in their normal daily lifestyle, and those in the 
flexibility group (as well as the exercise group) reported becoming more active generally, as 
they relaxed and undertook a planned programme. This general increase in activity, although 
not formal exercise, may also have been sufficient to increase certain parameters, particularly 
in the flexibility group, who also showed a greater exercise tolerance after the 3 months. 
However, an increased maximum aerobic capacity was only measured in those subjects who 
had followed the exercise programme, and those who initially followed the flexibility 
programme did not show a significantly increased aerobic capacity until they had crossed 
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over into the exercise treatment. Related to this, self rated symptomatic improvement in 
physical fatigue, physical function and general health were greater following the more 
strenuous exercise programme. It could be argued that the physiological improvements 
measured after the flexibility treatment were sufficient, and that they were achieved with a 
much less strenuous and demanding treatment than the aerobic exercise programme. 
However, irrespective of this, the patients themselves did not rate their improvement as 
significant after the flexibility programme, with only 27% feeling much better compared to 
double this percentage after the exercise treatment. Taking this into account, and also 
considering the significant differences in the symptomatic measures of physical function, 
fatigue and general health, it appears that the CFS patients do not actually feel or notice such 
a large improvement in symptoms until they experience noticeable physiological changes. 
Alternatively, it could be that taking part in a more strenuous programme of aerobic exercise, 
is a greater stimulus to make them feel that they are taking control of their illness and actively 
reversing the deconditioning. The increase in metabolic rate, body temperature and heart rate 
associated with aerobic activity is far more exhilarating than would be experienced after 
stretching, such that even if they are only doing a relatively small amount of aerobic exercise, 
they may still feel that they are taking a more positive approach to treatment. This is possibly 
what is reflected in their CGI scores and the symptomatic measures. 
In determining whether a group of CFS patients have reduced exercise tolerance or strength, 
the result frequently depends on the comparison group used, the test mode, or the end point 
criteria. However, the results of the current study show that this initial baseline level, 
determined by the subjects' own perception of maximum, can be significantly increased. 
There was a definite trend (p = 0.08) towards an increased test duration following the exercise 
programme, compared to the flexibility treatment. As would be expected, more marked 
improvements in exercise response were observed at submaximal levels of exercise in both 
heart rate and RPE at 6,8,10 and 12 minutes of treadmill walking, where significant 
decreases were measured at all stages for both parameters, following the exercise 
programme. There were more noticeable changes in physiological parameters at the 
intensities at which patients had been exercising (40 - 60% of their maximum capacity) 
141 
rather than at maximum levels, due to an improved efficiency and economy of effort leading 
to a reduced perception of effort at these intensities. This was further confirmed by the 
significant difference between treatments in area under the curve for submaximal heart rate 
between groups after 12 weeks of treatment (p=0.02) and perceived exertion rating (P=0.04) 
(Figures 4.3 and 4.4). This effect was also reported by Newham and Edwards (1979) after 
just 2 weeks of cycling two to four times per week for up to 30 minutes, with a reduced 
exercise heart rate at 85 watts, in a group of patients with "effort syndrome". 
A high heart rate tends to lower the mechanical efficiency of the heart which may, with a 
lowering of the stroke volume which can, in turn, reduce the amount of oxygen delivered to 
the muscles. We would expect changes to be more significant at the intensities at which the 
individuals had exercised rather than at maximal levels, which were never reached during the 
exercise programme itself. One of the more significant adaptations to training is a slowing of 
the heart rate at any given exercise intensity, thus reducing general physiological disturbance 
and significantly lowering the intensity of sympatho-adrenal activity (McArdle et al, 1986). 
The slower heart rate reduces myocardial work, which is important since heart rate is the 
major determinant of energy expenditure by the heart muscle. Greater submaximal 
improvements were also observed by Cramer et al (1991), in a group of sedentary women 
walking 5 times per week, at 60% of maximum heart rate for 15 weeks. They measured a 
significant improvement in submaximal heart rate and ventilation but no increase in maximum 
oxygen uptake or ventilation. However, highly significant improvements were measured in 
general well-being, particularly "energy level" and "freedom from health concerns and 
worry" which were strongly correlated with improvements in submaximal fitness for all 
subjects. 
As described earlier, the highest level reached in the isometric strength test was recorded, as 
well as whether this was achieved with or without electrical stimulation. The twitch 
interpolation technique was used to assess whether they could fully activate the quadriceps 
muscles but, due to limitations in equipment, the difference between voluntary maximum and 
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that added by the twitch could not be measured accurately. Therefore, when discussing 
MVC, it implies the highest level recorded from the 5 trials on each assessment. 
In contrast to previous studies which found no significant difference in strength in CFS 
patients compared to healthy controls (Stokes et al, 1988; Rutherford and White, 1991), the 
highest levels recorded in the MVC test, with or without stimulation, were lower than the 
controls. Both groups significantly increased their quadriceps strength level from baseline 
with treatment. Values for the maximum isometric strength test can be compared with 
normal ranges for height and body mass (Edwards et al, 1977). The mean pre-treatment value 
for both groups of patients of 339 Newtons was below the expected range of 375 - 650 
Newtons, but following the graded aerobic exercise programme, the mean value was 
increased to within this range (430N), and just reached the lower end of the range following 
the flexibility programme (378N). No specific strength training was done as part of either 
exercise regime. Therefore, any strength improvements were more likely to be due to a 
generally more active lifestyle, and in the case of the flexibility group, possibly a reduced 
muscle tension resulting from the stretching programme. Pain and stiffness are often felt in 
muscles and joints during and after flu-like illness, which is not dissimilar to some of the 
symptoms described by CFS patients, and this may also inhibit muscle contraction, such that 
improved flexibility can influence this. Those patients who began in the flexibility group and 
then continued with 12 weeks of graded aerobic exercise showed further increases in MVC 
from 378 (182) to 412 (152) Newtons putting them within the expected range for their 
weight. 
An independent lifestyle may become impossible when major muscle groups, such as the 
quadriceps, become weak, with important implications for both health and lifestyle. Taking 
the optimum range for MVC (50-75% body weight) recommended by Edwards et al (1977) 
into account, the lower limit for the current group should be approximately 340N with an 
optimum of 500-52ON (75%). Therefore, improvements enabled CFS patients to increase 
their strength levels from the lowest level, up to 62% and 56% of body weight after the 
exercise and flexibility programmes, respectively, with no specific strength training involved. 
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The cross-over group increased to 62% of body weight following the exercise programme. 
Considering the low initial levels measured, it would be recommended that future exercise 
programmes with CFS patients should incorporate strengthening exercises for the legs and 
also the upper body. This would also take into account the recommendations by Edwards et 
al (1977) for minimum strength levels in the major muscle groups, such that they could 
expect to reach the levels consistent with a independent lifestyle. 
The measures of body fat, body mass index and resting lung function were taken for the point 
of determining if patients were within normal or expected ranges. There were no significant 
changes in body fat levels or body mass index during the course of the programme, with both 
flexibility and exercise treatments. This would be as expected with the levels of exercise that 
the patients were doing. Although individual patients may have experienced small decreases 
in body fat (total skinfold) levels, the difference was small and non-significant for the whole 
group. This measure would have had little effect on the treatment outcomes, but it was 
important to establish that there were no significant differences in body composition between 
groups prior to treatment. For this reason, and the lack of change in these measures, the post- 
treatment values were not reported. Since resting lung function was within desired ranges, 
indicating that there were no observed airways obstructions or restrictions that might limit 
exercise response, it is again not unusual that there were no significant changes in these 
measures over the course of the treatment. 
Some research has examined the beneficial effects of exercise on several other chronic 
conditions whereby patients have traditionally been recommended to restrict their activity 
(Kottke, 1984; Basmajian & Wolf, 1990). A few studies have measured large increases in 
cardiovascular fitness in fibrornyalgia patients following a programme of regular aerobic 
exercise compared with a flexibility programme (McCain et al, 1988) or no treatment 
(Mengshoel, 1992). McCain et al (1988) found that 50% of fibromyalgia patients showed a 
clinical improvement with 3x 20 minute exercise sessions per week for 20 weeks, compared 
to a 10 % improvement with flexibility. The improvements related to the exercise programme 
were unrelated to changes in psychological stress levels, suggesting that the positive effects of 
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exercise were not mediated through a reduction in stress levels. However, both of these 
studies used fully supervised exercise sessions throughout, whereas the current study involved 
only one supervised exercise session per week, with prescribed sessions for the remainder. In 
ore for the long term, this gives the responsibility and control to the patient, with the aim of 
developing a self-regulated exercise habit suited to the individual's lifestyle, but this may not 
produce such dramatic results in the short-term. 
Goldstein et al (1994) studied the use of exercise in the rehabilitation of patients with chronic 
obstructive pulmonary disease (COPD), a group of patients who would also be expected to be 
deconditioned. This also involved supervised exercise sessions for the first 8 weeks, 
followed by 16 weeks of unsupervised activity. The exercise programmes used an interval 
approach, interspersing low and moderate intensity activity, to attain a sufficient duration of 
activity, combining treadmill walking, upper body ergometry and mobility exercises. 
Significant inter-group differences were found on re-testing in physiological measures of walk 
distance and submaximal. cycle time and on self-rated measures of dyspnoea, fatigue, 
emotional function and mastery. The authors suggested that the self-rated questionnaire 
replies may be a better reflection of function than measurements of walking or cycling, 
particularly since they quote a study by Toshima et al (1990) with a similar group of patients, 
in which they measured a 57% improvement in treadmill time, but no improvement in quality 
of life. This would lead us to question which are the more important improvements, and 
helps to emphasise the importance of the patient-rating on the CGI score as the main outcome 
measure in the current study, above and beyond the physiological improvements, since it is 
the patients' own perception of illness or recovery that will have the most influence on their 
ability to resume and maintain normal daily activities. 
By way of comparison, Nordemar et al (1976) carried out a 16-week physical training 
programme with 10 rheumatoid arthritis patients, involving 2 hours of supervised activity per 
day (3-4 minutes cycling at 50-70% V02 max interspersed with 2-5 minutes rest, quadriceps 
strength training, walking and stair-climbing), on 5 days per week. Four out of 10 patients 
had a decrease in tender joints. Mean improvement was 6% in walk test duration, 11 % on the 
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stair test, 25 % increase in bicep strength and a 35 % increase in maximal physical work 
capacity. They also found significantly improved psychological status. The prescribed 
exercise in the current study was considerably less intensive, but still resulted with a 27% 
increase in isometric quadriceps strength, a 19% increase in walk test duration and a smaller, 
13%, increase in maximum aerobic capacity (the pooled exercise data resulted in 20%, 14% 
and 10% increases in strength, test duration and V02 max, respectively). In contrast to 
Nordemar's results, a relatively modest increase in aerobic capacity, in this study, translated 
to a large increase in test duration and thus exercise tolerance, and a similar magnitude of 
increase in strength of a larger and perhaps more important muscle group, without any 
specific strength training. As mentioned previously, patients involved in an exercise 
programme tend to become more active throughout the day, as confidence increases and they 
take on previously avoided tasks, which may explain the large increase in strength despite the 
absence of a prescribed strength training programme. Weyerer and Kupfer (1994) have also 
suggested that just participation in a regular exercise programme per se may produce a sense 
of accomplishment and enhanced self-sufficiency. 
The studies just discussed serve to highlight the fact that the use of graded exercise therapy in 
many different forms and structures has been used successfully with several different chronic 
illnesses in the past. This approach would not have been the most conventional treatment for 
conditions such as rheumatoid arthritis or COPD but was associated with significant 
improvements in patients' well-being and symptoms. Based on these results it is equally 
appropriate to explore and examine the use of exercise with CFS as in this study, and to 
incorporate some of the positive aspects of previous work. A recent study with a similar 
design to this one compared a4 week aerobic and circuit type exercise programme with 
standard medical care (lifting techniques and posture control) in a group of 81 patients with 
chronic low back pain (Frost et al, 1995). Significantly greater improvements were reported 
on the main outcome measure - the Oswestry low back pain disability index - after the 
exercise programme compared to the control treatment, and this was maintained at 6 months. 
Improvements were also observed in self-efficacy, willingness to tackle physical tasks and in 
walking capacity, but not in general health. Twelve patients from the control group, who 
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crossed over to the exercise treatment after the second assessment, reported less disability, 
but these differences were not significant. This is similar to results of the cross-over group in 
the current study who showed less physiological improvements than the original exercise 
treatment group, although symptomatic improvements were observed. It appears that smaller 
physical changes are seen when patients are given an alternative therapy prior to the main 
treatment and this may be important in determining the patient's attitude to particular 
treatments. This may have influenced the attitude of the original flexibility group towards 
exercise throughout their involvement, whereby they regarded flexibility exercise to be 
equally as important as aerobic activities in their treatment. This will be discussed further 
later. 
On the symptomatic measurements, random allocation into groups, did not prevent baseline 
intergroup differences in physical fatigue as measured by the visual/analogue (V/A) scale and 
in SF36 vitality. Therefore, percentage changes versus baseline in measures were calculated 
after the 12 weeks on either treatment, resulting in significantly greater positive changes in 
fatigue following the exercise treatment compared to flexibility, and physical fatigue at 
baseline did not have any effect on response to treatment (ANCOVA results). This was 
further indicated by the highly significant intergroup differences in these measures after 
treatment. Further significant positive effects were measured in V/A total fatigue, Chalder 
fatigue, which incorporates both physical and mental aspects of fatigue, SF36 total score and 
physical function, with a tendency towards improved physical role following exercise 
treatment. These improved SF36 scores indicate that subjects after the exercise programme 
perceived less problems with work or other daily activities and that they felt that they could 
undertake physical activities without limitations due to health. This complies with a greater 
tendency to tackle physical tasks during their normal daily lifestyles, that they had previously 
felt were restricted by CFS effects. One of the theories about the effects of exercise on a 
person's psychological health suggests that exercise can lead to a feeling of mastery or a way 
of regaining control over their bodies which can, in turn, lead to increased confidence and 
self-efficacy, which may generalise to other areas of their life (de Coverley Veale, 1987). 
Several mechanisms have been proposed for the psychological effects associated within 
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regular exercise. Those most relevant to CFS patients, include improved physical fitness, 
providing people with a sense of mastery, self-control and self-sufficiency. Exercise provides 
a distraction, diversion or time-out from unpleasant cognitions, emotions and behaviour. 
Alternatively, exercise competes with negative affects, such as anxiety and depression, in the 
somatic and cognitive systems (Weyerer & Kupfer, 1994). In this respect, patients learn to 
overcome a major barrier that may have prevented them from leading a normally active 
lifestyle. This barrier could be both mental and physical leading to a two-pronged effect of 
the exercise programme. 
No changes were observed in HAD scores with treatment in either group, but this is to be 
expected since the mean scores for both anxiety and depression were below case level at 
baseline (below 7) (Zigmond and Snaith, 1983). The authors give a score of 8- 10 for 
borderline and above 10 for a definite "case" of clinical anxiety or depression. However, 
Wood et al (1992), found a significant difference in HAD depression scores between current 
(6.2±2.7) and recovered (3.1±3.3) CFS patients, with a non-significant difference in HAD 
anxiety scores. In the current study, improvement was not associated with a decrease in the 
HAD depression or anxiety scores. In addition, no significant changes were observed in the 
PSQI score during either treatment, again because sleep quality was at the lower end of the 
scoring range (0 - 21) at baseline and also because those with sleep disorders were 
successfully treated prior to entry into the trial (Buysse et al, 1988). Alternatively, it could 
be that exercise may improve subjects' fatigue and functioning without altering mood or sleep 
quality. 
Another treatment study with CFS patients compared the effects of 16 weeks (21 sessions) of 
cognitive behaviour therapy (CBT) with normal medical care. Outcome measures included a 
6 minute walk test, HAD scales for depression and anxiety, visual analogue scales of fatigue, 
CGI scores and the Kamofsky scale of capacity (Karnofsky et al, 1948) over the previous 
month (Sharpe et al, 1996). They found that 27 % (versus 20 % of controls) made a significant 
improvement by 5 months (immediately after completing treatment) with CBT, compared to 
52% who were better with the exercise treatment in the current study, assessed 2 months 
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earlier. At final follow up, outcomes were similar with 70 per cent of patients rating 
themselves as "improved" with CBT (at 12 months), which compared with 76 per cent with 
exercise therapy. However, treatment outcomes were not the same, with the CBT study 
concentrating on functional rather than symptomatic improvement. It is interesting that the 
CBT treatment was associated with a delayed emergence of a psychotherapeutic effect over 
the follow-up period. The authors suggested that the improvement resulted from changing 
patients' assumptions and maladaptive coping patterns. Deterioration, noted as a rating of 
"worse" or "much worse", was reported by 13 % in the CBT group and 10 % in the medical 
care only group, which is higher than with exercise in the current treatment study, whereby 
only I patient (3%) considered themselves worse with exercise treatment. A recent study 
compared 13 sessions of CBT with relaxation therapy carried out over 6 months in a group of 
60 CFS patients, with a greater perceived physical incapacity (Deale et al, in press). At 6 
months 28 % vs 7% were no longer fatigue cases, while at final follow-up 1 year after 
treatment onset, 70% on CBT and 19% on relaxation treatment achieved a "good outcome" 
(a substantial improvement in physical functioning). 
Both CBT studies treated subjects with concurrent psychiatric disorders. It may be that CBT 
would be equally as effective as exercise treatment in the absence of co-morbid disorders. 
Further research should compare the different treatments and also explore their combination. 
Similarly to the current study, Deale et al (in press) used relaxation therapy as a control 
treatment, whereas Sharpe et al (1996) compared CBT to normal medical care. However, a 
reason for the large eventual difference between treatments in the latter study could be the 
lack of active treatment in the medical care only group, who were given a diagnosis, advised 
to increase their activity level and referred back to their GP. The control treatment in the 
current study was considerably more active, with the same amount of patient contact time and 
advice given, which may explain the improvements seen in this group. This also further 
emphasises the exercise treatment as being more effective, not just than waiting list control or 
vague one-off advice, but than a matched treatment with regard to time, attention and 
feedback. Additionally, Guthrie (1994) has cautioned that the absence of control for the non- 
specific effects of psychotherapy raises certain doubts regarding the claimed specificity of 
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treatments. Wilson et al (1993) had previously found that no additional therapeutic effect was 
obtained from CBT in comparison to good clinical care characterised by illness explanation, 
education, validation of symptoms and support form health professionals. 
It can only be speculated on how important it was to treat or exclude subjects with psychiatric 
disorders or sleep disturbance. Treatment success was independent of both psychological and 
sleep improvements. The only subjects to feel worse after completing treatment had both 
developed depressive illnesses. The present evidence suggests that these maintaining factors 
should be treated before embarking on an exercise programme. Because of the nature of the 
illness and the duration, it is understandable that a significant proportion of patients may 
develop a minor psychiatric disorder, particularly depression, and unless this is treated 
alongside or prior to the exercise or CBT treatment, it would be difficult to be specific about 
the outcome. In this respect, it could be that a patient suffering from depression may improve 
physically and overcome many of the fatigue symptoms, but they may be incapable of 
recognising this due to a low self-esteem and continued depressive mood. Treating the 
depression separately, allows us to examine the effects of exercise on the fatigue syndrome 
itself, while allowing patients to experience and recognise these improvements. Most of the 
previous research on the psychological effects of exercise has examined its use with anxiety 
and depression, and it would be unreasonable to presume that an exercise programme alone 
could be the most effective treatment for more complicated psychiatric disorders, such as 
hysteria, phobias and eating disorders. Therefore, patients suffering from mild depression or 
anxiety, of the type that may result from a long-term illness, in addition to chronic fatigue, 
could be expected to respond positively to the type of programme outlined in this study, but 
those with major psychiatric disorders, such as those mentioned above should be treated 
appropriately beforehand. 
A comment must be made on the improvements observed in the group performing only 
flexibility and relaxation for the first twelve weeks. No changes were found in their aerobic 
capacity but their overall exercise tolerance improved. In this respect, the effect of weekly 
contact and discussions about progress, regardless of the amount and type of exercise 
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undertaken appears to have had a significant effect on perception of difficulty, confidence and 
willingness to tackle physical tasks and may have helped them to overcome general fears or 
anxieties about physical activity. As with Deale et al, (in press), who found that relaxation 
was not a pure placebo treatment, our comparison group (flexibility and relaxation) also 
benefited from the sessions, and many patients in the Deale study reported that relaxation 
aided pain control, sleep and rest, such that the authors suggested that it may be useful as an 
adjunctive technique in clinical practice. It appears that these changes are independent of 
improvements in fitness. However, self-rated symptomatic improvements in physical fatigue 
and physical function and general health were greater following a more strenuous exercise 
programme. This discrepancy between decreased fatigue symptoms and changes in aerobic 
capacity was also seen in the cross-over group after three months on the aerobic exercise 
programme. This was associated with significant improvements in physical fatigue and 
increased physical function and general health, but with a lesser magnitude of change in 
aerobic capacity and exercise tolerance than the original exercise group. We know, from their 
activity diaries, that they recorded the same amount of time exercising as those in the original 
exercise group, but this may have been at a lower intensity, despite being prescribed target 
exercise zones, having started with three months of non-aerobic activity 
The analysis of the cross-over group, comparing the results after exercise with those after 
flexibility and relaxation are shown in Appendix E. The changes following the flexibility 
indicated an improved exercise tolerance revealed by the increased test duration, peak heart 
rate and peak blood lactate, while the increase in aerobic capacity, indicated by an increased 
V02peak was only observed after the aerobic exercise programme. This again points to a 
general increase in lifestyle activity, but not aerobic exercise, during the flexibility treatment, 
sufficient to improve exercise tolerance and patients' willingness to push themselves. These 
changes were then increased, although not significantly during the exercise treatment, which 
was, in addition associated with an increased aerobic capacity. It was not until they crossed- 
over and completed the exercise treatment that significant changes were observed in physical 
ftinction and general health and thus their own perceived physical capacity. However, the 
regular therapist contact and involvement in a physical treatment programme during the 
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flexibility treatment was sufficient to stimulate changes in social activities and perceived 
energy levels. In this respect, it is worth pointing out that participation in any activity, no 
matter how little, has positive physiological and psychological benefits, such that sufferers 
should never feel intimidated by their low levels of ability to begin with. 
Martinsen (1990) also found that an increase in aerobic fitness was not necessary for the 
psychological benefits of exercise to be observed. Similarly, two studies by Veale et al 
(1992), examined the effects of moderate and low intensity exercise on depression. They 
found no significant difference after 12 weeks between the low and moderate intensity 
exercise on their main physiological measure of estimated V02 Max, although the value 
increased in the exercise group. However, they did find significantly lower clinical interview 
schedule (CIS) score and Spielberger trait anxiety after 12 weeks of the moderate exercise 
programme. Their second study found no significant differences in CIS scores, Beck 
depression inventory, or Spielberger trait anxiety, or aerobic fitness between the groups who 
followed either a aerobic exercise programme or a low intensity programme consisting of 
stretching, relaxation and yoga. This implies that there is no relationship between change in 
aerobic fitness and change in observed ratings of mental state and that the therapeutically 
effective component of the exercise programme was not the improvement in aerobic fitness. 
The current study suggests that improvements rely initially on introducing patients to a 
regular pattern of activity that may or may not be considered of sufficient intensity to 
stimulate increases in maximum aerobic capacity, but with the aim of gradually increasing the 
intensity over time as confidence, self-esteem and a sense of control over physical symptoms 
are achieved. The quantity and quality of exercise needed to obtain health-related and positive 
behavioural effects may differ from that which is recommended for fitness benefits, 
particularly in patient groups. Although the objectives of the exercise programme are to 
reduce fatigue and to reverse the deconditioning effects, the initial low levels of activity and 
very gradual progression, may have stimulated relatively small increases in physiological 
capacity, while allowing larger improvements in symptoms. Psychological improvements 
with exercise training can occur when submaximal. cardiorespiratory fitness improves, despite 
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no change in VO. max. (Cramer et al, 1991), which agrees with our findings of continued 
and maintained improvement, in the form of decreased HR and RPE, at submaximal levels. 
It must be pointed out at this stage that, the aim was not solely to examine whether the 
physical fitness levels of CFS patients could be improved through a prescribed aerobic 
exercise programme. Improvement of exercise tolerance was utilised as a means of reversing 
the physiological deconditioning associated with this illness (shown to be true in the first part 
of the study through comparison with healthy sedentary controls). Therefore, as a treatment 
study, the main aim was to examine the efficacy of the given treatment in relieving the 
symptoms of the illness. Given the nature of CFS, any successful treatment would be 
expected to have both physiological and psychological effects. Therefore, the target would 
have been to find the minimum amount of exercise, to achieve a small improvement in 
exercise tolerance or fitness, while also promoting improvements in self-confidence and self- 
esteem and symptom reduction. This would, in turn, encourage adherence to the 
programme, by the very nature that it is perceived as manageable to the patients. These 
objectives were certainly reached if we consider the CGI scores and the low drop-out rate as 
reliable indicators of effectiveness of the treatment, particularly from the patients' 
perspective, which must, after all, be of prime importance in any treatment study. 
The use of exercise in the treatment of CFS has been criticised in the past due to reports of 
patients experiencing a "relapse" of severe symptoms following exercise (Gibson et al, 1993). 
However, McCully et al (1996) found only I out of 16 CFS patients had a significant relapse 
after a maximal treadmill exercise test, lasting 30 to 40 minutes. In the current study, some 
patients occasionally reported a resurgence of symptoms but these were not necessarily 
associated with increases in activity. At these times the volume of activity was decreased, 
until symptoms regressed. McCully suggested that the trigger for a relapse is not simply a 
bout of strenuous exercise, but that other factors are involved. In retrospect, it is true that 
those patients who did experience a relapse, or resurgence of symptoms, usually reported that 
they had taken on more than normal, physically, psychologically or by way of home 
pressures/ activities, in the preceding one or two weeks. 
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To ftirther examine the efficacy of the exercise treatment the results of all those who had 
followed the exercise treatment programme (original exercise plus cross-over groups) were 
pooled together and analysed. The significant improvements over baseline in almost all 
physiological measures and most symptomatic measures in the total group of 51 CFS patients, 
after exercise, lends further support to the value of this type of treatment for this condition. 
As mentioned previously, the lack of change in measures of mental health suggest that 
effective treatment is independent of antidepressant or anxiolytic effects. Although the PSQI 
total score at baseline did not identify any significant sleep disturbance, regular participation 
in the exercise programme had significant positive effects on sleep quality and quantity, as 
has been previously reported (O'Connor & Youngstedt, 1995). Therefore, pooling the data of 
all those who completed the exercise treatment indicated that, regardless of starting group, 
CFS patients respond positively, through both physiological adaptations to exercise, and 
associated improvements in the main symptoms of the syndrome. These affects were 
measurable after just 3 months on a regular and moderately intense aerobic exercise 
programme. 
Follow-up: 3 month and I year 
The most significant result at follow-up was that the CGI scores continued to improve which 
indicates the patients' own rating of how much they have recovered. Sixty-seven and sixty- 
nine percent of those in the flexibility (and cross-over) and exercise alone groups, 
respectively, rated themselves as at least much better at 3 months. Even more positively, 
74% of the CFS patients who had followed the exercise programme had the same rating a 
year later. and Those who had followed the exercise programme only, had maintained all 
of the physiological improvements at follow-up, three months after completion of the 
supervised programme, although theV02 peak had decreased slightly. Those who began 
with flexibility, and crossed-over to exercise, maintained most of the physiological changes 
measured post-exercise, excep V02peak and maximum ventilation. As an observation, this 
group tended to place a lot of emphasis on the flexibility training throughout their exercise 
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programme and this was occasionally substituted for a more strenuous session, when they felt 
fatigued. Also, since they had a more gradual introduction to exercise, starting with 12 weeks 
of stretching and relaxation, they may not have exercised as strenuously as the exercise 
group, particularly in the period between completion of the trial and follow-up, when the 
amount of exercise they did was at their own discretion. They continued to exercise, but 
possibly at a lower intensity, which was sufficient to maintain improvements at submaximal 
levels, but not in maximum aerobic capacity. 
Improvements in Chalder and V/A fatigue scales were maintained in both groups at follow- 
up, whereas the Barsky score was improved only in the cross-over group compared to 
baseline. This measure indicated a decreased tendency towards amplification of bodily 
symptoms and an increased threshold for pain, which complimented the increased exercise 
and lactate tolerance. Somatic amplification, along with symptoms and discomfort, have 
been shown to be significant predictors of impairment of functioning (e. g. curtailing of daily 
routine, work or social activities) (Barsky et al, 1988). Increased attention to internal cues 
results in greater perception of fatigue and physical symptoms (de Coverly Veale, 1987) and 
it may be that the exercise provided a distraction from increased attention to bodily 
symptoms. In short, these measures indicated that patients continued to experience a decrease 
in the predominant symptom of the illness and the symptom that they were most likely to 
notice or complain of, i. e. fatigue. This may have been associated with less awareness or 
attention to the illness symptoms as a result of changed habits and renewed interests in other 
activities. 
Those who had followed the exercise programme alone, showed increased social ftinction, 
emotional role and total SF36 score indicating that they felt that any physical or emotional 
problems were less likely to interfere with social activities, and that they no longer felt that 
emotional problems interfered with work or daily activities. This would imply a general trend 
towards a greater feeling of control. Those who followed the flexibility and then the exercise 
programme showed significantly greater capacity for social and physical activities, which 
were less likely to be restricted by their health, and an improved feeling of calm. After either 
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treatment, patients were more inclined towards resuming normal social and physical activities 
and lifestyles. Emotional/mental improvements in both groups further illustrated the effects of 
regular aerobic exercise on psychological well-being, in addition to the well-documented 
effects on physiological capacity. The cross-over group, in particular, chose to continue 
exercise at a lower level, which was sufficient to reduce their fatigue symptoms, but was 
below the level necessary to maintain the previous improvements in maximum aerobic 
capacity, although other physiological improvements were maintained. Improvement in 
submaximal. exercise tolerance is more relevant to maintenance of daily activities and 
functions. 
In the same way as we pooled together the results of all those who had completed the exercise 
treatment, we pooled the 3 month follow-up results of all those patients who had completed 
the exercise programme and attended for follow-up. This gave very similar results as the 
pooled data post-exercise results immediately after treatment with all physiological 
improvements being maintained at 3 months, and all measures significantly improved 
compared to baseline (Table 4.21). The maximum aerobic capacity of the total follow-up 
group had decreased slightly, compared to immediately after the exercise programme, but this 
value was still significantly greater than baseline. General exercise and pain tolerance were 
also maintained, indicated by the increased test duration, peak heart rate and peak blood 
lactate results, as was also shown by the results immediately after the exercise programme. 
Submaximal exercise response and strength, which may have a greater bearing on general 
functional capacity, were also maintained. In addition to the reduction in perceived exertion 
and heart rate levels observed on completion of the exercise programme, oxygen uptake was 
also significantly lower at all submaximal test stages (between 4 and 12 minutes) (Figure 
4.8). In this respect, short term adaptations to regular exercise caused a lowering of the 
exercise heart rate and a subsequent reduction in RPE, a combined physiological and 
psychological effect, whereas a greater efficiency of oxygen extraction and consumption and 
improved economy/efficiency of effort may be considered to be more longer term 
adaptations, and thus, were not observed until they had participated in regular exercise for a 
longer period. It is possible that at this stage we are beginning to observe the effects of an 
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increased stroke volume, without the relative tachycardia that was necessary in the previous 
assessment, to maintain the cardiac output. All of the symptomatic improvements, were 
maintained or improved upon. Therefore, once patients had established a regular exercise 
routine and experienced the associated improvements in physical and symptomatic levels, 
they continued with the exercise, albeit at a lower level, but one which was sufficient to 
maintain improvements. 
A further confirmation of the efficacy of exercise treatment can be seen by comparing these 
pooled results at 3 month follow-up with the results of the healthy sedentary controls assessed 
for the baseline comparison. This could determine if, in the short term, CFS patients who 
showed significant deconditioning initially, actually reached similar fitness levels to a healthy 
sample from the general population, following a tailored exercise programme. With this 
comparison, absolute peak V02, maximum ventilation, maximum heart rate, peak blood 
lactate and test duration all reached levels similar to those measured in the sedentary control 
group. Leg strength did not improve to these levels, which is not surprising due to the 
absence of specific strength training during treatment. Although one could argue that the 
control group, being sedentary, had a fitness level below the optimum, it must be 
remembered that they represented a group of healthy individuals with no recorded difficulties 
in maintaining "normal" lifestyles, nor with any major complaints of fatigue. If the CFS 
patients were to continue with a regular activity programme, even at a lower level than 
during treatment, we could expect further improvements in fitness towards optimal levels, 
particularly with regard to leg strength. However, although all of the symptomatic measures 
increased significantly compared to baseline, they did not reach the same levels as those 
measured in the control group on most scales. The two measures that did improve to these 
levels were mental health and emotional role. Therefore, although patients felt much 
improved after treatment, confirmed by 68 % scoring I or 2 on the self-rated CGI scale, their 
score on measures of fatigue, physical function or general health had not returned to levels 
that might be considered healthy or normal. However, six or nine months is a relatively 
short period of time in relation to the average illness duration of over 3 years. In many 
patients, the main barrier to physical treatment, may have been a perceived low physical 
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capacity and fear of worsening their symptoms. Therefore, one could reasonably expect 
changes in these parameters to take longer, while patients have to adapt their whole attitude 
to activity and their ability to deal with physical tasks that have remained a potential barrier 
or potential cause of relapse for such a long time. Physical changes can probably occur in 
spite of individual beliefs and/or confidence levels, if they increase their activity levels, 
wheras psychological changes, particularly in terms of long-term attitudes and perceptions, 
may take a lot longer to alter. 
There have been criticisms that CFS patients, despite initial improvements, tend to relapse 
several months after a treatment programme and that the general long term prognosis does 
not indicate a good recovery rate. In a 3-year follow-up study of 103 CFS patients, only 6 
recovered fully and 20% could not perform substantial physical activity (Wilson et al, 1994). 
Kroenke et al (1988) found that only 28% of patients with chronic fatigue improved after 1 
year. In the current study, we followed-up CFS subjects 1 year after completion of the 
programme (15 or 18 months after trial entry, depending on initial treatment group). The 
percentage rating themselves "much" or "very much better " had increased to 74%. This 
result, together with a general trend towards a return to work or study and a continuation of 
activity, indicates a very positive long-term effect for this type of treatment. It is far more 
significant than any improvement that might have occurred spontaneously in the absence of 
this intervention, taking these previous follow-up studies into account (Wilson et a, 1994; 
Kroenke et al, 1988). There was a moderate increase, from 18% up to 26%, in the number 
working or studying part-time and more substantial increase, in those returning to full-time 
employment or education (20% up to 40%). This may reflect the general trend towards a 
resumption of normal lifestyle, beginning with part-time and moving towards full-time 
employment. It would be interesting to follow the group up 1 year later, to determine if a 
significant number of those working/studying part-time had substantially increased their hours 
or returned to full-time employment or education. 
Bombardier & Buchwald followed a group of CFS patients one and a half years after initial 
assessment, during which time several patients had tried antidepressant medications. Sixty- 
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one percent had improved a little but few had returned to premorbid levels (fully recovered), 
with I I% resuming full-time and 13 % resuming part-time work. This is considerably lower 
than the 66% working/studying full- or part-time (40%ftill and 26% part-time) after 
treatment, in the current study/. This represents a 27% increase from the proportion 
working/studying at baseline (39%) (25/66). Wilson et al (1994) found that 50% of CFS 
patients, followed up 3 years after initial assessment, some of whom had enrolled on an 
immunoglobulin treatment trial, reported some improvement. Only 6% of this group 
considered themselves completely recovered, with 20% unable to do any form of physical 
activity and 40% unable to maintain any social activities. We reported that 68% of those 
patients followed up a minimum of 18 months after initial assessment still considered 
themselves regularly active, which, interestingly, was significantly higher than the 55% who 
considered themselves regularly active prior to the illness. In this respect, some individuals, 
who had not been involved in sport or any regular activity for some years, even before 
developing CFS, reported a renewed interest, either through noticing improvements in fitness 
levels or feeling more confident when appropriate guidelines were given. 
Recovery rates (41 %) were slightly better in a two and a half year follow-up study, which 
also used the SF36 health survey questionnaire to assess mental health (50.5 (21.8) vs 61.3 
(14.4)) and physical function (36.3(29.6) vs 44.8(30.3)) at baseline and at follow-up, 
respectively (Clarke et al, 1995). Baseline values were somewhat lower in both measures than 
those in the current study, probably due to our exclusion of psychiatric disorders in the case 
of the mental health measure. Although assessed only up to 6 or 9 months after initial 
baseline measurements, the exercise treatment was associated with a 56% improvement in 
physical function, compared to 23% in Clarke's study. At 4 year follow-up, during which 
time cognitive behavioural therapy, with or without antidepressants, was available, 50% of a 
group of 29 CFS patients considered themselves recovered or almost recovered, while 64% 
of those who had accepted and completed treatment (14/22) reported a sustained improvement 
at 4 years (Bonner et al, 1994). Overall, the long-term results from the current exercise 
treatment study, show a sustained improvement and maintained recovery rating on the CGI 
score, which exceeds long-term outcomes of other treatments, such as antidepressants or 
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immunoglobulin therapy. The only other treatment that has been shown to have comparable 
long term positive outcomes is CBT. It should be noted that both of these approaches, 
exercise and CBT, involve lifestyle changes and subsequent attitude/belief changes, which are 
absolutely essential for the long-term effectiveness of treatment. The main difference is that 
CBT actually works directly on changing attitudes to the illness and its symptoms, whereas 
these changes tend to occur as a consequence of participation in a tailored graded exercise 
treatment programme. However, it should also be noted that regular contact and discussion 
with the exercise physiologist may also act as a form of CBT. 
One of the limitations of the current study is that the follow-up can only be extended to 18 or 
21 months after initial assessment, but it would be interesting to examine the long tern 
outcome of CFS patients completing an exercise trial for an extended period as other studies 
have reported (with little or no treatment offered). All of the reported follow-up studies 
included patients with current psychiatric disorders and all reported these to be strongly 
associated with incomplete or no recovery. Indeed, Wells (1989) reported that affective 
disorders seem to play a significant and independent role in determining functional outcomes 
among a wide range of chronic medical conditions, again justifying the approach of treating 
these before embarking on a physical treatment programme. 
How, then, did the exercise treatment work? It was independent of mood and sleep changes, 
was associated with increased aerobic capacity, strength, exercise tolerance, and reduced 
perception of effort. I believe that success depended on both a physiological training effect 
and a graded exposure to the feared stimulus of physical activity. Perception of effort 
significantly improved with exercise, suggesting further research should examine perceptual, 
as well as physiological, responses to exercise. It was also shown that CFS patients differed 
from the depressed group, who were equally as unfit, in their perception of physical function 
and role. This may again be one of the barriers that are broken down by exposure to a 
physical treatment. It was stressed at all times that it was more important for them to slow 
down and to continue exercising for the entire period than to adhere to a faster pace 
for 
shorter periods. People who may have been inactive for a long time are inclined to do too 
160 
much too soon, and then give up, and this seems to have been the previous approach of many 
of the CFS patients who had tried exercise. They were encouraged to listen to their own 
body and to slow down, rather than stop, if the exercise felt to difficult to continue. This 
ultimately results in faster improvements in fitness than more intense, but less continuous 
exercise. It also makes the exercise more enjoyable and encourages patients to monitor their 
own progress. By following-up patients 3 months after treatment completion, during which 
time they were told how to maintain and progress their exercise, they were given the control 
to choose the level comfortable for them, while also knowing that they could seek advice if 
needed. Indeed, Deale et al (in press), suggested that treating patients until they reach 
optimum functioning may be unnecessary. Outcomes could be enhanced by treating patients 
until they take over responsibility for their treatment and they could then be followed up with 
"booster" sessions. 
The results presented in this study suggest that appropriat exercise, whereby careful 
monitoring and planning is gradually handed over to the patients, has an important role to 
play in the rehabilitation and recovery of patients with CFS. Because of the low level of 
exercise tolerance in this group, such an exercise programme needs to begin at a low 
intensity, whereby regularity, rather than volume, is the goal. Progression should be very 
gradual, aiming for a general increase in daily activity, using an exercise regimen resembling 
that for the unimpaired, but adapted in duration and intensity. Patients should avoid 
"overdoing it" during the good phases of the illness but also they must try to continue the 
activity pattern, albeit at a reduced intensity, during the relapse phases. The key to recovery 
must be through regular and moderate activity. The results show that it is possible to change 
the course of the illness by minimizing the deconditioning process and by keeping patients at 
an optimal level of physical functioning, through an exercise prescription designed for the 
individual patient. Regardless of amount and intensity of exercise, the importance of a 
regular routine and taking positive action cannot be over-emphasised. 
The combination of approaches described in this study allows us to look at the different 
treatments alone and, with the cross-over group, a combination of treatments. Taking into 
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account the results of the cross-over group, it appears that the most important aspect is the 
participation in regular physical activity, no matter what type or how little, is the important 
starting point. The psychological changes associated with only small improvements in 
traditional measures of fitness, indicate the value of regular positive reinforcement (therapist 
contact), attention and guidance, in changing the patients own perception of physical ability 
and their willingness to tackle and control certain aspects of their illness. Exercise or activity, 
of any type, is a method of treatment that they can understand and can control themselves, 
which can ultimately lead to an increased confidence and self-esteem, while also allaying 
general fears about physical tasks. The first target is getting them to do enough activity to 
overcome that initial barrier, and only after this is achieved will they be happy to carry on 
and progress. 
4.4 Limitations of the study 
The nature of the study, involving an initial treadmill walking test, as well as weekly visits to 
the laboratory, excluded those who were more severely disabled, who would not have 
managed the travel or the assessment itself Therefore, the treatment described in this study 
would not be applicable to those CFS patients who are either bedridden or wheelchair-bound. 
However, all exercise prescriptions are adaptable and suitable exercises could be devised for 
such patients, taking into account their restrictions, with a view to improving their ftinction 
very gradually to the stage whereby they could begin a low intensity aerobic exercise 
programme. This may have to be carried out through an in-patient programme. 
Throughout the study the exercise physiologists were not blind to the treatment group of the 
patient. Initially, there was only one physiologist involved, but after the first six months, 
there were always two, aiming to alternate the person with whom the patients did their 
exercise sessions to avoid bias or attachment to one therapist. Also, care was taken to 
standardise the protocols and any verbal encouragement given to all patients during their 
physiological assessments. Patients were also informed that the those carrying out the study 
were assessing both treatments, either of which could be more effective and there was no 
contact between the patients while on the different treatment programmes. To reduce bias, 
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the main outcome measure, the CGI score, was carried by a psychiatrist who was blind to 
the treatment group. 
It may be considered more complete if the protocol had allowed those patients who completed 
the exercise treatment first to cross-over into the flexibility programme, as the other group 
did. However, this would have been difficult to put into practice, since patients once 
introduced to a regular aerobic exercise programme, would probably have continued with a 
lesser amount, even if they were instructed to avoid aerobic exercise. We also wanted to 
assess the effects of an exercise programme alone, from baseline to follow-up. In addition, 
the nature of the cross-over protocol meant that there was no 3 month post-treatment 
assessment for those who had followed the flexibility programme alone, as the majority of 
those who had completed the flexibility took up the option of joining the exercise programme. 
In an ideal situation, perhaps they should not have been given this option. However, when the 
aim of the treatment is to improve both the patients' symptoms and their overall perception of 
improvement, it would be very difficult and, indeed unfair, to deny them the option to take 
part in a treatment programme which was associated, from an early stage, with better 
improvements - particularly in terms of the CGI score. 
Due to that fact that those following the flexibility programme did not use heart rate 
monitors, we did not know if their heart rate was sufficiently elevated during their stretching 
sessions to cause a training effect. This, and the fact that, once part of an active treatment 
programme, they tended to become more active in general and to take on previously avoided 
physical tasks, despite being instructed to avoid aerobic activities, may explain some of the 
improvements found in this group following the flexibility programme. 
Given the high prevalence of psychiatric disorders in CFS patients, exclusion of this group or 
treatment prior to entry restricts the application of the results to CFS patients without a 
psychiatric disorder. However, since a psychiatric diagnosis has been shown to have strong 
effects on outcome and recovery, this exclusion was necessary in order to assess the effects of 
the exercise and flexibility treatments on CFS alone (as was discussed previously). It was 
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interesting that the two patients who reported feeling worse after treatment were both 
suffering from a depressive illness when assessed. This lends support. to the fact that 
psychiatric disorders should be treated prior to the exercise programme and this would be 
continued throughout, possibly through the implementation of CBT alongside the exercise 
programme. 
Despite these limitations, this study has confirmed that individually tailored and graded 
exercise therapy has an invaluable role to play in the treatment, with regard to both 
physiological and symptomatic improvements, and long-term recovery of patients with 
chronic fatigue syndrome. The nature of any study dealing with patients and examination of 
the efficacy of various treatments, inevitably implies that some compromises may have to be 
made in terms of the protocol, to ensure that the patient care and their access to appropriate 
treatment, is considered first and foremost. In this respect, some of the limitations could have 
been avoided, such as control of the flexibility group activity, but others, particularly in 
terms of design of the study, such as the cross-over protocol, were a necessary compromise 
for the care of the patients involved. Nonetheless, the results still leave no doubt as to which 
treatment is associated with a greater overall improvement in physical and psychological 
symptoms. 
It could be argued that CBT is potentially as effective a treatment, and indeed, the results of 
both treatments are very similar after one year. The very nature of both treatments implies 
that there are similarities in that should compliment each other. Both incorporate 
recommendations to increase activity, to a greater or lessor extent, and both employ a certain 
degree of patient therapist contact, discussion and counselling. To date most studies using 
CBT have included patients with co-morbid psychiatric disorders, which prevents a direct 
comparison. In the future, the next step should be to compare both CBT and graded exercise 
therapy with the same type or group of CFS patients. However, it could reasonably expected 
that graded exercise would emerge as equally, if not more, effective in patient improvement 
and long-term maintenance of improvement, while also suggesting that CBT has an important 
role to play in dealing with CFS. Physiological improvements associated with CBT take 
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longer, but these are ultimately the improvements that patients tend to notice first, as they 
begin to cope with physical tasks and activities better, allowing them to resume social and 
daily activities, which are important to them. In terms of patient rating of improvement (CGI 
score), there is no doubt that graded exercise therapy has been shown to have the most 
positive long-term outcome in improvement in the symptom of CFS than most other 
treatments to date. 
As a follow-on from this study, practical guidelines with details on the implementation of a 
graded exercise programme with CFS patients will be produced. This will be in a format 
applicable to doctors, physiotherapists, nurses and cognitive behavioural therapists. This 
type of approach, also has applications in the treatment and rehabilitation of several chronic 
medical conditions and it is hoped that we will continue to apply a similar format to further 
research in these areas in the future. Having considered all of these results, there is a very 
clear evidence that graded exercise therapy is an effective and invaluable treatment in 
facilitating the recovery of patients with Chronic Fatigue Syndrome. 
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CHAPTER FIVE: SUMMARY AND CONCLUSIONS 
The initial comparison between a group of CFS patients and a healthy sedentary control 
group revealed that individuals suffering from CFS have a significantly reduced level of 
physical fitness as measured by a significantly lower peak aerobic capacity, pain tolerance, 
exercise tolerance and strength, and a higher perception of exertion at submaximal levels of 
intensity. It must be stressed that CFS patients were compared to a healthy, but inactive, 
control group, and the fact that they had a significantly lower fitness level than this group, 
confirmed that they were, indeed deconditioned. The CFS group exhibited detraining effects 
that could be associated with a very inactive lifestyle, and a perceived inability or a barrier to 
tackling physical tasks. Due to this reduced physical function and associated physical and 
mental fatigue, the CFS patients had restricted their lifestyles and social lives to cope with 
this long-term illness. We could expect that this had consequential effects on mood and 
emotional health. Despite exclusion of CFS patients with psychiatric disorders, these groups 
were significantly different on measures of physical and mental fatigue, general health, social 
and physical function and bodily pain compared to the control group. These symptoms are, 
therefore, due to the illness rather than depression, particularly as clear differences emerged 
when the CFS patients were compared on the psychological measures, with a small subgroup 
of depressed patients. The CFS group studied were typical of CFS patients in general, in 
terms of duration of illness, gender distribution, employment and causal attribution. 
Therefore, it is reasonable to assume that these results can be generalised to other patients 
with CFS. These patients were indeed out of condition, weak and fatigued, all of which are 
parameters that could potentially be improved, if not reversed, through a gradual return to 
activity and an attempt to break the circle of inactivity, decreased exercise tolerance, 
frustration, further activity avoidance and depression. 
Participation in a carefully controlled, graded aerobic exercise programme was associated 
with improvement in aerobic capacity, exercise tolerance, submaximal exercise capacity, 
efficiency and strength after three months. Smaller changes in exercise tolerance and no 
increase in aerobic capacity were observed in CFS patients who followed a similar duration 
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programme of flexibility and relaxation. This indicates that the aerobic exercise is a more 
effective treatment, particularly with regard to reversal of the effects of deconditioning 
associated with this condition. Further evidence of the efficacy of this treatment was shown 
by the similar improvements measured in those who crossed over to the exercise treatment 
following the flexibility programme. 
Important positive symptomatic changes included improved general health, decreased 
physical and mental fatigue, increased vitality, physical and social function, which improved 
to a greater extent with the exercise treatment. The patients' overall rating of improvement on 
the CGI scale, which was significantly better with exercise (55 % vs 27 %), ftirther confirmed 
this. This scale is an important objective (from the therapists point) and subjective (from the 
patients perspective) measure of the overall effectiveness of the treatment. The value of such 
a scale, which involves the patients'own estimation of improvement has been discussed. One 
of the most important criteria in a treatment trial has to be whether the patients or subjects 
feel the benefits or effects, and this was successfully demonstrated throughout this study. 
After all, what must be considered to be most important, is whether the patients themselves 
feel that they have improved and are continuing to recover from Chronic Fatigue Syndrome. 
The long-term outcome of the treatment also indicated that these improvements, both 
physiological and symptomatic, were maintained, and, in some measures, exceeded. More 
importantly, the patient rating of improvement also increased (68%) at follow-up, three 
months after completion of the treatment. Longer term follow-up indicated a continued 
improvement in symptoms, whereby three-quarters (76%) of those who completed the 
exercise treatment considered themselves "much" or "very much better" a year after 
completion, with a general trend towards a return to work or study and a maintenance of a 
regular activity programme by the majority. This is a very important long-term health, 
symptomatic and lifestyle change, which must be considered a very important improvement. 
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Compared to other trials, this study represents a more holistic improvement in symptoms and 
physiological effects and a greater treatment effect, which was maintained. Wilson et al 
(1994) commented that there have been notably few double-blind, placebo-controlled studies 
in adequately defined patient samples in CFS treatment research, and this study, although not 
double-blind, does represent a step towards bridging the gap. They also suggested that the 
absence of objective response markers has also meant that the outcome of many studies has 
relied on highly subjective measures, whereas the current study employed a combination of 
subjective and objective symptomatic measures and objective physiological measures to assess 
treatment outcome. 
Future studies should examine the combination of CBT and exercise, since CBT alone has 
also been shown, in the more recent trials, to be associated with a similar rate of 
improvement in CFS patients. Recommendations on increasing daily activity levels are 
frequently included in CBT treatment such that the more comprehensive approach to 
treatment could include the combination of psychological (CBT) and physiological (exercise) 
programmes supervised by the relevant professionals working together. Indeed, Deale et al 
(in press) incorporated a planned graded activity programme with CBT, involving activities 
such as walking and gardening. Patients were encouraged to persevere with their targets and 
not to reduce them on a bad day or not to exceed them on a good day, similar to the approach 
in the current study. They considered graded activity to be the key component in the study, 
making it more successful than some previous CBT trials that excluded exercise (Freidberg & 
Krupp, 1994). 
With regard to future recornmendations and the use of this treatment with CFS, the next step 
could be to examine application within an NHS setting, carried out through a physiotherapy 
department, but supervised by an exercise physiologist. This should also employ an 
integrated approach including collaboration with other therapists. Monitoring and control 
should gradually be handed over to the patient, with a decreasing frequency of visits and clear 
explanation on progressive exercise. Baseline and post-treatment measures should be taken; 
utilising whatever monitoring equipment is available, so that programmes can be individually 
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tailored and improvements can be objectively assessed. When full metabolic/gas analysis 
equipment is not available, heart rate monitoring during and after progressive walking, 
cycling or step tests would be sufficient, with/without estimations of aerobic capacity, if 
required. Symptomatic measures should also be taken using appropriate and validated scales. 
The programme should ideally begin with regular, low-intensity, aerobic exercise and should 
include exercises to improve flexibility, while basic strengthening exercises should also be 
incorporated at a later stage focusing on the legs (mainly the quadriceps) and the upper body 
(particularly for the muscles involved in lifting and carrying). In some cases, it may be more 
appropriate to begin with one or two weeks of predominantly flexibility exercises and a focus 
on increased daily activity, and then progress towards prescribed aerobic exercise. A lot of 
control of the programme can be eventually handed over to the patient, with proper 
education, such that visit frequency can be gradually decreased. Analysis needs to be carried 
out on cost, frequency of visits required, optimum duration of contact sessions, equipment 
required, number of patients that can be treated together, referral structure and patient 
suitability. 
Ultimately, this treatment would work out more cost effective than expensive drug 
treatments, which have not proven to be reliably or uniformly effective to date. In order to 
facilitate this approach, general practitioners need to be alerted to the prevalence of chronic 
fatigue syndrome and how to recognise it, such that patients can access treatment more 
readily. Literature and guidelines could be available to them on the implementation of 
exercise in the treatment of CFS such that the programme could begin through the practice 
under the guidance of appropriately trained personnel, with a view to linking up with a local 
physiotherapy or exercise physiology department when available. Major psychiatric 
disorders should be treated prior to entry to an exercise programme, as there is evidence that 
these have separate effects on outcome. 
There is no doubt that graded aerobic exercise, appropriately tailored to individual 
conditions, has an invaluable role to play in the treatment of, not only CFS, but also, 
potentially, several other chronic conditions, which are also associated with deconditioning. 
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APPENDIX 
Chronic fatigue syndrome - Holmes et al (1988) 
A case of CFS must fulfil major criteria 1 and 2 as well as the following minor criteria: either 
8 or more of the II symptoms or at least 6 of the II symptoms and at least 2 of the 3 
physical signs specified. 
Major criteria 
1. The onset of persistent or relapsing, debilitating fatigue or easy fatigability in a person 
who has no previous history of similar symptoms, which does not resolve with bedrest, and 
that is severe enough to reduce or impair average daily activity below 50% of the patient's 
premorbid activity level for a period of at least six months. 
2. Other clinical conditions that may produce similar symptoms must be excluded by 
thorough evaluation, based on clinical history, physical examination and appropriate 
laboratory findings. Among the specific exclusions is chronic psychiatric disease, either 
newly diagnosed or previously experienced, (such as endogenous depression; hysterical 
personality disorder; anxiety neurosis; schizophrenia; or chronic use of major tranquilizers, 
lithium or antidepressants). 
Minor criteria 
Symptoms 
A symptom must have begun at the time of onset of increased fatigability and must have 
persisted or recurred over a period of at least 6 months (individual symptoms may or may not 
have occurred simultaneously). 
1. Mild fever - oral temperature between 37.5 degrees C and 38.6 degrees C, if measured by 
the patient - or chills. (Note oral temperatures of greater than 38.6 degrees C are less 
compatible with chronic fatigue syndrome and should prompt studies for other causes of 
illness. ) 
2. Sore throat 
3. Painftil lymph nodes in the anterior or posterior cervical or axillary distribution 
4. Unexplained generalised muscle weakness 
5. Muscle discomfort of rnyalgia 
6. Prolonged (24 hours or greater) generalised fatigue after levels of exercise that would have 
been easily tolerated in the patients pre-morbid state 
7. Generalised headaches (of a type, severity, or pattern that is different from headaches the 
patient may have had in the pre-morbid state 
8. Migratory arthralgia. without joint swelling of weakness 
9. Neuropsychologic complaints (one or more of the following: photophobia, transient visual 
scotomata, difficulty thinking, inability to concentrate, depressions) 
10. Sleep disturbance (hypersomnia or insomnia) 
11. Descriptions of the main symptom complex as initially developing over a few hours to a 
few days (this is not a true symptom, but may be considered as equivalent to the above 
symptoms in meeting the requirements of the case definition) 
Physical criteria 
Physical criteria must be documented by a physician on at least two occasions, at least one 
month apart 
I- Low grade fever - oral temperature between 37.6 and 38.6 degrees C or rectal temperature 
between 37.8 and 38.8 degrees C 
2. Non-exudative pharyngitis 
3. Palpable or tender anterior or posterior cervical or axillary lymph nodes (Note : lymph 
nodes greater than 2cm in diameter suggest other causes. Further evaluation is warranted) 
APPENDIX B 
PATIENT'S CONSENT FORM 
Consultant: P. D. White Investigator: K. Fulcher 
Pull2ose of tbc study and brief description of procedure tO be carried out: 
This study has been designed to answer the question "is gradual rehabilitation with exercise 
helpful to patients with chronic fatigue syndrome ? ". 
You will be given a short interview and asked to fill out four brief questionnaires. These ask 
about tiredness, weakness, sleep disturbance and emotional symptoms. Your muscle strength 
and physical fitness will next be measured using standard techniques. This will involve 
sitting in a chair and pushing your right leg straight against a strain gauge. Then you will 
walk on an exercise treadmill for several minutes at slowly increasing speed and increasingly 
uphill. 
At the same time you will breathe in and oiut of a mouthpiece, so that the level of gases you 
breathe can be measured. At three separate moments before, during and after the exercise, we 
shall take a droplet of bleed form your fingertip to measure the amount of lactic acid you 
produce. 
At the same time you will be allocated by chance to one of two treatment groups. In total you 
will attend here for approximately one hour per week for 13 weeks. In one treatment you will 
be given stretching and relaxation exercises to do. In the other, you will be given aerobic 
exercises to do, starting at a low intensity and gradually increasing intensity over the weeks. 
You will be encouraged to practice the exercises at home on a regular basis. 
After 13 weeks your ability to exercise will be measured again in the same way as before. 
You will also be given the same questionnaires to fill in. 
This study has been explained to me and I understand: 
(a) What the study involves. 
(b) That refusal to participate will not affect my treatment in any way 
(c) That I may withdraw at any time. 
I therefore agree to take part in this study. 
Signature of patient .................................................. Date ..................................... 
I HAVE BEEN PRESENT WIIILE T14E PROCEDURE HAS BEEN EXPLAINED TO THE 
PATIENT AND HAVE WITNESSES fHS/HER CONSENT TO TAKE PART 
Signature of witness ............................................... 
Date ..................................... 
(Tbe witness should be a person nol connected with the study). 
Full name and address of patient- 
AMEN-DI Xc 
ACTIVITY QUESDONNAM 
List any sports or recreational activities that you have participated in during the past three 
months 
Sport, recreation or other physical activity Number of 
times 
Average time per 
episode 
Hours Mins 
A 
B 
C 
D 
E 
2. Which of the following best describes your lifestyle? (please tick one) 
a) I take enough exercise to keep healthy 0 
I ought to take more exercise 13 
c) Don't know 
cl 
I Considering a 7-day period, how many times on average do you do the following kinds of 
exercise for more than 15 minutes during your free time? 
a) -Strenuous exercise (heart beats rapidly) 
(i. e. running, jogging, hockey, football, soccer, squash, basketball, vigorous swimming 
or cycling 
b) Moderate exercise (not exhausting) 
F-I 
(i. e. fast walking, tennis, easy cycling, badminton, easy swimming, dancing) 
C) Mild exercise (minimal effort) Fý 
(i. e. yoga, darts, fishing, bowling, golf, easy walking) 
4. Considering a 7-day period during your leisure time, how often do you engage in regular 
activity for long enough to work up a sweat, get the heart pumping or get out of breath? 
a) Often r-1 
b) Sometimes ED 
c) Never M 
HEALTH STATUS QUESTIONNAIRý(SF-3) 
R THE FOCLOWING QUESTIONS ASKFOR YDUR VIEWS ABOUT YOUt 
Hqýý, *'H, 'O*W ýeQU'FEEL ýkND HOMv'ELLYOLj ARE ABLE TO DO YOUR 
t- ACTIVITIES. IF YOU ARE UNSURE ABOUT HOW TO ANSWER ANY US UA. L 
'. . QUESTiON.. PLEASE GIVý', TýE BESMSýý YOU CAN AND MAKE ANY 
POMMENTS IN THE SPAqE AVAILý. BLE AFTER QUESTION 10. 
1. In general would you say your health is- ' 
Please tick one 
Excelient 
0 
Very good 
0 
- Good 
0 
Fair 0 
Poor 0 
Comparedjg! Qne year acQ. how would you rate your health in generial 
r-M ? 
Much better now than one year ago 
Sornewhat better now than one year ago 
About the same 
Somewhat worse now than one year ago 
Much worse nc)w than one year ago 
0 
0 
0 
0 
0 
For otfice vse 
F7 
I Comýnu&d 
For otfice - 
HEALTH AND DAILY ACTIVITIES 
3. The following questions are about activities you might do during a typica J 
day. Does your health limit you in these activities? lfso, howmuch? 
Please tick one circle on each line 
Yes, Yes, No, not 
limited limited limited 
a lot a little at all 
a. Voorous Pclivý; es. such as 
running, lifting heavy objects, 
parltizýaltlng in: -. renuous spoils 
b. Mrd-rafe Pctivities, such as 
moving a table, pushing a 
vacuum cleaner. bowring or 
playing golf 
c. Lifting or carrying groceries 
d. C[irnbIng=, /P-mjfl; gfT, sofVaIrs 
e. Climbing. Qn-- flight of stairs 
--------------- f. Sending, kneeling or stooping 
-- 0 
--------------- 
g. WaWng rnore lhan a mi; - L 
-- -- 0 ------ 0 -- 0 
--------------- h. WaRing half ý m, il;,, 
-- 0 ------ 0 - -- ---- 
--------------- i. Walking 100 Yards 
--- ------ --- 
Bathing and dressing yourself -- 0 ------ -------- 
4. During the past 4 weeks, have you had any of the following problems with your work 
or other regular daily activities as a result of your phvilcal health? 
Answer Yes or No to each question 
P-. Cut down on the ;: rnounl Of 112-11ý1 You spent on woek or other activities 
b. Acc-mm. nrishped faia than you would liýe 
c. Were limited in the Lm_d of worlK or other activities 
d. H2d 6TV-11tv Performing the woek or other activities 
. (e. g. it took extra effort) 
F-I 
F-I 
F7 
El 
YES NO 
0 0 
0 
.0 
0 0 
0 0 
S. During the pasl 4 weeks have you had any of the following problems with 
For ctfice u: 
your work or othpr regular daily activities Ps a regult Qf any emllanal 
plobterna (such ai feeling depressed or anxious)? 
Answer Yes or Ho to each qu estion 
YES NO 
a. Cut do", n on the arnnunt of urne you spent on work or other acthities 
0 0 
El 
b. Aocom,,, )Fýhe-ýj toes than you would like 
0 0 
c. Didn't do work or other activ?, Ies as c; nrellulfy as usual 
0 0 
EJ 
6. During the past 4 weeks, to what extent has your physical health or 
emotional problems interfered with your norrinal social activities with 
family, friends, neighbours or groups? 
please tick one 
Not at all 
0 
Slightly 0 
Moderately 0 
Ouille a bit 
0 
Extremely 0 El 
7. How rnuchtaýa pain have you had during Ihe p3st 4 yleekS? 
None 
Ver/ mlid 
Mild 
Moderate 
Severe 
Very severe 
S. During the pact 4 wf,, eks, how much did D-j: fa interfere with your normal 
work (including work both outside the home and housework)? 
Not at P. 11 
A little bit 
Moderately 
Cuile a b4 
Extremely 
3 
0. 
0 
0E 
0 
0 
CønJnu 
f, YOUR FEELINGS 
9. These questions are about how you feet and how things have been with 
you! ýurina the past or each question, please ind, ýate the one . -mQnth. (F ansiver that comes closest to the way you have been feering) 
Please tick one circte on each line 
How much time during 
All 
of the 
Most A good 
of the bit of 
Some 
of the. 
A little None- 
of the of the 
th-e Dast monVj: time time the time time time time 
; f 
0 0 0 0 0 0 
a. D e? d you feet full of lif 
---- - --- ---- -- -- --- --------- 
b. Have you been a very nervous 
-- 
0 0 0 0 0 0 
per-son? 
c. Have you felt so down in the 
dumps that =hirg could dieer 
000000 
you up? 
d. Have you feft calm and 
peaceful? 
00 0 00 0 
-------------- 
e. Did you have a lot of energy? 
000000 
f. Have you fal dovrnhearted and 0 
low? 
0 0 0 0 0 
g. Did you feel worn out? 
0 
---- 
0 
--- 
0 0 0 0 
------------ 
h. Have you been a happy 
0 0 0 0 0 0 
person? 
i. Did you feel tired? 
0 0 0 0 0 0 
Has your 
sc, cip. 1 pctivý; es (like vishing 
friends or close relatives)? 
For cýi: e vs 
171 
171 
F-I 
r-I 
7 
F-I 
7 
4 
, 
HEALTH IN GENERAL 
10. Please choose the answer that best describes howl= oriala each of the 
following statements is for you. 
Please tick one circle on each line 
For ol", ice use 
Definitely 
true 
Mostly 
true 
Not 
sure 
Mostly 
false 
- 
Definitely 
false 
------------ 
a. I seem to get ill more easily 
----- 
0 
--- 
0 
---- 
0 
- -- 
0 
---- 
0 El than other people 
- ----- --- ---- ---- ---- b. I am as healthy as anybody I 0 0 0 0 0 El know 
--------- - - - - C. I expect my heafth to g-et worse 0 0 0 0 0 11 
d. My heafth is excellent 
- ----------- 
0 
----- 
0 
---- 
0 
----- 
0 
---- 
0 
---- 
El 
Comments . 
Thank you very much for your assislanco 
Please refurn the completed booklet in the envelope provided. 
NO STMAP IS REQUIRED. 
f----'l lAadical Cafe Resawch Unit Depar%rnant of Pubric Health Medicine. ý-5 
Un? versily of ShOfield 1, Wical School. SGýoch Hill Road. Shelrield. SID 2RX 
5 
. -tifFLIFICATION QUESTIOXNWRE 
I/ SUDDEN NOISES REALL Y DISTUR3, VE. 0 1*2 3 4. 
21 I'M VýRY UNCOMFOR274BLE TTWENPH IN 
.A 
FLA CE THA T IS TO 0 HO T OR COLD. 0 12 3 4. 
I C. -LY'T STLVD FALY AS WELL AS MOST 
FEOýLt CAX 01234. 
41 1 FIND PA f0 FTýff AI VARE 0F VA PJO US 
THINGS HAPPENING rY, IfY EODY 01234. 
S/ I'M QUICK TO SENSE THE HUNGER 
CONTRAICTIONS !, Y if YS TO. 1 1.44CH. 0 12 3 
O=A'OTA7'AL, C. 1=. 4LI77LE. 2= MODEF14TEik. 
3Q UITH A EI7' . ,= EX TREA fEL Y. 
FAT I 
T woijld no-4 liL-e you to jvdf: e how tired vou have been. Please indicate wit'i 
a pen for last week 
1. PERSISTE147T 1EIRAI, FATIGUE. 
.K 
in mental energy have v How cen'tally tireJ or lackint persistently felt 
in the last wee%? 
1" 
-'xtre=ely NO r-z. a 1 Extre=ely 
Tired 
2. PFIRSISTEN-7 PhYSICAL F^TID-J'=, 
JTow -ahvs, -ýallv 
tired or lacking in -ph. -ysical energy 
have YOU Persistently 
felt in the last week? 
II-I 
lp pt. 
Extre=ely Extremely 
Tired Energetic 
3. E)S-RTIONA'-'j P. -HYSICAL FATI=. 3- 
-Dhysically tirel cr lacking in -, )ý: -, -sical enerEy you felt in-the 
laS4- we-e-: <- -aftE-er mhysical, exertion? 
Extre=ely !. 'o =. a 1 I-Extreme Iy 
Tired Ene rGe tic 
=RTIOITA, '-rj PM-NTAI, FATICUE 
ha Fow mentallv tired or lacking in mcntal. energ- ve yo-ý felt im the las.,, 
wee. < after =entaleyertfibn? 
-al tre=ely 
Tirel --thergetic. 
TEXT BOUND INTO 
THE SPINE 
FT2Ifl2] 
MOCLOSEMIDE VERSUS CLOMIPRAMINE. 114 FATIGUE 
AND DEPRESSIVE SYMPTOM. S 
Patient Number LLLJ 
Please use only BLACK BALL POINT PE14 DO NOT WRITE IN CLOSED BOXES 
WEEK 2 CLINICAL ASSESSllENT (continued) 
- FATIGUE 
QUEST1014NAIRE 
ISN Ivi- 40033 
lVe %ýould Nke to know whether or not you have been having any problems with feeling tired, weak or 
12cking h-. energy in the last fe%v weeks. Please answer ALL the questions simply by underlining or 
ticking the answer which jou think mosi nearly applies to you. We would like you to answer the 
questions whether or not you havi these symptoms. We would like to know ho%y you feel either at the 
moment or recently, rather thih a long time ago. If you have been feeling tired for a long time, Yee want 
you to comp-are yourself lo hqsvyou fell when last ivell. ' 
Do you have problems Less * with tiredness? Sual than u 
Do you need Less 
to rest more? than usual 
Do you feel Less 
sleepy or drowsy? than usual 
Do you have problerns Not 
starting things? at all 
You start things without Do tier Be" 
difluculty, but get %, g, eak as than usual 
you go on? 
Do you have enough Vore 
energy? than usual 
Po you ýave enough strength 1,1, ore 
Inyourmuscles? than usual 
No more IvIore 
than usual than usual 
No more Miore 
than usual than usual 
No more More 
than usual than usual 
No more More 
than usual than usual 
Same as 1,1, ore 
usual than usual 
Much more 
than usual 
Much more - 
than usual 
Much more El than usual 
Much more 
than usual 
Much more D than usual 
IvIluch P-, %-., ar EJ than . upal. 
hiuch 
than usual 
Much rnore 
than usual 
1,1, uch more El I than usual 
MIuch rnore E than usual l 
IAUýh M. ore E than usual l 
Miuch m6re 
. than usual 
Much worse 
than usual 
I. Iuch more Fý than usup-1- I I 
NO more Less 
than usual- than usual 
140 more Less 
th an *u su a t1han usual I 
Do you feel weak? Less Same 1, /, Ore ' thari usUal as usual thaý U sual 
Do you have diff icultY Less Same I-Aore . 
concentrating? than usual as usual than usual 
Do you have probrer-, ls Less Nor more More 
thinking clearly? than usual than usual than usual 
00 you make slips of the Not 140 more. IvIore 
tongue when, speaking? at al than usual than usual 
Do you find 11 more difficult Less Nlo more More 
10 find the correct wor4? than usual than usual týan usual 
How is your mernOrY? 6e it er No worse Worse 
than usual than usual than usual 
Have you lost interest in Pot Sarne More 
the. things You used to do? al all as USUS. 1 than usual 
HAD Scale 
Name Date: 
Doctors are aware that emotions play an important part in most illnesses. If your doctor knows about these feelings he will be able to help you more. 
This questionnaire is designed to help your doctor to know how you feel. Read each item and place a firm tick in the box opposite the 
reply which comes closest to how you have been feeling in the past week. Don't take too long over your replies: your immediate reaction to each item will probably be more accurate than a long thought-out 
response. 
7-ick only one box in each section 
I feel tense or'wound up': I feel as If I am slowed down: 
Most of the time ............................... Nearly all 
the time ................................. 
A lot of the time ................................ Very often ............................................. Time to time, Occasionally .............. 
Sometimes ........................................... 
Not at all .......................................... 
HI 
Not at all ............................................... 
IF, 
I still enjoy the things I used to enjoy: 
Definitely as much ........................... 
Not quite so much ............................ Only a little ....................................... 
Hardly at all ..................................... 
I get a sort of frightened feeling like 
'butterflies'ln the stomach: 
Not at all ............................................... 
Occasionally ......................................... 
Quite often ............................................ 
Very often ............................................. 
I get a sort of frightened feeling as if 
Something awful Is about to happen- I have lost Interest In my appearance: 
Very definitely and quite badly ......... 
Definitely .............................................. 
Yes, but not too badly ...................... 
I don't take so much care as I should ..... 
A little, but it doesn't worry me ......... 
I may not take quite as much care ........ 
Not at all .......................................... 
P1 
I take just as much care as ever ........... 
I can laugh and see the funny side of I feel restless as If I have to be on the 
things: move: 
As much as I always could .............. 
Very much indeed ................................ 
Not quite so much now .................... 
Quite a lot ............................................. 
Definitely not so much now .............. 
Not very much ...................................... 
Not at all .......................................... 
IN 
Not at all ............................................... 
Worrying thoughts go through my I look forward with enjoyment to things: 
mind: As much as ever I did ........................... 
A great deal of the time .................... Rather less than I used to ..................... 
A lot of the time ................................ Definitely less than I used to ................. 
From time to time but not too often .. Hardly at all .......................................... Only occasionally ............................ 
iii 
If eel cheerful: 
Not at all .......................................... 
Not often .......................................... 
Sometimes 
...................................... 
Most of the time ......................... ..... 
can sit at ease and feel relaxed: 
Definitely ...................................... 
Usually 
............................................ 
Not often ......................................... 
Not at all ......................................... 
I get sudden feelings of panic: 
Very often indeed ................................. 
Quite often ............................................ 
Not very often ..................................... . 
Not at all ............................................... 
I can enjoy a good book or radio or TV 
programme: 
Often .................................................... 
SOMeE ........................................... 
Not often ............................................... 
Very seldom ......................................... 
Do not wrrte lviow tnis line 
BEST COPY 
a 
AVAILABL 
Variable print quality 
%%'c! stcin. L.: Dcric-It. W. C.; Rcdington. D.: and Guillcminault. C Insomnia in the San 
Francisco Szy Area: A telephone survey. SkeplWcke Dzordcrs. ' Pefurd HZr: ory. 
cn. d Lor;. 7'erm CvoIw; orL New Yo. -L: Riven ? rc: s, 19S3. pp. 73-95. 
Appendfx. Pittsburgh Steep Quality Index (PSGO 
Narne to s-Oz: e- Age. 
It-s! rjcuor. = 
for n pasý rxx t -I. Y Ou ars ic--Llq rzves: lors re!;.: e to your usual s-le-p hab's du-Ing e o, Yrw* 
Should indl-cale Lie incsl ac. -u.; 
P-'ezsse "-wet all quesia-m 
!e lep! y f--, Lýe r. a., od. -y of days Lr. d n; ghts in Vie pZZI r4fl-% 
1. Duing týe Pa-V -witi. %%Iýen h2ve you vs; jae-f gone to ! >ý at nig-7 
VSUAL 950 -time 
2. Dunng the past how 1,. -IS Cut his Zys,. zlly take you to fag Lstep each niýh:? 
briv. MR Oi'-'ýNVTES 
nC PZSt riOn. 4% when h2ve you usue. y 93. ', en up in VIC MO. -M. "s? 
USUA. I. GETTNG UP TIMS 
4.0;.. Ln; the par, riar.., %, how. -. z., Iy hou. -s of d5d you get at m3hr? (7h: S In2y be d; ferc-I)t 
tM-3 ne nU. Mt--f Of hours you s; >-- 4 in !;, --) 
HOU=S OF SL-cSP. PF-R 1,111ý 
Foc each of I. he re: nalnLng quee. zý%ý C., %ý_-k L%e O., je btý., cspyjse. Please visn'-wer Aff quev: ýW-,. 
S. D-jxig ' he h. -w e&n have you tad trouble L-2-ca; *e yo-j- 
(F) Cz-'L%-4 get 10 S'el-; ) %yi: 11i 31 rninuies 
Not du. -ing -. 'Ie L- VI; u-n 
Once OC -three or rnore 
p= on=aweek_ Wceawee-K- li-Inas a we- k 
%Yzke VP in Výe r. -a: j: Ze o! the nigh( or e a., ýy r. -to-N. -. 2 
Not dl., 4ns týe Le= . ýart Once or 
Thn-e or m.., a 
;=-C. -W. = aw C-e k IWC ea we,; k frn es a w---K' 
(: I Xzve 10 get up to use -ie '-,. h=. -n 
?. ': x d; j4., Ig he L- ý. zn once oe Three of 
p= - 0, ý-- a we-z k Wce a we-. k 
Cnes a week 
(c) C LL-, CK b. - e : ', ) ec It 
Not dumig Cle L-= tLan Once or Th. -e-. oc r4ee 
F2-,, rnorl". 11 - 0-ý=Zwe-ek- tW. ceaweek- 
(e) covsh OC sr-O, e Io; jcIY 
No! du. -L-Ig te Lecs G. -C e Ce Tlree of M. re 
W. = aW C--- k t.; --e a wee k 6rný a we-- k Fee% Uro cold 
Not during Oe L= t. zm Once of -M. ee cc r-. w a 
pz:;! r,:, %. Ii - cý= a we-; k t. ice a we-e k fr. nes a wet. k (C) Fee! too hot 
NO, dvrLng C-. e L &ýs :: ý-, 1 On :a or -6 hi c-. or MW e 
paz-, n70.1 -. 'I - olm a wet k W: e a We.: k ennas a Week (h) Ha I tad d. ezr-, s 
NO, dv. ing the Less, ý; -I Once cc Thret or more 
pz: Z - v. = a vieek to4: e a we-ck enes a wc---k nj F2ve F&I 
du, in 5 tý a Le= t= Cne-e OC T 7wei ix r-* a 
MU. ". h - C. -I= a we-. k t,, 4c ea we- 6, nes a Week- 
ul 0,. Ner teasor4sl. please desclsibe 
How Oen durinS the past monuh have you had DoWe SIC--; ); ng because of ViIs? 
Not during Lhe Lezs týan Once or Three or more 
past mon: h - i6inceaweek- tw; ceaweek- 
C. nesawe--k- 
6. Outing Lýe past vion0i. how would you rate your sle-p quar: -. y 6veral.? 
Very goA 
Fairly qo. -ýj 
FaLrfy tad 
Vie ry bad 
7. During Cle past*r--%*: -.: % how oten have you taken irnedicine (prescirim-4 of 'over Vie covn: er-I to I 
- you sleep? 
Not during the Lessthan Once or Three or more 
past irno., 101 - on: eaweek- twiceaweek- 
Urnesaweek 
S. Outing 11he past mon: h. hcw emn have you had llovb! e S12ying awake while driving. ea!,: -. g real. c 
ensa; jng in social av; vq? 
Pot during C)e Le., s Lhan Once or Thr " or mor e 
past mn. 4 -- on-zeaweek- t-victaweek- 
Umesaweek 
9. During Vie past mon.. 1thow mvch of a proWom 11, as 4 been for you to kcep up enou;. h en. husiasirr 
Get tNInSs dome? 
No prciý! em at as 
Only a ve. -y sr-ghd prob! enn 
Somewhat aa proWen 
A vvy W; ;, coem 
10. C60 yov have a beýd ; Lnmr or rownim. ate? 
1: 0 bed or tOD--. a,, e 
Paf'., )eriroc--%:,,; fe in mher tozinn 
Par-mr in sarne r=n. býr not same t+J 
Pamnef in sa. -ne " 
L'you have a rovnrxe orWl; anner. ack him. /heir hcwoten in Lhe pastrnon. h you have had- 
(a] Lo-id'sncNing 
Not during Lie Less Lhan Once of Thre-- cc mve 
pasl mon. 4 - vice a week - t. ýize a week - 
Cm-es a week 
Long ppuses ! ý-.! weten btevhs while asleep 
Not during tý. e Le: s than Once or Three cc more 
Fzzl rno-, 10 - once a week - toe; ce a week - 
C. -nes a we-ek 
(c) L--, s tov?, c. hL-, w je. t. x,; whi`, e you sle-ep 
Not during Zýe Le=s than Oft: e or Three or m. re 
P ast r. - vict a week - *, %; ce a week - 
Cnn esaw et k 
Epý-Sodes of d7svlen-. Zýý or confusion dl-ing SIC-2 
14,01 dvnim; tie te: 3 týlzn Once or 7hre-- or rno. a 
par, mon. ) - 0-1: eawe-ek- t-iiceaweeý- 
Urnes a we-- k 
(el C-ýer res'lec-s--tý. s wh7e you s-Ic-ep-. p! ease dt-s-cn: t-a 
Not dvirýrwg 1ý-e Lem tý; -n Once or 
-ilaree or mor e 
; Z= r. 1 or. -, I - onceaweek- twýceawetk- ý. -nesaweek- 
Q O'. her teasor4si. p, 'east desvibe 
How 0, en during Lhe pw r. non: h have you tad trow! "ie sl"p; nq bencause of M: s? 
No(during oe Less Lýan once or Three or more 
past rnomh - 
inceaweek- tw; -. ea%%eek- Umesawe--k_ 
6. Outing the pasirrionth. how would you rate yo-if sleep quarcy 6veraf:? 
Very qoA 
Faýý 9:.:. j 
FaLrly . ad 
Ve ry bad 
7. Owing Lhe pas1`nw, -:. % -how o! en have you taken rnedicine (prescra. --d of 'over the coun: arl to I 
you sleep? 
Not duting the Lessthan Once or Thr" or more 
; ISl rno. -IO - on,. eaweek- t-iceaweek- tirriesaweek- 
8. Oviong the past mon. 1% how aen have you had ItoWe slaying awake while driving. eating meal. e 
enga ; Ing in so: Ial acgvq? 
. 
Rot during L-ie Less Lhan Once or Thre-e or mote 
past mon'. 1i -- on. -eaweek- twiceaweek- 
Urnesaweek 
9. During Lhe past rriW% low much of a ptobliarn ýas k t>een for you to kc-eep up enough en. husi*astr 
set t-L-ISS done? 
No proý! ern at ad 
Only a ve., y sr-gla prob! enn 
Somewhat of a pfoblern 
A vefy b;; 
10. -Do you have a b^d p"itr of roz. -nmate? 
No bed ; a: -.: %er or i oomstr. a -, e 
PaMnerho:. -unve in c,. I. er roD. n 
Partner in saine town, b;.,. not Same te-d 
Partner ir Same t-d 
If you 11 2ve a tcv, -%r.!: e or Wl panner. a -k himil er how ciýen in the past rrion'. 1i yo-i have ha d- 
(a) Loud snoring 
Not duriN C-, e te: S oric a of Thr&e or rio. a 
past mon. 4 - ence a week - 
W. -e a week - C. -nes a week 
tbI Lv. g p2L: ses te-weei breaulIS veisle asleep 
Not during tý. e Lem Iýzn On. - a of Phree or more 
past rno.. 10 - on: e a wee k- toe;, ze a week - 
C-mes a we-ek 
(c) L-as or je. 0rin.; while yo-i sleep 
, ot durLn L"ie U= Lýan N 01'. a or ThtL-e or m. re 
past rrrnLI - vicz a wee rWce a week - 
C. -ne sa we--- k 
Epýscddes of of conýjsion dcmn; Ste--: ) 
Not duimn; t. e Lem týan Chce or Mte-a or r. o. e 
par, rnon,,. ý - on-eawe-k- tAiceaweeý- 
6. -nes a wee k 
(e) cw. ýer tes-Ileý-sne: S w%! 'e you S! C-ep. plea: e de=; t-a 
Not du. -L-19 Lýe Lem týan Once or or rnor a 
F= - onceaweek- tWceawe-ck- 
U. -nes a week - 
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APPýýF 
Explanation of coding for psychological raw data 
I= baseline assessment 
2= retest 1 
3= retest 2 (F group) of 3 month follow up E group 
4=3 month follow up F group 
999 missing data 
hada HAD anxiety 
hadd HAD depression 
pmf persistent mental fatigue 
ppf persistent physical fatigue 
epf exertional. physical fatigue 
emf exertional mental fatigue 
wessely Wessely total fatigue score 
wesp Wessely physical fatigue 
wesm Wessely mental fatigue 
psqia Pittsburgh sleep total score 
psqib Pittsburgh sleep duration 
psqi6 Pittsburgh sleep latency 
hsq Health Status questionnaire 
hsqpf physical function 
hsqrp role physical 
hsqbp bodily pain 
hsqgh general health 
hsqvi vitality 
hsqsf social function 
hsqre role emotional 
hsqmh mental health 
barskey Barskey somatic amplification total score 
Newdata 
code group basegrps sex retest illdur med cause age height 
1 1 1 5 2 1 5.0 0 0 38 174.0 
2 4 1 5 1 5 4.0 1 11 28 178.0 
3 10 1 5 1 1 3.5 1 11 23 171.5 
4 12 1 5 2 1 2.0 0 1 34 169.5 
5 13 1 5 1 1 4.0 0 1 22 179.0 
6 15 1 5 2 1 4.5 2 1 47 169.0 
7 19 1 5 2 1 3.8 0 0 57 169.5 
8 14 1 5 2 1 .8 0 
1 35 170.0 
9 20 1 5 2 1 5.5 3 11 44 157.5 
10 21 1 5 1 1 3.5 1 1 50 179.0 
11 24 1 5 2 1 5.0 0 11 42 155.0 
12 25 1 5 2 5 3.8 0 2 36 173.5 
13 26 1 5 1 1 7.0 0 3 22 183.5 
14 28 1 5 2 1 2.0 0 11 23 165.0 
15 
16 
34 
36 
1 
1 
5 
5 
1 
2 
1 
1 
4.0 
2.0 
0 
0 
1 
2 
52 
33 
170.0 
169.0 
17 42 1 5 2 1 1.0 0 1 
39 167.0 
18 43 1 5 1 1 2.5 1 4 39 
175.5 
19 45 1 5 2 1 7.0 2 1 31 169.0 
20 46 1 5 2 1 2.5 3 1 52 162.0 
21 53 1 5 1 1 4.5 2 1 39 180.0 
22 57 1 5 1 1 1.5 1 0 49 183.5 
23 58 1 5 2 1 5.0 0 3 38 168.0 
24 60 1 5 2 1 1.5 0 11 32 171.0 
25 62 1 5 2 1 4.0 1 2 39 154.0 
26 63 1 5 2 6 .8 2 
1 29 161.0 
27 64 1 5 2 1 11.0 0 0 45 
165.0 
28 65 1 5 2 1 17.0 2 0 44 170.0 
29 66 1 5 2 1 3.0 0 11 28 166.0 
30 50 1 5 2 6 2.0 0 0 38 162.0 
31 23 1 5 1 6 1.5 1 1 48 171.5 
32 35 1 5 2 6 4.0 0 0 31 158.5 
33 16 1 5 2 1 4.5 11 2 43 176.0 
_ý4 
2 2 5 2 4 5.0 
1-1 
Newdata 
weight bmi vo2maxm vo2maxl hrmax vemax hrrec perhr testd rpe 
1 lac14 
1 67.2 22.2 34.5 2.32 166 100.0 106 90 12.0 75 3.6 
2 84.4 26.6 43.4 3.66 176 111.9 114 93 14.0 89 _ 9.9 
3 62.8 21.2 36.7 2.88 179 104.1 126 92 12.0 89 3.0 
4 61.1 21.4 31.7 1.94 153 75.4 86 81 12.0 71 1 1.41 
5 83.8 26.2 37.9 3.17 190 94.7 120 99 14.0 92 4.6 
6 61.4 21.5 38.4 2.36 170 94.5 120 94 12.0 76 3.9 
7 61.5 21.5 32.0 1.97 183 80.2 90 106 10.0 77 1.6 
8 65.7 22.7 35.8 1.69 189 71.8 115 101 10.0 67 3.0 
9 54.9 22.0 36.5 2.00 151 64.6 113 83 8.0 64 1.3 
10 82.7 25.8 33.3 2.76 162 136.8 120 91 6.5 58 5.3 
11 61.5 25.6 27.8 1.71 163 59.6 94 89 8.0 60 1.4 
12 59.5 18.9 29.9 1.78 166 61.5 88 89 12.0 69 1.6 
13 69.0 20.4 44.9 3.10 206 121.0 129 105 18.0 118 4.2 
14 58.7 21.5 37.7 2.22 207 89.7 147 106 13.5 109 2.0 
15 85.0 29.0 31.1 2.47 149 65.8 88 85 11.0 66 2.8 
16 58.6 20.5 29.4 1.72 185 66.6 108 98 10.0 72 2.7 
17 82.6 29.3 20.8 1.72 128 71.3 70 69 4.5 1 53 2.0 
18 71.2 23.0 40.0 2.85 182 125.8 119 98 14.5 84 4.0 
19 78.0 27.3 18.8 1.47 171 73.6 139 90 8.5 58 4.1 
20 50.0 19.0 24.8 1.24 136 52.4 91 77 5.5 45 1.9 
21 102.0 31.1 30.7 3.12 167 120.0 112 89 11.0 87 4.3 
22 86.9 25.7 44.5 3.87 170 130.9 100 96 20.0 106 4.3 
23 61.9 21.9 27.3 1.66 162 66.2 119 85 10.0 67 3.5 
24 68.6 25.5 25.6 1.73 165 59.7 106 87 10.0 74 1.6 
25 56.3 23.7 22.0 1.24 156 45.6 94 84 7.5 62 3.7 
26 48.1 18.6 27.7 1.33 164 56.9 103 86 10.5 68 2.1 
27 57.0 20.9 38.4 2.16 183 63.8 110 101 16.0 118 1.0 
28 54.8 19.0 18.3 1.00 154 41.3 74 85 7.0 65 2.5 
29 55.4 20.1 28.4 1.57 185 65.3 116 94 12.0 80 2.8 
30 52.1 19.9 35.1 1.82 178 71.0 113 95 11.5 78 2.4 
31 95.4 32.2 18.8 1.79 159 60.1 118 89 2.5 14 1.7 
32 50.6 20.0 31.9 1.61 184 61.6 131 97 8.0 55 .5 
33 136.4 43.7 99.9 9.99 177 999.9 108 97 6.0 55 4.8 
34 48.0 1 18.8 30.6 1.47 161 63.2 95 89 12.0 84 4.1 
1-2 
Newdata 
lacl4b postlac isostr fevl fvcl ratiol skf hadal haddl pmfl ppfl 
1 9.9 7.8 263 9.9 9.9 99 999.9 5 5 76 74 
2 9.9 99.9 696 9.9 9.9 99 999.9 3 6 999 999 
3 9.9 8.3 468 9.9 9.9 99 -25.5 13 3 999 999 
4 9.9 1.8 253 2.7 4.4 61 999.9 8 11 77 87 
5 9.9 6.7 663 4.0 5.4 73 99.9 3 4 88 93 
6 9.9 6.7 383 3.0 4.1 73 99.9 3 2 80 65 
7 9.9 6.5 273 9.9 9.9 99 47.2 5 2 31 55 
8 9.9 7.2 308 3.2 4.1 77 68.5 1 2 57 65 
9 9.9 4.8 273 2.8 3.6 78 48.3 6 12 79 100 
10 9.9 6.9 427 3.6 4.8 73 999.9 8 5 57 57 
11 9.9 4.8 149 2.2 3.7 60 67.6 12 10 85 74 
12 9.9 3.3 235 2.9 4.1 70 37.1 4 9 66 71 
13 9.9 6.3 433 9.9 9.9 99 42.8 7 2 48 40 
14 9.9 5.2 331 9.9 9.9 99 29.9 6 9 82 92 
15 9.9 5.0 489 2.2 3.6 62 999.9 3 5 67 81 
16 9.9 3.7 352 2.3 31] 75 44.6 3 9 100 100 
17 9.9 4.3 239 2.2 3.4 64 92.0 4 10 88 90 
18 9.9 8.9 447 4.1 4.7 88 49.7 8 11 79 94 
19 9.9 7.4 304 9.9 9.9 99 100.8 2 3 85 85 
20 9.9 2.9 165 2.1 2.6 81 30.3 7 5 76 82 
21 9.9 3.3 575 4.6 5.5 83 83.1 9 2 66 64 
22 9.9 8.3 588 4.3 5.2 82 45.4 
T 
12 19 72 72 
23 9.9 5.2 128 1.9 2.9 64 54.5 4 2 66 76 
24 9.9 2.9 246 3.5 4.2 81 53.1 8 1 68 63 
25 9.9 4.0 290 2.3 2.6 88 63.6 12 7 100 100 
26 9.9 3.7 401 2.9 3.2 91 34.8 99 99 999 999 
27 9.9 2.6 247 3.6 4.2 87 36.4 5 5 76 63 
28 9.9 5.8 164 2.9 3.5 83 52.2 1 5 72 82 
29 9.9 6.1 248 3.5 3.9 89 55.5 6 2 62 85 
30 9.9 4.9 290 2.7 3.3 82 47.6 12 2 50 75 
31 9.9 1.7 170 3.4 4.3 79 999.9 4 9 72 79 
32 9.9 4.2 354 2.7 3.2 83 35.5 0 3 68 87 
33 9.9 7.4 348 2.4 3.3 74 999.9 1 5 70 97 
34 9.9 7.2 268 9.9 9.9 99 999.9 14 61 999 999 
1-3 
Newdata 
epfl emfl wesselyl wespl wesml psqlal psqibi psqi6l hsqpfl hsqrpl 
1 73 69 31 20 11 8 0 o 999 999 
2 999 999 20 12 8 4 0 0 999 999 
3 999 999 10 7 3 7 1 0 999 999 
4 88 77 33 14 19 9 1 1 999 qqqý 
5 100 100 30 18 12 12 1 1 999 999 
6 87 91 32 22 10 5 0 0 999 999 
7 65 65 32 19 13 10 0 0 95 0 
8 62 54 is 12 6 99 9 0 999 999 
9 100 82 34 21 13 7 1 1 999 999 
10 62 63 25 14 11 9 1 1 999 999 
11 74 93 33 20 13 8 0 0 40 0 
12 53 79 37 20 17 3 1 1 55 0 
13 61 52 11 5 6 8 0 1 75 75 
14 97 91 37 20 17 6 1 1 30 0 
15 59 54 21 15 6 8 0 0 85 25 
16 100 100 36 23 13 5 1 0 35 0 
17 94 94 35 21 14 8 1 0 15 0 
18 69 57 33 21 12 5 0 0 45 0 
19 84 84 38 21 17 7 1 0 45 0 
20 89 87 30 18 12 3 0 0 40 0 
21 70 73 28 14 14 8 0 0 50 0 
22 84 83 35 24 11 7 0 1 70 0 
23 92 90 25 16 9 4 0 0 40 25 
24 86 '68 24 17 7 5 0 0 70 50 
25 100 100 34 22 10 99 9 9 999 999 
26 999 999 99 99 9 9 999 999 
27 74 76 28 17 11 99 0 9 999 999 
28- 86 86 25 17 11 5 0 o 35 50 
29 96 83 28 19 9 5 1 0 45 0 
30 93 94 22 15 6 4 0 1 55 0 
31 95 85 32 19 13 6 0 0 40 0 
32 94 72 29 19 10 1 1 01,5 0 
33 97 66 31 20 11 9 1 0 999 999 
34 999 999 28 16 12 7 11 
1-4 
Newdata 
hsqbpl hsqghl hsqvil hsqscl hsqre hsqmel baskeyl skidal skidbl age2 
1 999 999 999 999 999 999 20 o0 38 
2 999 999 999 999 999 999 7 00 28 
3 999 999 999 999 999 999 8 00 23 
4 999 999 999 999 999 999 6 00 34 
5 999 999 999 999 999 999 4 0 0 22 
6 999 999 999 999 999 999 6 o 0 47 
7 90 57 60 12 38 33 12 o 0 57 
8 999 999 999 999 999 999 99 0 0 35 
9 999 999 999 999 999 999 12 0 0 44 
10 999 999 999 999 999 999 10 0 0 50 
11 42 47 40 67 0 40 13 9 0 42 
12 41 25 35 40 loo 68 13 9 0 36 
13 84 50 0 75 100 70 3 0 0 22 
14 90 45 5 0 33 72 2 9 0 23 
15 74 37 35 88 0 56 6 99 99 52 
16 41 35 50 50 0 64 5 0 0 34 
17 12 45 30 0 33 72 10 9 0 40 
18 52 20 15 25 0 36 13 9 0 39 
19 31 50 20 38 100 92 9 0 0 31 
20 52 50 40 38 100 76 7 0 0 52 
21 41 45 40 50 66 76 0 0 39 
22 25 25 25 13 0 44 9 0 0 49 
23 31 62 20 38 100 72 9 6 0 38 
24 32 45 45 63 33 64 10 0 0 32 
25 999 99 999 999 999 999 13 9 0 39 
26 999 999 999 999 999 999 99 0 0 99 
27 999 999 999 999 999 999 6 0 0 45 
28 50 20 10 88 loo 60 4 0 0 44 
29 31 15 45 75 100 76 11 0 0 28 
30 51 52 55 63 33 64 12 0 0 99 
31 31 40 45 13 100 72 11 0 0 99 
32 21 15 40 13 100 88 9 0 0 99 
33 999 999 999 999 999 999 8 0 0 43 
34 999 999 999 999 999 999 13 0 0 46 
1-5 
Newdata 
height2 weight2 vo2maxm2 vo2maxI2 vemax2 hrmax2 perhrm2 hrrec2 testd2 
1 174.0 64.2 36.5 2.38 95.0 170 92 116 14.0 
2 178.0 80.4 45.0 3.62 156.4 186 97 135 16.0 
3 171.5 63.1 47.2 2.98 118.4 187 96 131 14.0 
4 169.5 61.5 36.2 2.20 69.4 154 82 86 10.0 
5 179.0 83.7 41.3 3.46 107.7 192 98 i 119 14.0 
6 169.0 60.8 38.1 2.31 104.9 173 96 118 15.5 
7 169.5 62.0 39.2 2.43 97.9 186 107 104 10.0 
8 170.0 65.2 32.8 2.11 81.5 187 loo 115 10.5 
9 157.5 54.9 36.6 2.01 94.1 176 97 115 12.5 
10 179.0 84.6 35.3 2.99 137.6 165 93 118 12.5 i 
11 155.0 59.6 34.1 2.03 68.1 154 84 94 10.0 
12 173.5 57.3 38.2 2.20 67.8 166 89 86 12.0 
13 183.5 65.7 49.7 3.26 113.2 194 101 123 20.0 
14 165.0 57.5 43.7 2.51 100.2 199 102 133 15.0 
15 170.0 84.8 30.5 2.59 63.6 139 79 68 12.0 
16 169.0 58.7 31.8 1.86 73.6 186 101 118 
17 167.0 88.9 21.2 1.89 85.6 142 77 63 6.0 
is 175.5 72.9 44.8 3.14 146.8 180 97 105 16.0 
19 169.0 80.5 27.0 2.17 91.5 172 90 141 10.0 
20 162.5 50.0 30.5 1.52 56.3 144 82 95 7.5 
21 180.0 103.0 39.6 4.08 125.2 167 90 132 
22 183.5 92.3 40.1 3.62 122.3 171 96 102 18.5 
23 167.5 61.9 27.6 1.71 75.5 160 86 98 10.5 
24 171.0 68.4 23.4 1.60 75.6 174 92 109 12.0 
25 154.0 57.7 23.1 1.34 50.3 165 89 114 10.0 
26 999.9 999.9 99.9 9.99 999.9 999 999 99.9 
27 165.0 58.5 33.7 1.97 66.8 160 88 90 17.0 
28 170.5 55.7 22.6 1.26 58.3 167 92 89 9.5 
29 166.0 55.5 30.0 1.66 75.5 179 93 105 12.0 
30 999.9 999.9 99.9 9.99 999.9 999 999 99.9 
31 999.9 999.9 99.9 9.99 999.9 999 999 99.9 
32 999.9 999.9 99.9 9.99 999.9 999 999 99.9 
1 
33 176.0 135.7 99.9 9.99 999.9 174 96 113 6.0 
34 160.5 47.8 30.2 1.38 57.5 161 95 84 14.01 
1-6 
Newdata 
rpe2 lac142 lacl4b2 postlac2 isostr2 fev12 fvc2 ratio2 skf2 hada2 
1 69 3.6 3.4 4.6 252 9.9 9.9 =99 999.9 5 
2 67 4.6 9.8 10.8 560 9.9 9.9 99 999.9 7 
3 72 2.7 3.3 8.9 675 4.8 5.4 89 26.4 5 
4 67 1.3 9.9 2.0 321 3.7 4.4 83 999.9 7 
5 90 3.6 9.9 7.7 1019 3.9 5.2 74 73.4 6 
6 76 3.0 9.9 9.1 412 3.0 3.8 77 999.9 3 
7 61 1.4 2.8 6.2 346 2.0 3.4 59 49.0 7 
8 68 3.9 3.7 9.1 387 3.2 4.1 77 65.9 0 
9 48 1.0 2.2 5.8 468 2.8 3.7 76 999.9 5 
10 45 2.0 4.0 7.3 562 9.9 9.9 99 41.2 9 
11 55 2.0 2.2 5.4 364 2.4 3.6 67 71.6 99 
12 62 1.4 9.9 2.9 235 3.0 4.2 71 34.1 99 
13 91 2.0 3.4 5.4 526 4.2 5.4 76 30.2 10 
14 86 1.8 2.2 4.9 362 2.7 2.7 97 31.2 99 
15 69 1.2 1.2 2.6 694 2.4 3.7 64 999.9 2 
16 68 1.9 1.9 4.5 479 2.3 3.2 74 999.9 4 
17 47 1.7 9.9 6.5 199 3.1 3.9 78 100.0 2 
18 79 3.2 9.9 10.8 607 4.3 5.1 85 48.6 6 
19 52 2.5 3.5 8.1 389 3.0 3.3 91 999.9 2 
20 41 1.1 1.7 2.6 233 2.4 3.1 77 27.1 3 
21 77 1.5 1.5 7.1 525 4.6 5.5 83 97.0 8 
22 116 4.2 9.9 7.7 555 4.1 5.0 82 45.5 8 
23 57 2.8 9.9 6.8 431 2.1 3.3 63 53.2 8 
24 68 1.9 4.9 4.8 298 3.5 4.2 1 81 67.2 1 7 
25 46 2.9 2.9 5.6 284 2.3 2.5 88 70.5 8 
26 999 9.9 9.9 99.9 9999 9.9 9.9 99 999.9 99 
27 98 1.1 2.0 2.7 290 3.3 4.0 84 38.0 5 
28 51 2.8 4.0 9.8 197 3.1 3.7 85 53.6 1 
29 67 2.5 9.9 4.9 259 3.4 4.0 88 53.8 8 
9 9.9 9.9 99.9 9999 9.9 9.9 99 999.9 3 
31 999 9.9 9.9 99.9 9999 9.9 9.9 99 999.9 99 
32 999 9.9 9.9 99.9 9999 9.9 9.9 99 999.9 99 
33 47 4.0 9.9 5.6 537 2.2 3.0 
-- 
72 999.9 4 
34 
ý 
83 9.9 4.6 3.7 
[ 
80 34.3 
1-7 
Newdata 
hadd2 
I 
pmf2 ppf2 epf2 emf2 wessely wesp2 wesm2 psqia2 psqib2 psqi6 
1 5 1 999 999 999 999 33 20 13 6 0 0 
2 3 50 50 50 50 11 3 8 7 1 1 
3 1 32 54 43 40 6 3 3 4 0 0 
4 10 75 75 91 75 28 14 14 10 1 1 
5 6 89 82 91 100 34 13 21 13 1 1 
1 56 45 45 87 20 15 5 5 0 0 
7 6 73 62 59 59 3 0 3 5 0 0 
8 1 54 70 66 52 22 15 7 1 0 0 
9 7 91 75 50 94 19 12 7 5 1 0 
10 8 54 53 53 64 28 16 12 7 1 0 
11 99 999 999 999 999 99 7 6 99 9 9 
12 99 999 999 999 999 99 99 9 9 
13 7 33 36 52 50 11 5 6 6 1 0 
14 99 999 999 999 999 99 14 4 99 9 9 
15 9 69 83 90 70 28 17 11 5 1 0 
16 11 72 72 57 64 28 17 11 2 0 0 
17 3 62 59 81 55 14 6 8 4 0 0 
18 7 63 66 61 65 27 16 11 5 0 0 
19 1 67 66 86 69 31 18 13 6 0 07 
20 4 63 77 88 83 22 13 9 4 0 0 
6 55 67 67 59 24 14 10 8 0 0 
22 9 67 66 79 63 33 23 101 5 0 0 
23 4 75 73 87 74 6 2 4 4 0 o 
24 6 57 60 81 59 20 14 6 4 0 o 
25 10 50 50 50 50 7 3 4 7 0 
26 99 999 F 999 999 999 99 - 99 9 
27 1 54 56 43 62 22 14 8 1 0 0 
28 2 52 52 58 61 31 21 10 5 0 0 
29 2 53 45 53 72 17 10 7 8 0 1 
30 2 65 61 63 67 21 16 6 5 0 0 
31 99 999 999 999 999 99 99 9 9 
32 99 999 999 999 999 99 99 9 9 
33 5 27 84 86 15 20 15 5 11 1 0 
34 5 999 1 
999 999 999 99 4 0 01 
1-8 
Newdata 
hsqpf2 hsqrf2 hsqbp2 hsqgh2 hsqvi2 hsqsf2 hsqre2 hsqmh2 baskey2 skida2 
1 999 999 999 999 999 999 999 999 99 0 
2 999 9 999 999 999 999 999 13 0 
3 100 75 62 77 50 63 100 84 10 0 
4 55 0 31 72 35 7 1 3 3 0 
5 65 0 51 40 25 13 33 20 10 0 
6 95 25 74 55 45 75 100 80 6 0 
7 80 25 72 85 70 88 67 84 10 0 
8 85 o 84 35 50 38 100 88 9 0 
9 75 75 72 67 40 63 100 64 10 0 
1 85 25 75 35 45 75 33 44 14 0 
11 999 999 999 999 999 999 999 999 99 99 
12 999 999 999 999 999 999 999 999 99 99 
13 100 100 loo 75 75 100 100 64 9 0 
14 70 50 54 40 30 63 100 84 99 0 
15 90 25 84 40 25 100 67 60 8 14 
16 75 25 90 45 20 63 67 64 9 99 
17 50 0 41 60 45 100 100 84 17 99 
18 60 25 90 40 40 75 100 76 9 99 
19 70 25 41 40 40 38 100 88 2 0 
20 30 0 51 65 35 38 67 68 6 0 
21 55 0 41 45 65 50 100 44 7 0 
22 80 0 84 30 40 38 0 36 3 9 
23 50 75 62 50 40 50 100 80 7 0 
24 1 75 75 62 35 40 88 100 76 10 0 
25 50 74 47 75 100 100 88 11 9 
26 999 999 999 999 999 999 999 999 99 0 
27 80 50 50 77 50 63 100 80 5 0 
28 55 50 50 30 40 88 100 84 6 0 
29 65 25 31 35 55 63 100 68 6 01 
30 60 0 90 50 40 88 100 76 13 o 
31 999 999 999 999 999 999 999 999 99 99 
32 999 999 999 999 999 999 999 999 99 99 
33 40 25 62 72 30 75 100 88 9 9 
341 999 
i 
999 999 999 999 999 -999 999 99 0 
1-9 
Newdata 
skidb2 cgio2 cgid2 cgip2 cgi2full age3 height3 weight3 vo2maxm3 
1 0 9 9 2 4 39 174.0 67.8 36.2 
2 0 9 1 1 1 99 999.9 999.9 999 
3 0 1 1 1 1 23 171.5 63.5 53.9 
4 0 1 2 2 169.5 61.9 27.9 
5 0 9 1 1 179.0 82.1 46.9 
6 0 2 2 23 47 169.0 61.0 38.2 
7 0 1 1 1 58 169.5 64.4 31.9 
8 0 9 1 3 35 170.0 65.4 28.5 
9 0 9 1 1 2 44 157.5 53.7 37.7 
10 0 1 1 1 1 50 179.0 85.6 36.6 
11 99 9 1 1 2 42 156.0 62.0 29.8 
12 99 9 9 2 4 99 999.9 999.9 99.9 
13 0 1 1 1 1 23 184.0 65.5 47.7 
14 0 1 2 2 3 24 166.0 60.4 38.4 
15 0 2 2 2 5 52 170.0 85.5 33.0 
16 99 3 2 2 3 34 169.0 59.0 35.7 
17 99 9 1 1 2 40 167.0 92.0 21.8_ 
18 99 9 1 2 39 175.5 73.4 42.8 
19 0 3 2 2 3 31 169.0 81.0 30.0 
20 0 3 1 2 3 52 162.5 50.1 17.2 
21 0 9 1 1 1 39 180.0 101.2 40.9 
22 0 3 2 2 3 49 183.5 92.8 40.3 
23 0 2 1 
P 
1 2 38 168.0 62.6 24.5 
24 0 3 2 2 2 3 32 171.0 67.1 28.1 
25 0 2 1 1 1 40 154.0 52.2 28.3 
26 0 3 2 2 9 29 999.9 999.9 99.9 
27 0 3 2 2 3 45 165.0 57.4 34.2 
28 0 4 2 2 3 45 171.0 54.8 23.3 
29 0 3 1 1 3 29 65.0 56.0 30.0 
30 0 9 1 1 9 99 999.9 999.9 99.9 
31 99 9 9 9 9 99 999.9 999.9 99.9 
32 99 9 9 9 9 99 999.9 999.9 99.9 
33 0 1 1 1 1 43 176.0 139.2 99.9 
34 0 9 2 2 3 46 160.5 47.6 36.5 
1-10 
Newdata 
V02maxI3 vemax3 hrmax3 hrrec3 testd3 rpe3 lacl43 lacl4b3 postlac3 
1 2.45 97.0 174 117 13.5 76 2.8 5.7 5.9 
2 9.99 999.9 999 999 99.9 99 9.9 9.9 99.9 
3 3.38 146.4 197 140 16.0 62 4.5 4.8 11.2 
4 1.72 57.0 142 82 10.0 63 1.5 1.5 1.7 
5 3.85 122.2 205 130 18.0 80 1.8 3.4 9.0 
6 2.31 92.9 172 112 12.0 79 2.1 2.3 8.4 
7 2.06 89.1 185 96 13.5 52 2.8 3.0 5.5 
8 1.87 77.0 186 124 10.0 69 2.0 3.9 7.3 
9 2.02 85.2 179 115 12.5 52 2.6 3.5 7.6 
10 3.13 140.6 164 119 13.0 41 2.7 5.8 7.8 
11 1.85 60.9 156 88 10.0 52 2.5 3.5 9.9 
12 9.99 999.9 999 999 99.9 999 9.9 9.9 99.9 
13 3.12 117.4 199 127 19.0 82 2.6 6.9 7.6 
14 2.35 90.8 208 130 14.0 98 2.2 3.2 6.0 
15 2.83 73.7 162 88 12.5 64 9.9 
1 
4.2 7.4 
16 2.11 87.5 194 118 14.0 67 3.4 6.7 7.0 
17 2.01 97.5 143 70 6.0 41 2.0 2.5 8.1 
18 3.14 163.4 184 118 17.0 70 7.9 7.8 11.3 
19 2.45 85.9 170 141 10.5 47 2.4 3.0 5.4 
. 87 34.6 115 
74 4.0 30 1.2 9.9 1.2 
4.14 137.2 164 113 17.0 75 2.2 1.9 6.4 
22 3.74 125.9 171 97 18.5 120 2.4 3.8 9.5 
23 1.53 67.6 161 101 9.0 60 3.2 3.8 4.9 
24 1.88 78.8 188 127 12.0 68 2.0 9.9 5.3 
25 1.48 58.5 185 107 10.0 52 3.2 9.9 4.7 
26 9.99 999.9 999 999 99.9 999 9.9 9.9 99.9 
27 1.96 71.3 172 101 17.0 87 2.0 2.9 4.3 
28 1.28 57.9 168 83 9.5 53 2.6 3.2 6.3 
29 1.68 70.0 176 93 12.0 78 .9 9.9 9.9 
30 9.99 999.9 999 999 99.9 999 9.9 9.9 99.9 
31 9.99 999.9 999 999 99.9 999 9.9 9.9 99.9 
32 9.99 999.9 999 999 99.9 999 9.9 9.9 99.9 
33 9.99 999.9 178 103 6.0 43 5.6 9.9 7.3 
34 1.74 67.2 168 90 13.5 77 3.0 5.2 6.8 
1-11 
Newdata 
isostr3 fev13 fvc3 ratio skf3 hada3 hadd3 pmf3 PPQ epf3 emf3 
1 262 99 9.9 99 999.9 8 2 24 26 27 31 
2 9999 9.9 9.9 99 999.9 99 99 999 999 999 999 
3 960 4.7 5.5 84 20.5 99 99 999 999 999 999 
4 494 4.1 4.7 86 999.9 6 8 50 76 80 50 
5 792 3.8 5.1 74 74.0 99 99 999 999 999 999 
6 388 3.0 4.0 75 999.9 5 1 76 67 52 99 
7 429 2.7 3.4 80 50.2 4 1 54 61 67 57 
8 360 3.4 4.2 80 62.6 0 2 56 71 68 53 
9 593 2.8 3.7 76 45.0 8 6 45 50 54 50 
10 644 4.0 5.3 75 39.7 11 8 49 52 52 52 
11 299 2.7 3.5 76 70.8 9 9 75 78 90 91 
12 9999 9.9 9.9 99 999.9 99 99 999 999 999 999 
13 585 4.1 5.1 80 20.5 10 1 27 31 61 57 
14 540 3.3 4.2 79 32.4 4 3 71 65 58 57 
15 622 2.2 3.8 61 999.9 1 6 55 89 97 53 
16 429 2.2 2.6 84 53.0 4 8 75 77 75 76 
17 256 3.2 4.0 81 107.0 6 8 79 87 53 59 
18 537 4.4 5.2 85 51.5 10 10 71 69 66 65 
19 485 2.9 3.5 83 103.6 0 2 64 65 67 65 
20 294 2.3 3.1 76 31.0 5 7 85 86 92 92 
21 612 4.5 5.3 85 72.0 5 3 74 1 
71 72 
1 68 
22 538 3.9 4.7 82 48.5 8 8 61 83 94 89 
23 417 1.9 3.2 60 55.8 7 12 54 50 68 42 
24 358 3.4 4.2 81 63.4 6 5 51 66 61 53 
25 9999 2.2 2.5 88 59,0 6 1 72 71 99 70 
26 9999 9.9 9.9 99 999.9 99 99 999 999 999 999 
27 301 3.6 4.0 90 37.4 13 8 77 50 50 76 
28 187 3.0 3.6 83 
1 52.5 3 2 64 68 70 67 
29 272 3.6 3.9 91 48.0 4 1 49 54 60 42 
30 9999 9.9 9.9 99 999.9 13 7 79 90 95 80 
31 9999 9.9 9.9 99 999.9 99 99 999 999 999 999 
32 9999 9.9 9.9 99 999.9 99 99 999 999 999 999 
33 465 2.4 3.3 74 999.9 4 2 60 75 68 57 
391 3.1 3.9 78 
[ 
33.8 3 4 55 55 53 55 
1-12 
Newcata 
wessely3 wesp3 wesm3 psqia3 psqib3 psqi63 hsqpf3 hsqrp3 hsqbp hsqgh3 
1 20 8 0 0 65 0 52 30 
2 99 99 9 9 999 999 999 999 
3 99 99 9 9 95 50 72 77 
4 32 12 11 50 25 31 50 
5 99 99 99 70 0 51 65 
6 4 5 00 90 25 72 35 
7 24 9 10 70 0 41 77 
8 22 1 00 80 0 84 35 
9 25 4 1 0 80 50 84 62 
10 26 7 1 0 go 25 42 47 
11 12 0 0 45 0 1 41 35 
12 99 99 9 9 999 999 999 999 
13 13 4 0 0 95 100 90 92 
14 28 7 0 01 70 50 84 52 
15 21 10 1 1 85 50 74 47 
16 24 4 0 0 75 25 90 45 
17 15 9 1 0 70 0 52 65 
18 29 6 50 74 60 
19 27 16 0 0 75 25 62 55 
20 21 4 0 0 55 o I 62 55 
21 26 12 1 1 40 25 51 30 
22 35 7 0 0 60 0 84 35 
23 4 5 0 0 70 25 74 57 
24 19 5 0 0 80 100 44 30 
25 16 11 2 1 50 0 31 25 
26 99 99 9 9 999 999 999 999 
27 24 7 0 0 85 50 50 77 
28 23 4 0 2 26 0 41 75 
29 23 15 85 0 1 80 0 44 40 
30 35 31 0 0 60 0 62 40 
31 9 9 1 999 91 999 999 
32 99 9 9 9 999 999 999 999 
33 18 5 1 0 35 0 62 67 
34 25 16 95 1 0 75 75 84 40 
1-13 
Newdata 
hsqvi3 hsqsf3 
I 
hsqre3 hsqmh3 
I 
baskey3 
I 
skida3 skidb3 cgio3 cgid3 
I 
cgip3 i 
1 0 38 38 T0 52 20 5 0 9 4 4 
2 999 999 999 999 99 99 99 9 9 9 
3 55 75 1 100 80 99 o o I I i 
4 45 75 67 64 4 0 0 1 3 3 
5 10 63 33 8 6 99 99 99 9 9 1 
6 35 63 100 80 6 0 o9 9 3 
7 70 6 80 9 99 99 9 9 1 
8 30 50 100 84 9 0 0 3 4 3 
9 45 75 0 56 7 0 0 1 2 2 
10 45 50 33 60 16 0 0 1 1 1 
11 30 50 100 72 12 99 99 9 9 3 
12 999 999 999 999 99 99 99 9 9 
13 60 100 100 60 5 99 99 9 9 2 
14 24 50 100 88 2 99 99 1 2 2 
15 20 100 100 84 7 2 0 9 9 4 
16 35 75 33 64 1 2 0 1 2 2 
17 50 75 100 88 17 99 99 9 9 
18 45 75 100 68 12 99 99 9 9 2 
19 40 38 100 72 4 0 0 9 2 2 
20 25 1 63 67 76 5 0 0 2 2 2 
21 55 38 100 84 8 0 0 9 2 2ý 
227 10 38 48 0 8 2 0 3 3 
-27 
23 60 63 100 80 9 0 0 2 1 2 
24 55 50 100 72 10 0 0 3 2 2d 
25 45 75 67 76 10 0 0 9 9 1 
26 999 999 999 999 99 99 99 9 9 9 
27 40 50 0 44 6 2 5 4 3 3 
28 25 75 100 60 99 0 0 4 3 
29 42 75 loo 98 14 0 0 2 2 2 
30 30 75 0 64 15 9 0 9 9 9 
31 999 999 999 999 99 99 99 9 9 9 
32 999 999 999 999 99 99 99 9 9 9 
50 50 33 80 11 0 0 
34 45 25 67 68 9 0 0 
1-14 
Newdata 
code group basegrps sex retest 111dur med cause age hei*ght 
35 3 2 5 22 2.0 2 2 61 162.5 
36 52 5 24 .6 0 2 32 165.5 
37 72 5 24 1.0 0 2 29 170.5 
38 82 5 14 1.5 0 1 64 176.0 
j 
39 92 5 23 3.0 0 1 24 160.0 
40 11 2 5 24 .8 1 1 27 164.0 
41 18 2 5 142.0 1 1 59 170.0 
----r- 
42 22 2 5 243.0 1 1 25 175.5 
43 27 12 
_ 
5 24 2.0 1 1 29 177.0 
2 5 22 .6 0 1 46 
170.5 
45 31 2 5 22 19.0 0 11 35 169.0 
46 32 2 5 22 1.3 2 1 40 163.0 
47 30 2 5 22 7.0 0 1 21 170.0 
48 33 2 5 2 4 5.0 1 4 24 161.0 
49 37 2 5 2 4 .8 0 4 29 160.5 
50 38 2 5 1 2 2.5 0 1 24 177.5 
51 39 2 5 2 4 2.8 0 1 36 152.0 
52 40 2 5 22 3.5 1 1 53 162.0 
53 41 2 5 13 1.4 0 1 37 180.5 
54 44 2 5 24 2.0 1 11 21 173.0 
55 17 2 5 24 2.0 1 1 51 169.0 
5-6 
ý4 
82 5 24 2.0 1 1 39 161.5 
57 49 2 5 24 2 1 48 160.0 
58 51 2 5 14 6.0 1 1 31 176.0 
59 52 25 1 4 6.0 0 1 45 176.0 
60 54 25 2 4 1.1 1 1 26 161.0 
25 2 4 1.0 0 0 32 164.5 
62 56 25 2 4 .8 2 1 47 
176.0 
63 59 25 11 2 4 1.0 0 1 24 179.5 
64 61 25 26 .8 2 4 
33 164.0 
65 47 2 26 2.5 1 1 39 170.5 
66 62 5 16 3.0 0 0 31 179.0 
2-1 
Newdata 
weight bmi vo2maxm vo2maxl i hrmax vemax hrrec perhr testd rpe lac14 
35 80.6 30.3 28.0 2.29 165 66.1 88 97 10.0 68 3.1 
36 75.4 27.4 28.4 2.14 180 68.8 135 95 8.0 58 3.0 
37 65.5 22.4 43.7 2.81 191 98.9 122 100 13.5 92 4.3 
38 53.2 17.7 40.5 2.02 166 67.2 120 99 10.5 67 1.5 
39 45.7 17.6 45.4 2.05 172 72.1 106 89 1 13.5 77 1.9 
40 57.2 21.3 23.7 1.35 194 54.8 125 98 8.0 64 1.7 
41 88.5 30.6 30.6 161 2.71 84.1 105 94 10.0 66 4.3 
42 82.6 26.6 27.2 2.25 194 112.2 1 136 100 7.8 57 6.1 
43 69.3 22.1 17.9 1.24 169 51.3 116 88 4.0 28 4.8 
44 66.9 23.3 24.8 1.66 160 58.3 94 84 8.0 58 2.4 
45 60.4 21.2 33.2 2.00 184 69.8 115 98 12.0 79 1.9 
46 59.1 22.2 14.9 . 88 115 
37.5 64 59 4.0 34 1.0 
47 51.9 17.9 34.7 1.80 182 72.7 121 93 12.0 84 3.4 
48 61.7 23.8 31.0 1.91 162 61.7 105 87 8.0 1 64 2.1 
49 67.8 26.1 25.0 1.70 182 56.2 104 95 8.0 54 4.2 
50 56.5 17.8 36.5 2.10 188 69.7 139 97 10.0 69 3.5 
51 63.5 27.4 26.1 1.66 171 50.1 106 93 12.0 737 1.0 
52 84.3 32.1 22.4 1.88 143 72.4 80 81 4.5 25 9.9 
53 79.8 24.4 27.0 2.15 149 74.0 105 80 6.5 39 4.2 
54 52.9 17.6 29.7 1.58 185 57.9 107 94 10.0 63 4.5 
55 74.8 26.8 22.8 1.65 169 77.8 111 97 60 57 1 4.1 
56 64.6 24.6 24.9 1.61 177 61.8 107 96 8.8 53 2.4 
57 65.4 25.5 28.4 1.86 176 61.0 112 98 8.8 55 2.0 
58 79.4 25.6 47.9 3.56 187 152.5 118 98 i 16.0 94 3.9 
59 72.0 23.2 49.5 3.56 184 131.5 127 100 18.0 119 2.11 
60 50.4 19.4 28.8 1.45 186 85.9 149 96 12.0 61 1.7 
61 79.0 29.0 26.8 2.11 151 67.3 106 80 8.0 63 1.3 
62 88.0 28.7 16.6 1.44 128 74.0 84 70 40 35 9.9 
63 79.2 24.4 23.8 1.89 195 75.9 109 loo 11.0 75 1.4 
64 56.7 21.1 14.5 . 82 155 66.5 107 
82 4.0 32 i 1.8 
62.9 21.5 28.2 
- - 
1.77 
- 
178 75.0 109 96 10.5 70 3.0 
66 78.2 24.1 
-4 
40 
t 
3.44 192 134.8 125 100 15.5 97 6.6 
2-2 
Newdata 
I lacl4b postlac 
I 
isostr fevi fvcl ratio I skf hadal haddl pmfl ppfl 
35 9.9 8.0 301 9.9 9.9 99 999.9 4 7 999 999 
36 9.9 3.9 235 9.9 9.9 99 999.9 8 7 999 999 
37 9.9 7.8 396 9.9 9.9 99 999.9 7 1 999 999 
38 9.9 2.6- 
1 
311 9.9 9.9 99 999.9 32 100 100 
39 9.9 W9 399 9.9 9.9 99 999.9 11 3 85 89 
40 9.9 5.6 376 3.3 4.0 82 45.8 34 46 81 
41 9.9 4.5 617 2.7 3.1 86 74.7 11 61 89 
42 9.9 8.7 349 2.3 2.8 80 104.2 10 8 100 100 
43 9.9 i 4.8 423 1 9.9 9.9 99 87.6 99 99 67 92 
44 9.9 3.2 338 9.9 9.9 99 57.1 3 2 65 62 
45 9.9 4.9 339 3.6 4.3 84 45.7 9 7 89 89 
46 9.9 1.6 153 9.9 9.9 99 48.7 0 3 53 95 
47 9.9 4.8 279 3.7 4.5 81 35.4 4 5 44 82 
48 9.9 3.6 298 3.0 3. 77 67.2 8 10 84 88 
49 9.9 5.4 326 9.9 9.9 99 86.4 1 9 70 76 
50 9.9 6.1 414 3.8 4.2 91 23.1 10] 9 69 68 
51 9.9 2.7 259 2.1 2.4 87 57.6 12 6 95 96 
52 9.9 99.9 209 2.8 3.0 79 84.6 2 10 88 90 
53 9.9 2.1 310 3.6 4.1 88 52.1 67 91 91 
54 9.9 7.8 286 3.3 3.6 89 28.7 15 94 95 
55 9.9 9.8 274 2.5 3.2 79 87.8 38 69 92 
56 9.9 7.2 228 3.2 3.8 84 71.4 11 10 80 90 
57 9.9 4-6 280 2.3 3.1 75 72.8 32 58 83 
58 9.9 9.2 491 4.2 5.0 83 50.0 10 5 85 87 
59 9.9 9.6 545 3.6 4.7 76 42.5 98 76 90 
60 9.9 5.8 486 94 35.5 42 50 73 
617 9.9 3.2 347 3.2 3.8 84 89.7 13 67 76 
62 9.9 2.9 355 3.8 4.5 84 96.0 05 64 73 
63 9.9 3.5 278 3.9 4.9 57.6 75 61 90 
64 9.9 3.6 175 3.6 4.4 82 34.3 38 53 91 
65 9.9 9.0 385 3.3 4.1 81 6 .6 
88 75 92 
66 9.9 9.2 512 9.9 9.9 99 999.9 10 5 999 1 999 
2-3 
Newdata 
epfl emfl wesselyl wespi wesml psqial psqibl psqi6l hsqpfl hsqrpl 
35 999 999 32 21 11 7 0 1 999 999 
36 999 999 35 22 15 6 0 0 30 0 
37 1 999 999 30 20 10 10 1 1 999 999 
100 27 38 100 22 5 15 1 999 999 
39 43 40 37 21 16 6 0 70 50 
40 96 48 22 6 5 0 0 999 999 
41 88 57 18 13 5 3 0 0 999 999 
42 100 100 33 22 11 12 1 1 999 999 
43 99 99 99 5 10 
0 15 0 
44 88 50 22 17 5 5 0 0 35 0 
45 89 87 99 5 0 0 50 25 
46 95 54 29 21 8 8 0 0 55 0 
47 94 1 49 34 22 12 5 0 0 45 999 
48 83 86 42 24 18 8 0 1 35 0 
49 87 86 28 16 12 7 0 1 40 0 
50 86 43 22 16 6 8 0 0 75 50 
51 87 92 30 16 14 7 1 0 95 25 
52 89 81 32 22 10 6 0 0 35 0 
53 90 96 1 25 
I 
14 11 17 1 1 999 999 
54 100 100 26 16 10 4 0 0 60 0 
55 97 80 35 22 13 6 0 0 999 999 
56 93 81 36 20 16 5 0 0 40 0 
57 97 58 31 18 13 6 0 0 55 1 0 
58 95 93 39 227 17 9 0 0 50 0 
59 100 94 38 24 14 6 1 0 70 0 
60 72 50 23 17 6 3 0 0 35 100 
61 90 94 31 22 9 1 0 0 30 0 
62 88 75 0 19 6 0 0 50 0 
63 96 70 30 20 10 4 0 0 45 25 
64 89 52 25 19 6 6 0 0 35 0 
65 92 93 38 23 15 4 0 0 25 0 
66 999 999 30 19 11 7 1 1 999 999 
2-4 
Newdata 
hsqbpl hsqghl hsqvil hsqscl hsqre hsqmel baskeyl skidal skidbl age2 
35 999 999 999 999 999 999 10 0 0 61 
36 52 25 20 25 0 64 7 0 33 
37 999 999 999 999 999 999 10 0 0 29- 
38 999 999 999 999 999 999 99 0 0 64 
39 84 30 35 63 100 80 13 0 0 24 
40 999 999 999 999 999 999 6 0 0 27 
41 999 999 999 999 999 999 3 0 0 59 
42 1 999 999 999 999 999 999 14 9 0 25 
43 0 20 0 13 100 64 19 9 0 30 
44 52 62 50 63 100 64 6 0 0 47 
45 22 40 15 38 33 40 13 0 0 35 
46 41 55 20 1' 75 100 88 6 0 0 40 
47 41 IT 15 50 67 60 12 0 0 21 
48 41 35 25 50 100 56 11 0 0 24 
49 22 30 20 25 100 68 7 0 0 29 
50 41 40 38 100 60 10 0 0 24 
51 84 52 45 88 0 52 11 0 0 36 
52 31 35 00 0 64 13 0 0 53 
53 999 999 999 999 999 999 9 0 0 37 
54 51 35 5 63 100 68 2 0 0 21 
55 1 999 999 999 999 999 999 10 0 0 51 
56 1 22 35 15 50 33 48 8 0 0 40 
41 60 30 63 33 92 18 0 0 48 
62 25 15 13 33 60 8 0 0 32 
59 41 72 25 50 33 48 12 0 0 
60 41 40 1 35 50 100 68 10 0 0 26 
61 61 57 20 13 67 84 12 0 0 33 
62 72 1 20 25 13 100 92 6 0 0 47 
63 41 20 i 25 25 66 64 11 0 0 24 
64 42 25 25 0 33 
1 
60 99 0 0 33 
65 84 10 20 13 100 68 16 0 0 99 
66 1 999 999 1 999 i 999 1 
999 999 5 0 0 99 
2-5 
Newdata 
height2 weight2 vo2maxm2 vo2maxI2 vemax2 hrmax2 perhrm2 hrrec2 testd2 
35 162.5 75.5 23.3 1.76 70.8 161 89 8 
36 165.5 75.9 . 
27.7 2.11 73.5 173 95 1 21 10.0 
37 170.5 65.2 39.8 2.59 100.8 192 92 118 14.0 
38 176.0 52.8 33.3 1.76 65.2 172 100 116 12.0 
39 160.5 45.9 44.1 2.03 63.4 172 101 96 11.5 
40 164.0 56.7 25.9 1.47 57.1 182 89 120 9.0 
41 170.0 89.2 29.8 2.66 85.6 161 95 106 10.5 
42 175.5 82.3 1 28.0 2.28 83.5 191 94 135 8.0- 
43 177.5 71.1 22.6 1.61 59.3 174 99 114 4.5 
44 170.0 67.5 26.2 1.77 63.0 149 92 76 8.0 
45 169.0 60.6 33.6 2.00 76.1 187 83 116 12.0 
46 163.0 57.8 21.3 1.23 42.9 135 100 76 5.0 
47 170.0 53.5 40.2 2.15 88.4 190 72 113 14.0 
48 161.0 61.0 40.0 2.41 90.6 175 97 110 12.0 
49 160.5 69.2 24.8 1.72 60.0 182 90 86 8.5 
50 177.5 57.5 37.7 2.20 85.2 195 95 146 12.5 
51 152.0 64.6 34.6 2.19 81.0 179 100 105 15.0 
52 162.0 87.7 21.1 1.85 87.7 161 96 105 6.0 
53 180.5 83.5 33.7 2.81 97.6 164 ul 100 10.5 
54 173.0 51.7 31.9 1.65 66.9 186 88 110 13.5 
55 169.0 75.6 24.4 1.85 76.2 174 95 114 8.0 
56 161.5 62.5 30.4 1.90 69.6 188 98 
1 132 10.0 
57 160.0 64.5 26.3 1.70 64.2 186 98 116 11.5 
58 176.5 Ou. 1 46.2 3.73 153.1 192 104 124 18.0 
59 176.0 73.1 41.2 3.01 125.2 182 100 128 19.0 
60 161.0 49.5 35.0 1.73 76.1 190 98 129 12.0 
61 164.5 80.1 27.2 2.19 70.0 160 85 104 10.0 
62 176.0 91.4 18.9 1.39 93.1 168 94 96 10.0 
63 180.0 1! 82.4 27.8 2.29 90.5 202 103 11 12.0 
64 164.0 56.7 14.5 1.27 66.4 172 91 112 10.0 
65 999.9 999.9 99.9 9.99 999.9 999 999 99.9 
66 999.9 999.9 99.9 9.99 999.9 999 999 99.9 
2-6 
Newdata 
rpe2 lac142 lacl4b2 postlac2 isostr2 fevl2 fvc2 ratio2 skf2 hada2 
35 61 9.9 7.4 7.5 391 9.9 9.9 99 999.9 2 
36 58 2.3 2.3 3.1 219 9.9 9.9 99 999.9 7 
37 94 2.2 9.9 7.8 490 3.2 4.1 77 999.9 9 
38 63 1.2 9.9 4.0 244 9.9 9.9 99 999.9 8 
39 80 1.3 9.9 2.5 464 9.9 9.9 99 999.9 7 
40 57 2.6 9.9 8.2 418 3.1 3.9 80 52.9 1 
41 72 3.0 2.7 7.2 597 2.8 3.6 79 80.8 2 
42 51 1 3.1 9.9 8.4 382 3.4 3.9 85 106.5 15 
43 28 3.7 9.9 5.5 367 3.9 4.7 83 94.2 8 
44 64 1.2 2.4 3.1 415 9.9 9.9 99 57.3 99 
45 82 1.0 9.9 5.6 326 3.6 4.2 84 51.6 10 
46 32 1.0 9.9 2.0 360 9.9 9.9 99 999.9 0 
47 83 3.1 9.9 6.6 410 3.4 4.2 82 999.9 4 
48 50 1.7 3.4 6.9 347 3.1 4.2 74 999.9 6 
49 48 2.7 9.9 4.3 435 2.4 2.9 83 85.4 0 
50 46 2.9 7.4 7.4 411 3.6 4.4 83 24.1 7 
51 68 3.2 6.1 5.3 284 2.3 2.9 77 999.9 7 
52 28 5.2 9.9 8.1 273 2.8 3.4 82 1 87.0 2 
53 39 2.6 2.8 5.3 513 4.0 i 5.0 80 54.7 10 
54 55 3.9 9.9 5.7 332 3.6 3.7 97 27.6 5 
55 34 4.4 7.3 10.8 386 2.3 2.7 87 83.8 4 
56 51 3.2 9.9 5.7 258 3.2 3.7 83 70.5 11 
57 42 2.4 2.9 5.0 252 2.5 1 3.0 83 72.4 3 
58 79 1 1.2 2.0 9.4 9999 4.1 4.9 84 58.0 6 
59 109 1.6 2.0 13.8 596 3.8 1 4.9 76 44.1 7 
60 54 1.6 2.2 6.7 398 2.7 3.2 86 48.8 9 
61 63 1.3 1.5 3.8 422 3.1 3.7 84 92.2 1 
62 26 2.6 4.2 1 6.7 376 3.4 4.3 80 85.2 1 
63 63 1.0 1.8 6.3 465 3.9 4.9 81 72.2 7 
64 26 2.0 3.1 5.5 186 3.5 4.1 85 33.8 9 
65 999 9.9 9.9 99.9 9999 9.9 9.9 99 999.9 1 
66 999 9.9 9.9 99.9 9999 9.9 9.9 99 999.9 99 
2-7 
Newdata 
hadd2 pmf2 ppf2 epf2 emf2 wessely wesp2 wesm2- psqia2 psqib2 psqi6 
35 3 45 59 60 35 25 14 11 10 0 
36 7 87 86 88 87 37 22 13 ]60 0 
37 4 23 63 77 52 27 21 6 8o I 
38 3 69 87 92 84 11 7 4 810 
39 1 73 73 99 81 26 18 81601 
40 3 52 74 82 53 27 21 j 630i0 
41 1 56 59 57 1' 46 21 16 5500 
42 12 96 95 100 93 33 22 11 12 11 
43 4 999 999 999 999 36 23 13 99 9 9 
44 99 999 999 999 999 99 99 9 
45 9 63 61 71 65 35 19 16 60 0 
46 2 94 95 94 90 27 18 9 80 0 
47 6 92 85 94 56 22 18 6 99 0 
48 3 71 73 87 78 12 7 5 91 
49 1 55 54 46 46 25 15 10 1 0 0 
50 5 36 46 52 35 12 7 5 6 0 0 
51 1 25 25 25 74 32 17 15 8 1 0 
52 1 88 1 96 97 84 38 24 14 80 0 
53 7 67 76 70 80 32 22 10 60 0 
54 9 54 56 100 73 24 15 9 40 0 
55 2i 23 70 83 50 22 14 8 0 5 0 
56 19ý 74 ! 83 74 :; 75 31 , 18 13 1 41 
'o 
0 
57 1 25 59 1 72 22 28 17 11 60 0 
58 4 83 81 96 95 38 21 17 8 0 1 
59 6 67 56 73 74 22 12 lo 4 1 0 
60 9 74 loo loo 61 29 20 98 1 0 
61 1 81 83 100 96 30 21 93 1 o 
62 4 85 73 90 84 32 20 12 6 o 0 
63 8 65 70 27 18 95 0 0 
64 6 51 77 85 50 25 19 65 0 0 
65 13 85 76 92 84 39 22 75 0 0 
66 99 999 999 999 999 99 99 9 9 
2-8 
Newdata 
hsqpf2 hsqrf2 hsqbp2 hsqgh2 hsqvi2 hsqsf2 hsqre2 hsqmh2 baskey2 sklda2 
35 999 999 999 999 999 999 999 999 6 0 
36 999 999 999 999 999 999 999 999 99 0 
37 70 0 41 15 45 75 100 60 12 0 
38 90 75 74 35 60 75 33 64 7 0 
39 45 0 44 35 25 50 100 80 12 0 
40 55 25 90 40 35 63 100 80 7 0 
41 80 25 90 65 45 75 100 92 5 0 
42 30 10 62 20 20 100 0 24 13 9 
43 35 0 0 1 20 5 13 100 68 3 99 
44 70 25 84 65 60 75 100 76 99 99 
45 60 0 22 30 35 38 0 40 13 0 
46 45 0 22 40 5 50 100 88 5 0 
47 50 0 31 20 15 50 33 40 6 0 
48 45 0 52 67 50 50 33 84 10 99 
- 
49 
- 
90 25 62 35 5ý5 63 100 88 3 0 
50 70 75 64 47 60 63 100 84 10 99 
51 100 25 42 65 70 50 67 56 14 99 
52 35 0 41 25 o 13 100 72 14 2 
53 40 50 51 40 40 1 75 100 64 8 0 
54 55 50 90 57 40 88 100 77 0 0 
55 25 0 62 40 45 38 33 
I 
60 5 0 
56 50 25 62 45 45 75 66 5 84 0 
57 55 50 44 40 65 loo 100 92 18 0 
58 65 0 72 40 35 38 33 52 18 0 
59 95 50 74 97 55 88 100 72 6 0 
60 25 0 2 25 35 50 100 64 12 0 
61 25 0 51 57 5 25 100 92 11 0 
62 40 0 90 30 15 13 0 88 7 0 
63 45 25 51 
:: 15 
30 50 i 100 76 8 0 
64 65 25 90 52 50 63 100 84 8 0 
65 45 0 54 999 25 25 33 48 99 9 
66 1 999 
1 99E 999 999 i 999 999 999 
ý 99 99 
2-9 
Newdata 
skidb2 cgio2 cgid2 cglp2 cgi2full age3 height3 welght3 vo2maxm3 
35 0 9 2 2 3 99 999.9 999.9 99.9 
36 0 9 2 2 3 33 165.5 74.5 27.7 
37 0 1 2 2 3 30 170.5 65.3 39.5 
38 0 9 2 2 3 64 176.0 56.2 33.9 
39 0 2 3 24 161.0 46.0 37.4 
40 0 1 1 2 3 28 164.0 58.8 27.8 
41 0 1 1 1 2 59 170.0 90.2 29.0 
42 0 4 2 2 6 26 175.5 79.0 29.7 
43 99 9 9 2 4 30 175.5 73.5 21.5 
44 99 9 9 2 4 99 999.9 999.9 99.9 
45 0 1 2 2 4 99 999.9 999.9 99.9 
46 0 9 2 2 3 99 999.9 999.9 99.9 
47 0 4 2 2 3 99 999.9 999.9 99.9 
48 99 9 2 2 3 25 161.0 60.4 33.1 
49 0 9 1 1 2 29 160.0 71.7 26.1 
50 99 9 2 2 3 99 999.9 999.9 99.9 
51 99 9 1 1 2 37 152.0 66.4 31.7 
52 0 4 2 2 3 99 999.9 999.9 99.9 
53 0 4 2 2 3 38 180.5 1 84.9 35.6 
54 0 2 1 1 1 21 173.0 52.2 39.1 
55 0 1 1 1 2 51 169.0 76.1 27.8 
56 0 3 1 1 2 40 161.5 63.7 31.5 
57 0 31 1 2 48 160.0 62.4 18.0 
58 0 2i2 2 3 32 176.0 83.4 46.0 
59 011 1 1 46 176.0 68.6 38.0 
60 o32 2 3 27 161.0 50.4 35.4 
61 092 2 3 33 164.5 82.7 28.7 
62 042 2 3 48 176.0 89.8 23.0 
63 03 2 3 24 180.0 82.3 28.6 
64 0 42 2 9 99 999.9 999.9 99.9 
65 0 91 1 9 99 999.9 999.9 99.9 
66 99 99 9 9 99 999.9 999.9 99.9 
2-10 
Newdata 
vo2maxI3 vemax3 hrmax3 i hrrec3 testd3 rpe3 Iacl43 Iacl4b3 postlac3 
35 9.99 999.9 999 999 99.9 999 9.9 9.9 99.9 
36 2.06 74.5' 187 126 12.0 56 6.4 9.9 7.6 
37 2.58 92.9 190 116 14.0 92 2.5 4.5 10.0 
38 1.90 71.1 179 110 12.0 61 1.7 3.0 4.9 
39 1.72 63.9 169 104 12.5 85 1.2 1.2 3.2 
40 1.63 64.7 182 120 8.0 56 1.8 9.9 7.2 
41 2.60 90.8 167 ill 8.0 68 4.0 4.0 7.6 
42 2.34 102.7 187 123 8.0 51 4.6 9.9 8.4 
43 1.58 56.3 173 121 5.5 24 2.6 4.8 4.9 
44 9.99 999.9 999 999 99.9 999 9.9 9.9 99.9 
45 9.99 999.9 999 999 99.9 999 9.9 9.9 99.9 
46 9.99 999.9 999 999 99.9 999 9.9 99.9 
47 9.99 999.9 999 999 99.9 999 9 ý9, 9.9 Sag 
48 2.00 79.4 168 107 12.5 43 2.2 9.9 6.5 
49 1.72 53.3 175 92 9.5 44 2.5 4.6 6.7 
50 9.99 999.9 999 999 99.9 999 9.9 9.9 99.9 
51 2.10 74.0 181 92 12.0 72 3.6 4.0 5.3 
52 9.99 999.9 999 999 99.9 999 9.9 9.9 99.9 
53 3.02 121.5 167 116 12.0 37 2.2 5.2 6.3 
54 2.04 79.1 199 122 16.0 54 2.1 9.9 7.1 
55 2.12 71.7 173 110 8.0 35 3.9 4.6 6.3 
56 2.00 67.6ý 178 103 11.0 48 2.4 3.5 99.9 
57 1.13 61.2 174 107 9.0 51 3.2 9.9 3.8 
58 3.80 146.0 194 114 18.0 85 2.2 2.3 9.6 
59 2.65 97.9 163 103 16.0 104 1.6 2.6 7.3 
60 1.78 83.0 189 136 12.0 54 1.1 9.9 5.3 
61 2.38 80.7 174 112 10.0 57 1.2 1.0 3.6 
62 2.07 105.2 1 159 100 9.0 26 1.3 2.3 6.0 
63 2.35 1 87.8 210 104 12.8 59. ý 1.5 1.4 4.8 
64 9.99 999.9 999 999 99.9 999 9.9 9.9 99.9 
65 9.99 999.9 999 999 99.9 999 9.9 9.9 99.9 
66 9.99 999.9 999 999 99.9 999 9.9 9.9 99.9 
2-11 
Newdata 
isostr3 fev13 fvc3 ratio skf3 hada3 hadd3 pmf3 ppf3 epf3 emf3 
35 9999 9.9 9.9 99 999.9 99 99 999 999 999 999 
36 328 1.8 2.4 74 999.9 99 99 999 999 999 999 
37 682 3.3 4.4 75 999.9 5 2 33 72 95 78 
38 272 2.5 3.3 74 999.9 1 8 8 74 84 93 72 
39 492 9.9 9.9 99 999.9 6 1 77 70 94 96 
40 453 3.3 4.1 78 999.9 i 5 2 44 75 43 24 
41 555 2.7 3.4 79 89.0 1 1 59 59 68 46 
42 333 3.3 3.8 88 104.9 11 9 98 99 92 97 
43 9999 3.8 4.4 86 91.2 5 5 89 97 91 99 
44 9999 9.9 9.9 99 999.9 99 99 999 999 999 999 
45 9999 9.9 9.9 99 999.9 99 99 999 999 999 999 
46 9999 9.9 9.9 99 999.9 99 99 999 i 999 999 999 
47 9999 9.9 9.9 99 999.9 99 99 999 999 999 999 
48 283 3.4 4.1 83 55.6 7 9 25 73 85 75 
49 313 2.7 3.0 90 999.9 7 6 53 54 51 1 52 
50 9999 9.9 99 999.9 99 99 999 999 999 999 
51 286 2. 2.6 75 67.8 9 7 93 69 39 82 
52 9999 9.9 9.9 99 qqqý 97 99 
99 999 999 999 999 
53 527 4.0 5.1 79 999.9 8 6 87 1 79 86 89 
54 i 361-1 3.7 3.8 95 28.5 4 7 50 50 65 50 
55 344 1 2.4 2.8 84 100.6 4 71 65 80 77 1 58 
-ý6 
268 2.9 3.9 74 70.4 8 8 64 66 62 50 
57 273 2.! 80 65.8 2 1 18 83 93 39 
58 852 4.0 4.7 85 45.0 9 6 72 76 90 91 
59 568 3.7 4.8 78 33.6 2 54 73 56 
60 325 2.9 3.3 88 53.7 12 10 95 96 100 99 
61 270 2.9 3.5 82 84 7 7 61 65 80 86 
62 425 3.6 4.5 80 99.8 1 8 5 51 72 84 51 
63 458 4.1 4 -9 
3 2 56 74 72 52 
64 9999 9.9 9.9 99 999.9 99 99 999 999 999 999 
65 9999 9.9 9.9 gg 999.9 99 99 999 999 999 999 
66 9999 9.9 9.9 99 99969 99 99 999 999 999 999 
2-12 
Newdata 
wessely3 wesp3 wesm3 psqia3 psqib3 psqi63 hsqpf3 hsqrp3 hsqbp hsqgh3 
35 99 99 9 9 999 999 999 999 
36 99 99 9 9 999 999 999 999 
37 31 22 9 7 0 1 60 o 62 20 
38 16 8 8 91 1 80 25 74 45 
39 99 1 99 99 999 999 999 999 
40 24 19 5 3 00 65 25 90 52 
41 20 15 5 3 0 0 80 50 90 67 
42 1 33 22 11 11 1 1 25 0 22 25 
43 51 2 5 0 0 40 0 12 30 
44 99 99 9 9 999 999 999 999 
45 99 99 9 9 999 999 999 999 
46 99 91 9 9 999 999 999 999 
47 99 99 9 9 999 999 999 vvu 
48 13 16 5 3 0 0 65 0 41 52 
49 20 10 10 2 0 0 85 100 84 45 
50 99 9 9 9 999 999 999 999 
51 30 16 14 10 1 0 95 0 31 57 
52 99 99 9 9 999 999 999 999 
53 27 15 12 10 0 1 45 75 61 50 
54 18 9 9 2 0 0 75 100 
jý ý72 
55 30 18 12 6 0 0 40 0 52 52 
56 25 16 9 4 0 0 55 75 62 67 
57 32 19 13 8 0 1 55 0 31T 62 
58 30 18 12 8 0 1 75 0 82 40 
59 22 14 8 3 0 0 95 100 84 97 
60 35 19 16 6 0 0 30 o 12 15 
61 24 16 8 4 1 0 50 0 72 30 
62 30 19 11 7 0 0 65 o 9 35 
63 25 15 10 5 1 0 65 50 31 75 
64 99 99 9 9 999 999 999 999 
65 99 1 9 9 9 999 999 999 999' 
66 99 99 9 9 999 999 999 999 
2-13 
Newdata 
hsqvi3 hsqsf3 hsqre3 hsqmh3 baskey3 skida3 skidb3 cgio3 cgid3 cgip3 
35 999 999 999 999 99 99 99 9 9 0 
36 999 999 999 999 99 0 0 9 2 2 
37 40 38 67 67 10 0 0 1 3 3 
38 50 63 33 44 7 0 0 1 22 
39 999 999 999 999 99 0 0 9 9 3 
40 45 75 100 84 4 0 0 9 9 3 
41 55 75 100 92 2 0 0 1 2 2 
42 5 13 33 52 15 9 0 3 3 3 
43 10 13 100 68 16 9 0 9 9 4 
44 999 999 999 999 99 99 99 9 9 9 
45 999 999 999 999 99 99 99 9 9 9 
46 999 999 999 999 99 99 99 9 91 9 
47 999 999 999 999 99 99 99 9 9 9 
48 40 1 50 67 44 5 0 0 9 2 2 
49 70 100 100 88 2 99 99 9 1 1 
50 1 999 999 999 99 99 99 99 9 9 9 
51 30 38 0 40 13 99 99 9 9 3 
52 999 999 999 999 99 2 0 9 4 3 
53 25 50 100 80 7 0 0 9 9 9 
54 70 100 100 88 3 0 0 9 1 1 
55 30 38 33 60 9 0 0 1 1 1 
56 45 100 66 76 4 0 0 2 2 2 
57 30 50 100 68 18 0 0 4 4 4 
58 40 38 100 76 5 0 0 3 3 3 
59 70 100 100 64 7 0 0 1 1 1 
60 0 38 33 36 12 2 9 4 5 5 
61 15 50 100 88 12 0 0 9 3 3 
62 25 38 100 88 6 0 0 4 3 2 
63 30 75 100 80 6 0 0 3 2 2 
64 999 999 999 999 99 99 99 9 9 9 
65 999 999 999 999 99 99 99 9 9 9 
66 999 999 999 999 99 99 99 9 9 9 
2-14 
Newdata 
age4 height4 welght4 vo2maxm4 vo2maxf4 vemax4 hrmax4 hrrec4 testd4 
35 99 999.9 999.9 99.9 9.99 999.9 999 999 99.9 
36 '33 165.5 76.1 24.1 1.84 61.5 172 108 8.5 
37 30 170.5 65.6 44.0 2.89 102.7 192 116 14.0 
38 65 176.0 54.9 38.9 
1 
2.14 82.1 171 125 15.0 
39 99 999.9 999.9 99.9 9.99 999.9 999 999 99.9 
40 29 164.5 58.4 28.3 1.65 55.9 177 los 8.5 
41 60 170.0 88.5 32.9 1 2.91 100.6 177 117 12.0 
42 26 175.5 81.2 27.4 2.22 95.3 192 132 8.0 
43 30 178.0 74.1 24.7 1.83 68.0 179 124 6.5 
44 99 999.9 999.9 99.9 9.99 999.9 999 999 99.9 
45 99 999.9 999.9 99.9 9.99 999.9 999 999 99.9 
46 99 999.9 999.9 99.9 9.99 999.9 999 999 99.9 
47 99 999.9 999.9 99.9 9.99 999.9 999 999 99.9 
48 25 161.5 59.4 37.2 2.24 94.0 179 115 14.0 
49 30 159.0 72.1 33.4 2.07 63.9 185 98 10.1 
50 99 999.9 999.9 99.9 
1 
9.99 999.9 999 999 99.9 
51 37 152.0 68.9 28.6 1.97 73.3 169 93 11.0 
52 99 999.9 999.9 99.9 9.99 999.9 999 999 99.9 
53 99 999.9 999.9 99.9 9.99 999.9 999 999 99.9 
54 21 173.0 51.8 41.2 2.13 84.2 197 124 17.0 
55 51 169.0 76.5 25.0 2.03 73.4 163 105 8.0 
56 40 161.5 62.5 33.6 2.10 66.6 186 115 11.0 
57 48 160.0 64.1 17.1 1.10 67.7 192 136 9.5 
58 32 176.0 83.4 40.2 3.. 36 127.6 194 123 18.0 
59 46 176.0 68.1 40.0 2.72 100.4 176 120 18.0 
60 27 161.0 48.0 21.8 1.08 50.7 167 92 8.0 
61 33 1 164.5 79.4 28.4 1 2.25 82.1 188 108 11.0 
62 48 i 176.0 93.7 21.8 2.04 114.7 174 110 1 10.0 
63 25 180.0 84.0 20.2 1.70 99.2 212 130 12.0 
64 99 999.9 999.9 99.9 9.99 999.9 999 999 99.9 
65 99 999.9 999.9 99.9 9.99 999.9 999 999 99.9 
66 99 999.9 999.9 99.9 9.99 999.9 999 999 99.9 
67 99 999.9 999.9 99.9 9.99 999.9 999 999 99.9 
68 99 999.9 999.9 99.9 9.99 999.9 999 999 99.9 
2-1 
Newdata 
rpe4 lac144 lacl4b4 postla64 isostr4 fev14 fvc4 ratio4 skf4 hada4 
35 99 9.9 9.9 99.9 9999 9.9 9.9 99 999.9 
36 62 1.6 1.8 1.9 276 1.9 2.5 77 999.9 99 
37 90 4.0 4.0 10.2 675 3.3 4.2 77 999.9 4 
38 51 1.6 2.6 5.2 394 2.7 3.7 73 18.7 6 
39 999 9.9 9.9 99.9 9999 9.9 9.9 99 999.9 99 
40 56 .91.7 5.5 409 3.6 4.1 
88 53.0 6 
41 66 3.0 3.2 9.6 592 2.7 3.4 79 90.5 6 
42 56 4.9 9.9 9.6 300 3.6 3.9 91 106.4 11 
43 21 2.0 9.9 4.9 465 3.2 3.7 92 86.6 3 
44 999 9.9 9.9 99.9 9999 9.9 9.9 99 999.9 99 
45 999 9.9 9.9 99.9 9999 9.9 9.9 99 999.9 99 
46 999 9.9 9.9 99.9 9999 9.9 9.9 99 999.9 
47 999 9.9 9.9 99.9 9999 9.9 9.9 99 999.9 
48 39 1.8 2.6 6.5 403 3.4 4.1 83 56.1 8 
49 42 3.0 9.9 6.5 300 2.6 2.9 89 999.9 7 
50 999 9.9 9.9 99.9 9999 9.9 9.9 99 999.9 99 
51 68 4.7 3.7 3.5 308 2.3 2.7 85 68.7 8 
52 999 9.9 9.9 99.9 9999 9.9 9.9 99 999.9 99 
53 999 9.9 9.9 99.9 9999 9.9 9.9 99 999.9 99 
54 49 2.1 2.5 6.8 1 334 3.6 3.7 95 27.6 2 
55 34 4.0 6.0 8.7 379 2.5 2.6 94 999.9 4 
56 51 1.2 1.7 5.2 356 3.2 3.8 85 66.3 10 
57 68 2.3 9.9 6.2 258 2-6 3.1 82 78.6 1 
58 80 1.8 9.9 7.7 726 4.0 4.7 1 
85 41.8 8 
59 89 2.7 9.9 7.6 552 3.7 4.9 76 31.2 7 
60 62 1.3 1 9.9 1.8 357 2.6 2.9 
90 40.1 12 
61 51 2.1 2.4 5.1 1 257 3.2 3.7 86 89.0 6 
62 22 6.0 6.3 10.2 331 3.6 4.6 78 75.2 8 
63 78 2.4 4.9 7.5 454 4.1 4.9 84 99.4 3 
64 999 9.9 9.9 99.9 9999 9.9 9.9 99 999.9 99 
65 999 9.9 9.9 99.9 9999 9.9 9.9 99 999.9 99 
66 999 9.9 9.9 99.9 9999 9.9 9.9 99 999.9 99 
67 999 9.9 9.9 99.9 9999 9.9 9.9 99 999.9 99 
68 999 9.9 
1 9.9- L 99.9 1 9999 9.9 9.9 99 9 ý9-ý- 9 99 
2-2 
Newdata 
hadd4 pmf4 ppf4 epf4 emf4 wessely4 psqia4 psqib4 psqi64 hsqpf4 
35 99 999 999 999 999 99 99 9 9 999 
36 99 999 999 999 999 99 99 9 9 999 
37 7 999 999 999 999 99 99 9 9 999 
38 7 50 50 50 50 10 10 1 0 95 
39 99 999 999 999 999 99 99 9 9 75 
40 7 47 73 85 49 26 3 0 0 55 
41 6 50 55 55 50 11 5 0 0 80 
42 10 98 90 95 97 34 11 1 0 40 
43 6 71 72 91 93 3 7 0 0 45 
44 99 999 999 999 999 99 99 9 9 
999 
45 99 999 999 999 999 99 99 9 9 999 
46 99 999 999 999 999 99 99 9 9 999 
47 99 999 999 999 999 99 99 9 9 
999 
48 10 34 60 59 55 14 3 0 0 
65 
49 4 50 48 57 50 1 3 0 
0 100 
50 99 999 999 999 999 99 9 
9 9 999 
51 10 24 27 42 61 19 8 
1 0 95 
52 99 999 999 999 999 99 99 
9 9 999 
53 99 999 999 999 999 99 99 9 9 
999 
54 1 50 50 50 50 18 2 0 0 80 
55 4 50 62 63 53 31 9 1 0 40 
56 55 55 77 76 12 3 0 0 70 
57 1 50 72 94 51 27 5 0 0 60 
58 5 65 65 63 67 28 6 0 0 85 
59 6 52 50 150 57 57 17 0 
0 0 95 
60 8 63 100 96 75 24 7 
0 1 35 
61 7 71 80 go 84 27 1 0 
0 60 
62 5 57 66 66 56 25 10 0 
1 60 
63 1 52 I 61 65 55 23 4 0 
0 75 
64 99 999 999 99 999 99 99 9 
9 999 
65 99 999 999 999 999 99 99 9 
9 999 
66 99 999 999 999 999 99 99 9 9 999 
67 99 999 999 999 
'1 
999 99 99 9 9 999 
68 1 99 999 999 999 'i 999 
11 99 
- 
99 
- 
9 9 999 
2-3 
Newdata 
hsqrp4 hsqbp4 hsqgh4 hsqvi4 hsqsf4 hsqre4 hsqmh4 baskey4 skida4 
35 999 999 999 999 999 999 999 99 99 
36 999 999 999 999 999 999 999 99 0 
37 999 999 999 999 999 999 999 99 2 
38 75 84 35 50 88 67 76 0 0 
39 50 54 40 30 63 loo 80 99 0 
40 50 90 47 35 63 100 84 6 0 
41 75 90 52 60 100 999 76 6 0 
42 0 52 25 10 38 33 52 14 9 
43 0 10 30 20 38 100 76 17 99 
44 999 999 999 999 999 999 999 99 99 
45 999 999 999 999 999 999 999 99 99 
46 999 999 999 999 999 999 999 99 99 
47 999 999 999 999 999 999 999 99 99 
48 0 41 52 40 50 66 44 11 0 
49 100 90 67 80 100 100 96 2 99 
50 999 999 999 999 999 999 999 99 99 
51 100 52 67 70 88 33 60 11 99 
52 999 999 999 999 999 999 999 99 99 
53 999 999 999 999 999 i 999 999 99 0 
54 100 90 77 90 100 loo 96 0 0 
55 0 74 50 50 33 76 4 0 
56 75 74 77 85 80 66 67 5 0 
57 0 31 67 35 100 loo 100 19 0 
58 0 74 45 50 60 66 84 5 0 
59 100 84 100 75 100 100 84 4 0 
60 25 47 15 15 38 33 44 8 9 
61 0 62 72 15 50 100 84 16 0 
62 0 84 40 30 13 100 92 5 0 
63 50 41 15 55 63 100 92 6 0 
64 999 999 999 999 999 999 999 99 99 
65 999 999 999 999 999 999 999 99 9 
66 99 9 999 999 999 999 9991 999 99 99 
67 999 1 999 999 999 999 999 999 99 99 
68 999 999 999 999 999 999 999 99 99 
2-4 
Newdata 
skidb4 cgio4 
1 
cg! d4 cgip4 
35 99 9 9 3 
36 0 9 2 2 
37 0 9 4 4 
38 0 9 3 3 
39 0 9 9 9 
40 0 9 9 9 
41 0 9 9 2 
42 0 3 3 3 
43 99 9 9 9 
44 99 9 9 9 
45 99 9 9 9 
46 99 9 9 9 
47 99 9 9 9 
48 0 9 9 9 
49 99 9 1 1 
50 99 9 9 9 
51 99 9 9 1 
52 99 9 9 9 
53 0 9 5 5 
54 0 1 1 1 
55 0 9 2 3 
56 0 9 1 1 
57 0 4 4 3 
58 0 2 1 1 
59 0 1 1 1 
60 0 2 2 2 
61 0 3 2 2 
62 0 2 2 
63 0 3 2 2 
64 99 9 9 9 
65 0 2 9 
66 99 9 9 9 
67 99 9 9 9 
68 99 9 9 9 
2-5 
